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Summary
Inappropriate hospital admissions are defined as those which do not result in health
benefit for the patient or in such benefit that could have been obtained on a lower
care level. Studies from many parts of the world have reported high rates of such
admissions. It is commonly believed that they represent a potential for significant
cost reductions. However, this assumes that they can be identified at the time of
admission, and, furthermore, that their cost is comparable to that of appropriate
admissions. These assumptions were investigated in the Department of Internal
Medicine at the University Hospital of Tromsø.
At present, any intervention to reduce inappropriate admissions would have to
involve clinical judgement in one way or another. To explore the feasibihty of this
approach, two panels of experienced clinicians used a two-round structured
consensus method for assessing the appropriateness of consecutive admissions to
the department during a six-week period. Both panels consisted of an internist, a
surgeon and a general practitioner, who were all board-certified. The panels first
tried to predict the appropriateness of the admissions solely from the information
available at the time of admission. After discharge, they then made a final judgement
of appropriateness with the additional information collected during the stay. To avoid
bias, one panel made the predictions and the other panel the final assessments for
half of the admissions, and vice versa for the other half. The assessments of
appropriateness were based on estimates of gains in life expectancy and quality of
life, and of necessary care level. The direct costs to the hospital of each stay were
estimated.
To explore the agreement between the panels, a 10% random sample ofthe
included admissions was assessed by both panels after discharge. This
demonstrated reasonable agreement about the assessments of health-related
benefits and appropriateness.
As judged by the panels after discharge, about one quarter of the admissions were
inappropriate. The health benefits were very unevenly distributed across the
appropriately admitted patients. A few patients had gains corresponding to life
during or shortly after the hospital stay. The mean cost of the inappropriate
admissions was less than half that of the appropriate, and the inappropriate
admissions only accounted for 12% of the total costs.
When trying to detect inappropriate admissions on the basis ofthe information
available at the time of admission, the panels performed poorly. Only about a quarter
of the admissions judged inappropriate in the final assessment after discharge was
identified. About a tenth of the appropriate admissions was falsely classified as
inappropriate. The savings from denying care for admissions considered
inappropriate at admission, would have been modest. Health losses would have
occurred because some patients with health benefits would not have been admitted.
Compared to other medical interventions accepted as cost-effective, the potential
cost savings were small relative to the potential health losses.
It is concluded that efforts to reduce inappropriate admissions based on predictions
of health benefit and care level at admission are unlikely to result in savings that will
justify the health losses.
1. lntroduction
The purpose of health care is to attain a state of “complete physical, mental an
d
social weIl-being and not merely the absence of disease or infirmity, as ambitiously
formulated in the World Health Organisation’s definition of health [1]. Although it is
recognised that health care is less important for this goal than political and soci
al
conditions, the expenditures for health care are increasing steadily in all parts of
the
world [21. In Norway, they rose from 4.6 % ofthe gross domestic produc
t in 1970 to
7.9 % in 1996. The corresponding percentages for the USA were 7.2 and 14.2,
which
were the highest in the world.
Parallel to this development, progress in medical science is creating a higher
demand for health care. A gap is emerging between what is technologically possib
le
and what society can afford. Already, in many situations, limited resources rather
than limitations in medical technology decide what can be done for patients. This
challenge has been met with various strategies for efficiency improvement, priorit
y
setting and cost-containment. While there is debate about which strategies should
be implemented, all seem to agree that health care that does not improve healt
h
should be reduced as much as possible, and that health care resulting in only
marginal health benefits may have to be rationed. It is widely believed that the
reduction of so called ineffective or inappropriate health care could lead to
considerable savings which would allow us to provide better care for other patien
ts
[3-5].
This belief provided the starting point for the Tromsø Medical Department Health
Benefit Study, which focused on inappropriate hospital admissions to a department
of internal medicine. The study was designed to investigate the relationship betwe
en




2.1 The effectiveness of medical care
Researchon inappropriate health care must be seen within the context of the debate
about the effectiveness of medical care in general, which has been going on since
the I 950s. Some of the most extreme critics of medical care have claimed that it has
very littie or even a negative effect on population health [6-10]. These claims were
supported by studies which indicate that health care has less effect on mortality and
morbidity than political and social factors [11-15], and by more anecdotal evidence
like the reduction in mortality observed during a doctors’ strike [16]. Others have
vigorously defended medical care against these affacks [17-22]. Studies have shown
that the mortality from diseases amenable to medical treatment has declined [23-25],
and the point that mortality may be a poor indicator of the effects of modern medicine
has been made [26-28].
An important implication of the criticism of medical care is that much of it may be
unnecessary or inappropriate. Studies of different kinds of inappropriate health care
will be reviewed in the following sections.
2.2 Inappropriate health care - terminology
There is no universally accepted definition of the term ‘inappropriate health care” in
the literature although it is commonly used about care that provides no health benefit
for the patient. Other terms are used for specific instances of such care, as eg.
‘inappropriate hospital days”. Though the subject of this thesis is inappropriate
admissions to hospitals, literature on both inappropriate admissions and other related
kinds of inappropriate health care will be reviewed.
2.3 Geographical variations in health care
Many studies have shown that there are geographical variations in care which cannot
be readily explained by medical factors. These variations have been taken as
indicators of inappropriate health care. The most important have been studies of
variation within small geographic areas. In a series ofstudies from USA, Wennberg
et al found large variations in hospital days, hospital discharges and surgical
procedures per 1000 persons in Vermont [29], and, later, in health care expenditures
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per capita between Boston and New Haven [30]. These differences were not
associated with different mortality rates in the two areas [31]. Other investigators
have found significant variations in the rates of surgical procedures [32,33] and in the
rates of both medical and surgical procedures [34]. The same findings have been
demonstrated in other developed countries [35]. Geographical differences in the
utilisation of hospital care, rates of surgical procedures and use of perioperative total
parenteral nutrition have also been reported from Norway [36-381.
lt is difficult to explain these variations by differences in the incidence of disease [39].
Rather, it has been hypothesised that they are caused by differences in physicians’
practice patterns. The greatest variations have been found for conditions for which
there is disagreement about diagnosis and treatment [29,30,34]. This has been
called the ‘professional uncertainty hypothesis” [40], and more research is called for
to fill the gaps in medical knowledge that presumably are the most important causes
ofthe variation [41].
A recent study investigated small area variation for a longer time period and
compared different methods of analysing the data. It was shown that the magnitude
of the variations depended on both the method of analysis and the time period,
indicating that the smalt area-variation in hospitalisation rates may vary substantially
less than has been previously reported [42].
2.4 Inappropriate medical interventions
lt has been discussed to what extent the small area variation in care is caused by
inappropriate use of interventions for which there is reasonable agreement about the
indications. This issue has been explored by the RAND-UCLA Health Services
Utilisation Study (HSUS), where consensus about appropriate indications for six
medical and surgical procedures was developed by panels of expert physicians [43-
45). Using these criteria, the authors found that 17% ofthe coronary angiographies,
32% of the carotid endarterectomies and 17% of the upper gastrointestinal tract
endoscopies were inappropriate, but that this could not explain the geographic
variation in the use of these procedures [46). Another study by Leape et al reached
the same conclusion [47].
The rates of inappropriate procedures reported in other studies vary. In the UK, the
rates for cardiovascular procedures were similar to those in the RAND-UCLA HSUS
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[48]. A study of second opinion of coronary angiographies for patients with stable
angina pectoris in Boston indicated that 50% of these procedures were unnecessary
or could be postponed [49]. In New York, lower percentages of inappropriateness
were found in a later study of coronary angiography (4%) [50], coronary artery
bypass graft surgery (2.4%) [51] and percutaneous transluminal coronary
angioplastys (4%) [52], but many procedures were carried out on uncertain
indications (20%, 7% and 38% respectively). Similar low rates of inappropriateness
have been reported from a consortium of academic medical centres in the USA [53]
and in Sweden [54].
Though some see these studies of inappropriate health care as heralding a
revolution in health care [4], others have attacked their methodological foundations
[55]. The theoretical basis of the “appropriateness” concept has been questioned
[56] as well as the method useci for establishing appropriate indications [57]. Data on
the method’s sensitivity and specificity have been called for, and it has been
suspected that the rate of procedures falsely judged inappropriate may be high [58].
2.5 Inappropriate hospital days
Other investigators have focused on inappropriate days spent in hospital. This was
the purpose of the Appropriateness Evaluation Protocol, which was developed in
1981 by Gertman and Restuccia [59]. The implication was that such days could be
eliminated and costs reduced. An inappropriate hospital day was defined as one
where..
.patients receive either services that provide no significant benefit or services that could be rendered
in a less costly lower-level institutional or outpatient setting.”[59]
The Appropriateness Evaluation Protocol is a screening tool consisting of a
diagnosis-inciependent set of criteria for review of medical records by nurses. It has
been validated both against the judgement of one physician reviewer [59] and panels
of physicians [60,61], and has been found reliable in several studies [59-66]. Using
this instrument, rates of inappropriate hospital days ranging from 8 to 15% in
Switzerland [67], 28 to 49% in Italy [68], 15 to 44% in Spain [69], 46% in Portugal
[70], 12 to 39% in USA [60,71] and 29% in South Africa [63] have been found in
different types of hospitals and departments.
12
2.6 Inappropriate hospital admissions
The first studies of hospital admissions characterised as inappropriate’ or judged to
confer the patient no health benefit appeared towards the end of the 1 950s. One of
the earliest was Crombie and Cross’ study of patients in the medical wards of a
Birmingham general hospital. They conclucied that a quarter of them had ‘. . . no
diagnostic or therapeutic requirements at hospital level” [72]. Several studies were
carried out in the 1960s, finding percentages of inappropriate admissions ranging
from 1.6 to 50 in different types of hospital departments [73,741. Most of these
studies used some form of physician judgement for detecting inappropriateness.
In the USA, concern over the rapid rise in expenditures for the Medicaid and
Medicare programs led to the establishment of Professional Standards Review
Organisations for performing utilisation reviews in hospitals by the early 1970s [751.
These reviews included studies of inappropriate admissions. Atter several attempts
to find a reliable method for detecting such admissions, the Appropriateness
Evaluation Protocol was developed by Gertman and Restuccia in 1981 [59].
Originally, the protocol was only intended to measure inappropriate days of hospital
stays, as mentioned above, but was later established as a tool for admissions as weIl
[66](Table 1). It has been valiciated against the judgement of physician reviewers
[60,61]. At about the same time, other similar sets of criteria were developed [61],
but have been less used than the Appropriateness Evaluation Protocol, judged from
the number of published studies.
In 1987, Payne reviewed the results of investigations of inappropriate admissions in
the USA [71]. She found percentages of inappropriate surgical and medical
admissions ranging from 10 to 40 in studies that had used the Appropriateness
Evaluation Protocol. In the late 1980s, the Managed Care Appropriateness Protocol
was developed on a commercial basis by one of the originators of the
Appropriateness Evaluation Protocol [75]. In a MEDLINE search, I was not able to
find any studies using this instrument.
Since 1990, few studies of inappropriate admissions in the USA have been
published. On the other hand, there are numerous stud ies using the Appropriateness
Evaluation Protocol from other parts of the world. Six per cent inappropriate
admissions were found in a teaching hospital in Australia [76]. In Europe, the
protocol has been used in a co-ordinated effort to assess inappropriate admissions
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by the European Union [77,78]. Using various modifications of it in different kinds of
hospitals and ciepartments, percentages of inappropriate admissions ranging from
1.3 to 25 were found in Portugal, Spain, Italy, Switzerland and France [67-70,79]. In
Britain, the Bed Study Instrument, a ciosely related instrument, has been used in
some studies where Iow rates of inappropriate admissions have been found, in one
study less than 1% [80]. This study has later been criticised on methodological
grounds [81]. A recent study from the UK found approximately 20% inappropriate
emergency admissions to a ciepartment of general medicine and care of the elderly
[82].
In Norway, three studies have assessed the appropriateness of admissions to
departments of internal medicine as judged by the attending physicians. Mosvold et
al investigated whether admissions to Aker Hospital in Oslo could have been
avoided. This was found to have been the case for 19% ofthe admitted patients [83].
In a later study from the same hospital, the percentage had dropped to 4 [84]. Even
though the first study was referred to in a publication from the latter [85], the
difference between the two studies was not commented. øie et al let cfischarging
physicians assess whether admissions to the department of internal medicine at the
Diakonissehjemmet Hospital in Bergen could have been avoided. This was found to
have been the case for 42% [86]. An observation unit was specified as one of the
alternatives to admission. If stay in such a unit had been defined as an adm ission,
the percentage would have decreased to 20.
These three studies used a form of clinical judgement calleci implicit review, i.e.
explicit criteria were not used [71]. Three other studies from the northern part of
Norway did use criteria for health benefit to evaluate admissions to departments of
internal medicine at local hospitals. Sander found that 48% of the patients admitted
to Kirkenes Hospital did not achieve any benefit as judged by one reviewer according
to three criteria for benefit [87]. Fram Narvik Hospital, Seip et al reported that only i
of 600 patients did not benefit [88]. This study did not specify its method for
assessment of benefit. In 1983, Syse et al repeated Sander’s investigation at
Kirkenes Hospital. They included a study of the agreement between two reviewers
using Sander’s criteria and found a kappa-statistic of 0.53. Thirty-five per cent of the
patients experienced no benefit [89], which was not very different from Sander’s
result.
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2.6.1 Factors associated with inappropriate hospital admissions
In 1987, Payne reviewed factors associated with inappropriate hospital admissions
[71]. She found that none of several patient characteristics tested in the reviewed
studies were consistently associated with inappropriate admissions. Sju et al
investigated the effect of cost sharing by the patient on the rate of inappropriate
admissions. No significant association was found, but cost sharing was found to
reduce the rate of appropriate hospitalisation [60]. In the same study, there was a
significant higher percentage of inappropriate admission of women [90J. In a more
recent study, Perneger et al studied factors in the patient’s social situation
associated with inappropriate admissions in Switzerland. Better physical functioning
of the patient, lower mental health status of the patient’s spouse, receipt of informal
help from family or friends, and hospitalisation by one’s own physician, were found to
predispose [91].
No hospital characteristic has consistently been found to be associated with
inappropriate admissions, though one study dici find an association between
inappropriate admissions and number of beds in the hospital, and another with
shorter length of stay [71]. Physician characteristics may be important as ane study
has reported great variation in the rates of inappropriate utilisation among physicians
within hospitals, and a significant effect of informational feedback [66,71]. One study
also found a higher percentage of inappropriate admissions by physicians licensed
for more than 15 years [90].
Three studies of inappropriate admissions according to diagnostic category found
wide variation in rates. Diseases of the blood and blood forming organs,
myeloproliferative disorders and digestive disorders had high rates in all ofthe
studies, while disorders of the eye, infectious and parasitic disease, pregnancy and
trauma had low rates [71].
Two studies did not find any association between admission rates and rates of
inappropriate admissions in different geographic regions in the USA [60,92].
2.7 The cost of inappropriate health care
Few studies of inappropriate health care have investigated its cost, but same studies
have explored the association between indicators of inappropriate health care and
cost. Most of these have been carried out in the USA.
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2.7.1 Poor prognosis and high cost
Several studies have examined the relationship between cost and survival from a
hospital perspective. Schroeder et al made a follow-up study of the 13% of patients
with the highest charges from fine acute-care hospitals in the San Francisco Bay
area in 1976. After two years, 34% of these patients had died [93,94]. Zook and
Moore examined outcome at discharge in relation to charges for a random sample of
patients at six different hospitals in the same year. They found that 20% of the
patients with charges greater than the 8O centile died in hospital, as contrasted by
4% of the rest [95]. Pompei et al also found a high mortafity for patients with high
costs in a medical service at a New York Hospital in 1984 [96].
These studies suggest that the average cost of patients with a poor short- or long
term prognosis is higher than for other patients, which could indicate a waste of
resources. This issue has been investigated more directly in several studies from
intensive care units in the USA and in some studies from Europe. The reason for the
special interest in these departments in the USA is that there are more intensive care
unit beds per inhabitant here than in any other country [97].
Detsky et al investigated hospital charges for survivors and non-survivors in a
general combined intensive and coronary care unit from 1977 to 1979. He found that
the charges of the 9% who died were about the double of those who survived. These
9% incurred 17% of the total charges in the study period [98]. Higher costs for non
survivors in a medical intensive care unit were also found by Fedullo et al for some
age groups, but only small differences when the total hospital charges were
compared [99]. In 1984, Oye et al found that the high-cost 8% of patients in a
medical intensive care unit used as many resources as did the low-cost 92%. The in-
hospital mortality was 71% in the first group and 20% in the second, and this
difference was statistically significant [100]. Similar results have been reported from
studies of intensive care units in Sweden, Germany and Spain [101-103].
High costs have also been found for cancer patients. Schapira found that about three
fourths of cancer patients admitted to an intensive care unit spent less than three
months at home before dying, and that the cost of one additional life year for this
group was USD 82,000 for patients with solid tumours and USD 190,000 for
haematological cancers [104]. In Finland, Holli and Hakama found that patients with
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breast cancer who died received more treatment than survivors. This study did not
include a cost analysis [105].
2.7.2 Med ical costs at the end of life
Since the introduction of Medicare and Medicaid in USA in 1965, several studies
have explored the relationship between survival and reimbursement by these
services. They have uniformly reported that a disproportionately high percentage of
the expenditures are used by enrolees in their last year of life [106]. Lubitz and
Prihoda found that, in 1978, the 5.9% who died accounted for 28% of Medicare
expenditures. Furthermore, the intensity of resource utilisation increased as death
approached, so that 46% of the costs in the last year of life were spent during the
last 60 days [107]. This pattern has persisted [108,109], and similarfindings have
been made in other developed countries [110,111]. The implication is that a patient
with short survival in spite of high costs has only had small benefit from whatever
med ical care he has received, and that these resources may have been wasted.
It was generally found that most of the costs incurred in hospitals. However, when
the distribution of costs were studied, few of the decedents had had costs that would
indicate treatment in intensive care units or similar costly life-supporting treatment
[1 07,1091. Consequently, the high average cost resulted from standard hospital
treatment with higher cost than for those who survive. Other studies have shown
wide variation with different causes of death, cancer being the most costly [112].
These studies did not investigate whether the care delivered to dying patients was
appropriate, i.e. whether these patients experienced improvement in quality of life or
at least some gain in life expectancy. In one small study, Scitovsky related the cost
of health care in the last year of Iife to the patients’ functional status. She found that
though the total cost was not influenced by the patient’s degree of impairment, the
cost of hospital care was markedly lower for patients with low scores for activities of
daily living, instrumental activities of daily living and cognitive status [113]. Instead,
these patients incurred higher costs for home health care and in nursing homes. If it
is assumed that these impaired patients had a lower probability than others of
achieving health benefits from more intensive treatment, these findings indicate that
health care for the dying may be more appropriate than is commonly believed.
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2.8 Inter.’entions to reduce inappropriate health care
In the USA, different strategies for cost containment in health care have been
implemented. Many of these are parts of so-called utilisation review, which
“encompasses a broad, heterogeneous group of interventions, most commonly
involving the prospective review of decisions to admit patients to hospital and
perform certain procedures, but also including concurrent evaluation of inpatient care
and of the management of high-cost cases.”[l 14]. Utilisation review has grown into a
industry of its own, and its effect on medical care has been explored in several
studies. There is some evidence that utilisation review can reduce hospital costs,
mostly through reducing the number of admissions [115-117] and by shifting some of
the costs to outpatient care [118]. However, as several investigators point out, Iittle is
known about how this affects the quality and outcome of care. Even if utilisation
review programs are meant to reduce only inappropriate care, one study has
suggested that the reduction is more an unspecific effect of being reviewed than of
the application of the criteria in the program [119]. This could indicate that
appropriate hospital utilisation is being reduced as weIl.
In at least two studies, the Appropriateness Evaluation Protocol has been part of the
utilisation review. One of these found a reduction in the mean percentage of
inappropriate admissions to six hospitals from 6.9 to 3.3 after the program had been
implemented [74]. However, in a controlled trial, Payne et aI found no effect of
feedback about the rate of inappropriate admissions to 11 hospitals in
Massachusetts, although there was a general decline in the percentage of
inappropriate admissions during the study period [120].
In Israel, two controlled studies of interventions to reduce inappropriate hospital days
have been performed for medical [121] and paediatric patients [122]. The
intervention consisted of the requirement that patients who did not fulfil the criteria of
the Appropriateness Evaluation Protocol for an appropriate hospital day should be
discharged unless a consultant gave his consent to a continued stay. The studies
found a reduction of inappropriate days in both the study and control groups, but
greater in the study group. Because of methodological limitations of the studies,
these results are difficult to interpret.
Other studies have assessed the potential for savings by reducing unnecessary and
excessive care at the end of life. One approach has been to promote the use of
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advance directives which are given by patients to avoid futile life supporting
treatment against their wishes. However, Teno et al found that an intervention which
increased the documentation of such directives did not decrease hospital resource
use [123]. In the same study, she demonstrated that the savings from reducing
interventions for patients at high risk of imminent death would only be modest [124].
An intervention to save resources through improved communication about
preferences for treatment between physicians and patients at high risk of dying was
ineffective [125]. Emanuel anci Emanuel reviewed the results ofthese and other
strategies for cost reductions at the end of life and concluded that the savings were
unlikely to be substantial [126].
2.9 Summary of the literature review
• There is great variation in the rates of inappropriate health care across different
studies. This applies both to interventions and to hospital stays. Some ofthis
variation is probably caused by differences in definitions and methods. However,
few investigators have reported rates below 10%. High rates have been reported
for both surgery and internal medicine and from countries in all parts of the
developed world. This indicates that health care which does not result in health
benefit for the patients is a serious problem.
• Several studies have shown that a large share of health care resources are used
on patients with short life expectancy. This applies both to patients hospitalised in
intensive care units and to patients at the end of life. While most of these studies
have been carried out in the USA, similar results have been found in several
European countries. Since these patients could only have achieved limited health
benefit from whatever interventions they had undergone, the implication is that
resources were wasted.
• In the USA, rates of hospital admissions and costs have been reduced through
various forms of utilisation review, but it has not been convincingly demonstrated
that interventions specifically targeting inappropriate admissions can obtain
savings. lt is also doubtful whether it is possible to save resources for care at the
end of life.
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2.10 Limitations ofprevious studies of inappropriate hospital admissions
Cost analyses to quantify the potential cost reductions represented by
inappropriate admissions have not been performed. Some studies have
demonstrated substantial rates of inappropriate admissions without investigating
cost, while others have studied the cost of treating patients with short survival
without making explicit assessments ofthe appropriateness ofthe care delivered.
Short survival after a hospital stay does not necessarily indicate that the
admission was inappropriate, since the patient’s life expectancy and quality of life
might have been worse without admission.
To obtain savings by recfucing inappropriate admissions, it is necessary that they
can be identified as such before oratthe time ofadmission, le. beforethe results
of diagnostic and therapeutic interventions during the hospital stays are known.
None of the referred studies of inappropriate admissions made clear when in the
course of the hospital stay the judgement of inappropriateness was made.
Several of the criteria of the Appropriateness Evaluation Protocol are based on
information that can only be obtained some time after admission (Table 1). It has
not been shown that inappropriate admissions can be identified from information
available at admission with sufficient accuracy to obtain savings while avoiding
health losses from denying appropriate admissions.
Few studies provide a definition of the term “inappropriate hospital admission”.
Those who do, base their definition on the concept “health benefit” [59]. I am not
aware of any study of inappropriate admissions which has included a description
of methods for measuring health benefits. Furthermore, few of the studies use
physicians for evaluating admissions, but instead rely on research nurses and
screening instruments.
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3. Definitions and aims
In this thesis, the following definitions wiII be used:
• Health benefit: lmprovement in life expectancy or health-related quality of life
from a hospital stay relative to a situation without admission.
• Inappropriate admission: A hospital admission which does not result in health
benefit, or which results in health benefit that could have been obtained on a
lower care level.
The aims of the study were:
• Primary aims
To investigate to what extent clinical judgement based on information available at the
time of admission can be used for identifying inappropriate admissions to a
department of internal medicine
To explore whether clinical judgement can in principle be used for reducing
inappropriate admissions and department costs without, at the same time, resulting
in unacceptable health losses.
• Secondary aims
To estimate the proportion of inappropriate admissions, and the share of the total
costs that they represent, in a department of internal medicine.




During a six week period from 1st February 1993, all 521 admissions to the
department of internal medicine at the University Hospital of Tromsø were eligible for
inclusion in the Tromsø Medical Department Health Benefit Study (Figure 1).
Patients are sometimes transferred for administrative reasons after having been
treated in other university hospitals. These patients were excluded (n=3), as were
also patients admitted to the clinical research unit (n=2) and one patient whose
medical record could not be found. Readmissions occurring in the study period that
had been scheduled during a stay prior to the study period were exciuded (n27).
Most of these patients were admitted for evaluation or continuation of treatment.
Readmissions in the period that had been scheduled during a previously included
stay were merged with the primary admission (n=9). The number of admitted patients
was 462 of whom 17 had 2 separate included admissions, i.e. they had one un
scheduled readmission in the study period. Accordingly, 479 admissions were
included in the study.
4.2 Design
Two expert panels were recruited, each consisting of an internist, a surgeon and a
general practitioner. Using a consensus method with two rounds, they estimated the
health benefit and appropriateness from each admission after discharge on the basis
of comprehensive summaries of all relevant information about the patient. To
investigate the panels’ ability to predict the health benefits, exactly the same
assessments were also made only from information available at admission. In the
following, the former will be termed “discharge assessments” and the latter
admission assessments”. Bias from letting the same panel make both assessments
for the same admission was avoided by using two panels. Each panel assessed half
of the patients at admission and the other half after discharge and vice versa (Figure
2). The patients were randomised to each half using a random number generator. A
10% random sample was drawn to study the agreement between the panels. These
patients were assessed by both panels after discharge.
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4.3 Assessment of health benefit and necessary care leve!
4.3.1 Health benefit
Benefits from hospital stays can be classified according to different criteria. One
distinction can be made between benefits for the patients and benefits obtained by
other persons or society, e.g. relatives. One example is the benefit to society from
isolating a patient with a communicable disease. For practical reasons, we only
assessed benefits experienced by the individual patients.
Another distinction can be drawn between health-related benefits and benefits which
are unspecific effects of hospitalisation, as e.g. the provision of shelter for a
homeless person or relief from a difficult social situation. The latter type of benefit
can be defined as not resulting from specific medical treatment or care. In the
present study, an attempt was made to study both kinds of benefit.
A third distinction is usually made between life expectancy gain (LEG) and gain in
quality of life. In this study, both were estimated and the results presented in Papers
2 and 3. The time trade-off method was used for estimating gains in quality of life
[127]. This technique gives a measure of quality of life ranging from 0 (corresponding
to death or coma) to i (corresponding to full health). Its validity and reliabillty have
been established by others [128]. The questionnaires used forthe assessments are
included in Appendix i and 2, and the details of the procedure explained in Paper 1.
In the Titerature, different reference groups have been used for measuring the quality
of life of health states. It has been discussed which groups should be used, since it is
known that the assessments of patients and e.g. physicians may differ [129].
Torrance says that “..The answer can be determined, in part, from the purpose and
the viewpoint of the study [127]. We wanted to examine the relationship between
use of resources and physicians’ assessments of health benefit, which justifies the
use of physicians’ assessments of quality of life in this study. A more detailed
discussion of this issue can be found in Paper 1.
The two dimensions of health benefit can be combined in a measure of life
expectancy adjusted for quality of life. The most common of these measures is the
quality-adjustedlifeyears (QALY) [130], which measures health outcomes as a
product of gain in quality of life and the number of life years that the patient get to
enjoy the health benefits. One QALY is equivalent to one year in perfect health.
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Although the use of QALY for prioritising has been criticised [131-136], this measure
is now widely used. In the present study, the closely related measure healthy-years
equivalents (HYE) was used [137]. The properties of HYE relative to QALY are
subjectto controversy [1 38-142]. The main difference is that while QALY are based
on health benefits in individual years being valued one by one and then added
together, HYE derive from holistic valuations of life scenarios. The latter approach
allows the valuator to take into account dependence between life years (contextual
effects), for instance the effect of prognosis. However, because it is more weIl
known, the term QALY” was used in Papers 4 and 5.
In principle, all benefits from hospital stays could have been measured in HYE.
However, our application of the time trade-off method had limited sensitivity for
benefits of short duration relative to the remaining lifetime of the patient. To illustrate
this, consider patients treated for chronic renal failure with hospital hemodialysis,
who have been found to have a quality of life around 0.50 in different studies (range
0.41 to 0.58) [1 43-1 47]. A gain of 1 HYE would be equivalent to restoring the life of
one such patient to full health for 2 years, which is a considerable gain. At the other
end of the scale, consider a patient with pain from a galistone attack which has
limited duration and can be effectively treated with drugs. This patient will probably
have a very low quality of life during the attack, e.g. 0.2, but because of its short
duration (e.g. 5 hours), the gain from treating the pain with analgesics could not
exceed 0.0005 HYE, which would have been the gain if the quality of life had been
raised from 0.2 to 1.0 while the attack lasted.
lt would have been very difficult to measure this gain with our application of the time
trade-off technique. For this reason, it was necessary to measure quality of life gains
during or shortly after the hospital stay on an ordinal scale. Separate scales were
used for health-related short-term quality of life gain (HSQG) and non-health-related
short-term quality of life gain (NHSQG). The definitions of the different types of
health benefit estimated in this study can be found in Table 2 and more details in
Paper 3.
Diagnostic interventions sometimes result in a diagnosis without any improvement in
the patient’s health. However, many patients will experience relief by being provided
with an explanation of symptoms and other manifestations of disease. The
elimination of a tentative diagnosis proposed by the referring physician may have the
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same effect. At least one study has shown that patients may be willing to pay for
diagnostic information, even If it does not result in any specific medical
consequences [1481. In the instructions to the expert panels, this type of
improvement in quality of life was explicitly defined as NHSQG.
It may also be argued that obtaining new diagnostic information shouki be regarded
as a benefit, regardless of whether it improves the quality of life of the patient. It is
certainly of value to physicians and the hospital to be able to solve diagnostic
problems, especially from the perspectives of research and education. The clinical
competence gained will benefit future patients. Since this study only aimed to assess
benefits for the included patients, we did not count diagnostic gains alone as a
benefit. However, the experts did assess whether a diagnosis that could explain
disease manifestations had been made.
4.3.2 Health benefit attributable to the hospital stay
To find the gain in HYE (zHYE) attributable to the hospital admission, it is necessary
to consider the patient’s situation in the event that he had not been admitted or
treated elsewhere for his current health problem. The experts therefore made a
separate assessment of the patient’s expected remaining HYE for this situation, and
the gain attributable to the hospital admission was found by subtracting this amount
from the HYE expected after the stay. Assuming that the patients would not have
received treatment if not admitted is unrealistic, since many of them would then have
been treated on a lower care level. This was taken into account by making a
separate assessment of the care level necessary to obtain the health benefit (see
next section).
For patients with chronic conditions, one hospital stay may be only one of several
care episodes which occur over many years and which include treatment in other
departments as well as consultations in the outpatient clinic. All these separate
episodes can be said to be necessary, but none sufficient alone, for obtaining the
health benefit that ultimately results from the patient’s contact with the hospital. Eg.
a patient with diabetes mellitus will have appointments for routine follow-up in the
outpatient clinic as well as stays for complications as diabetes coma, diabetic
nephropathy, diabetic retinopathy etc. The patient will probably achieve health
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benefit from his contact with the hospital, but there is no obvious way to apportion
this benefit to each of the care episodes.
In the present study, we defined the health benefit from an included stay as the
health benefit for which it was a necessary condition. This means that if the stay was
a part of a prolonged contact with the hospital for a chronic condition, the
assessment of health benefit took into account the expected effect of future care for
the same condition. E.g. if a patient with end-stage renal disease was admitted for
the initiation of hemodialysis, the assessment of benefit from this stay presupposed
that the treatment would continue after discharge.
4.3.3 Care level
The concept of appropriate level of care plays a central role in the cost containment
debate. The experts were asked to consider whether patients with health benefits
could have obtained the same gain on a lower care level. They were given the choice
between “primary care”, “outpatient clinic” and “hospital”. This was done as a part of
both the admission and the discharge assessments.
The University Hospital of Tromsø is a tertiary referral hospital, and many of the
elective patients are referred from local hospitals which represent a lower care level.
In this study, no attempt was made to distinguish between different levels of hospital
care.
4.3.4 Data
Both the admission and discharge assessments were made from summaries of
ciinical information which were based on the medical record at admission and the
discharge reports respectively. To ensure that the admission summaries should be
as complete as possible, the project co-ordinator (B.O.E.), who is a board-certified
specialist of internal medicine, checked the medical records for completeness and
obtained missing information from the physicians and nurses in charge ofthe patient.
No information was deleted in the editing process, so that the full text of the medical
record was contained in the summary. The summaries were prepared before the
admissions were randomised. They were blinded for data which could identify patient
or physician.
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After discharge, the same procedure was applied to the discharge reports.
information about planned interventions within two months after discharge was
included. It coud be argued that a Tonger period would have improved the estimates.
While this is certainly true for patients with acute or subacute conditions, only
observation tiI death would have sufficed for some of the patients with chronic
diseases. Since the ength of any period would have been arbitrary, we chose to
make the estimates as soon as possible after discharge.
Both the admission and the discharge summaries typically consisted of from i to 2
typewritten A4 pages. To avoid confusion, the admission summaries were printed on
yellow and the discharge summaries on green paper.
4.3.5 Expert panels and the consensus method
As explained above, the two expert panels made the same assessments at
admission and after discharge, with the difference that information collected during
the stays was available only for the discharge assessments. To investigate whether
the two panels could reach a reasonable leveT of agreement for making these
judgements, a random sample was drawn for assessments by both panels after
discharge (Figure 2). The panels were blinded to which admissions were included in
this sample. Results of the agreement study were reported in Papers 1, 3 and 5.
The consensus method has been used for a wide range of problems where it is
difficult to obtain data by other methods. Its use in medicine has been reviewed by
others [149-1 51]. Our application ofthe method is a modification ofthe nominal
group technique. Hotvedt et al used a similar method in their study of the benefit of
helicopter evacuation, which also included estimates of gains in Tife expectancy and
quality of life [152].
Instead of using three internists, two specialists from other disciplines were chosen.
The experts were required to fulfil three criteria: They should
• be board-certified specialists with long practical experience
• not have any affihiation with the investigated department
• practice in northern Norway, so that they would be acquainted with the conditions
of health care in the region served by the department.
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The experts cannot be considered to be representative of their respective disciplines
in the sense that they were not randomly drawn from the population of all possible
experts. Rather, they were chosen because it was believed that they would be
especially capable of making the estimates required by the study. The justification for
this was that the study aimed to investigate whether the prediction of inappropriate
admissions was possible in principle.
4.3.5.1 Instructions to the experts
At the start of the study, the experts were convened for a thorough review of the
study protocol. The assessment method, and in particular the time trade-off method,
was explained in detail and discussed. The experts also received written instructions
(see Appendix 3).
In some studies, experts have been given reviews of relevant literature, as e.g. in the
RAND-UCLA Health Services Utilisation Study for establishing appropriate
indications for different procedures [43]. This was not possible in our setting, since it
would have involved literature from the entire field of internal medicine. Instead, the
experts were instructed to use the best evidence available in each case: randomised
controlled trials when possible, other empirical evidence or, as a final resort, pure
clinical judgement.
For the assessments of quality of life with the time trade-off method, it was
emphasised that the experts should use the instrument as if they themselves had
been in the patient’s situation, as opposed to making assumptions about what the
response of a particular patient might have been.
4.3.5.2 Pilot study
A pilot study of 10 admissions was performed. This study, which only consisted of
one round, confirmed that the experts mastered the assessment method. From its
result, minor changes to the instruction manual were made (Appendix 3).
4.3.5.3 First round
Essentially the same procedure was used for the admission and discharge
assessments. The admission summaries were sent to the experts within 24 hours
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atter admission, and the discharge summaries when the results of all diagnostic
interventions were avallable.
In the first round, the experts made their individual assessments at home. Agreement
in the panel about a particular admission was defined to exist when all the following
predefined criteria were satisfied:
• the difference between the maximum and minimum LEG estimates did not
exceed 25% of the average estimated life expectancy of the patient after the
hospital stay,
• the difference between the maximum and minimum LQG estimates did not
exceed 0.20
• the HSQG, NHSQG and care level assessments did not differ by more than one
category
• the assessments of diagnostic gain were identical
The cases with disagreement were selected for the second round. For both panels
combined, this amounted to 90% ofthe admission and 84% ofthe discharge
assessments.
4.3.5.4 Second round
In the second round, the three experts of each panel met to discuss the cases with
disagreement. These meetings were led by the project co-ordinator (B.O.E.), who did
not take part in the discussions except to clarify issues related to the protocol. The
admission and discharge assessments were discussed in separate sessions.
At the beginning of the discussion of each case, the project co-ordinator stated which
type of disagreement existed and the assessment of each expert. The experts then
read the summary, and the expert with the most deviating estimate gave the reason
for his or her assessment. The case was then discussed. An attempt was made first
to reach agreement about the patient’s prognosis in medical terms, and then about
the estimates of health benefit. At the end of the discussion, the experts were given
the opportunity to revise their estimates. The median was taken to represent the
panel’s assessment whether agreement was reached or not. For both panels
combined, there was still disagreement accord ing to one or more criterion for 42% of
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the admission and 32% of the discharge assessments at the end of the second
round.
In each meeting, the cases were discussed in random order to avoid bias from
temporal changes in the experts’ estimates as far as possible.
Because agreement had to be reached for several measures, a high percentage of
the cases had to be discussed in round 2. During these discussions, the experts met
in Tromsø for 2 to 3 days at a time. Discussions began at 8 AM and often continued
till 4 PM.
4.4 Cost analysis
Direct costs from the hospital’s viewpoint during the included stays were estimated
using the principles outlined by Drummond et al [153]. When two or more stays were
merged, the costs of all the stays were included. Data for the analysis were obtained
from the hospital’s annual report [154], from the hospital’s computerised account
system, from various clinical databases and from the medical records.
4.4.1 Capital and depreciation costs
Capital costs are not routinely included in the hospital accounts and were not
incorporated in this analysis. Neither does the hospital calculate depreciation costs of
equipment, but lists its cost when it is purchased. These costs were included, but
because considerable variation from year to year can be expected, they were
averaged over the years 1992, 1993 and 1994 for each department. We are aware
that this approach may over-estimate depreciation costs because it also includes
investment in new equipment in addition to renewal of the old. However, the method
was chosen because data for calculating the true depreciation costs were not
available. Since the costs of equipment, renewal and maintenance were only 3.1% of
the hospital’s total costs and 0.7% of the costs of the department of internal
medicine, the error made from using this method was small.
4.4.2 Research and education
Research and education are integral parts of the activities of a university hospital and
may contribute to higher costs than in other hospitals. It was not possible to estimate
these costs separately at the level of the cost centres, and consequently, these costs
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were included in the calculation of unit costs for the patient-related services. Since
research and education of personnel are necessary to produce these services, this
seems justified.
4.4.3 Cost centres
Each clinical service department and each clinical department except the department
of internal medicine were defined as separate cost centres. Each ward of the
department of internal medicine, including the outpatient clinics, geriatric day care
centre and coronary care unit were considered as separate cost centres, as was also
the intensive care unit. The intensive care unit is a part of the department of
anaesthesiology.
4.4.4 Step down allocation of overhead
The step down allocation method with iterations was used to allocate overhead costs
to the cost centres, both for the hospital as a whole and for the allocation of
overhead costs within the department of internal medicine [153]. The allocation basis
was number of employees, square footage, riumber of admitted patients or number
of patient-days as appropriate.
In the accounts, physician salaries were included in the overhead costs of the
department of internal medicine. These costs were deducted from the overhead
costs and allocated to the cost centres in the department according to the actual
assignments of physician Iabour in 1993. The same approach was used for physician
labour in the intensive care unit.
4.4.5 Estimation of unit costs
4.4.5.1 CIinicaI seniice departments
4.4.5.1.1 Radiology, clinical chemistry, microbiology, immunology/haematology,
pharmacofogy, pathology, gastroenterology, dialysis
In the Norwegian health care system, inpatients are not charged directly, and the calculation of the
costs of services by these departments was based on the fee sehedule for outpatients. The total
charges in 1993 of each department according to this schedule were calculated as fall patients had
been outpatients, and the cost-to-charge ratio was found by dividing the department’s total costs atter
allocation of overhead by this amount. The cost of each produced unit was then set at the charge
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according to the outpatient fee schedule multiplied by the cost-to-charge ratio for each department.
Information about department output was found in the hospital’s annual report for 1993.
4.4.5.1.2 Physical and occupationaltherapy, socialworkers, clinical nutrition
For these departments, the cost per patient (social workers) or per consultation (physical and
occupational therapy) was found by dividing the total costs after allocation of overhead by the output for
1993.
4.4.5.1.3 Laboratory ofcardiology
Fees for all the services provided by this laboratory could not be found in the outpatient fee schedule.
Instead, an investigation of actual costs of these services in a similar hospital was used in the same
way as described above [155]. Fees for some services that could not be found in this investigation
were set by clinical judgement after discussion with the head of the section of cardiology. The fee for
percutaneous transluminal coronary angioplasty was set at the fee fixed by the central health
authorities.
4.4.5.1.4 Laboratory of haematology
The total cost of this department was NOK 268,334 (USD 35,778), or only 0.3% of the total costs of the
department of internal medicine. The services of this laboratory were not registered for each patient. lts
costs were includeci in the department’s overhead costs, and as such allocated to the wards according
to number of admissions.
4.4.5.1.5 Laboratory of pulmonary physiology
Of the services provided by this laboratory, only bronchoscopies, which were the most costly, were
registered for the individual patient. The cost of bronchoscopy was calculated as for the other service
departments. Clinical judgement was used for setting the fees of some services which were not found
in the outpatient fee schedule.
4.4.5.1.6 Referrals to other departments
Patients are sometimes referred for evaluation by physicians in other departments. We are not aware
of any commonly accepted method for calculating the costs of such referrals, and they were not
included in the present analysis.
4.4.5.2 Pharmaceuticals
The total cost of each pharmaceutical for the department of internal medicine in
1993 was obtained from the database of the hospital pharmacy. Drugs which
accounted for more than 1% of the department’s total drug costs were identified. The
use of these drugs by each patient was registered from the medical records. The
costs of un-registered drugs were allocated to each patient on the basis of length of
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stay separately for each ward (see section 4.4.6.2). In 6 ofthe medical records, the
drug prescription forms could not be found, but in all cases it was possible to infer
the drugs used from information in the discharge reports.
4.4.5.3 Wards
4.4.5.3.1 Medical wards, including the coronary care unit
For each ward, the allocated overhead costs, the allocated physician labour costs and the nurse labour
costs were divided by the total number of patient-days for 1993 to obtain the cost of one patient-day for
each of these services. The cost of un-registered drugs for the individual patient was found by
subtracting the cost of the registered drugs from the total drug costs of each ward (see previous
section). The result was divided by the total number of patient-days for each ward to obtain the cost of
the un-registered drugs per patient-day.
The ward costs not accounted for by the categories physician and nurse labour, overhead or drugs
were labelled hotel costs” and also divided by the number of patient-days to obtain unit costs.
4.4.5.3.2 Intensive care unit
The costs of this unit were treated in the same way as for the wards. Of the patient-days included in
the study, only 10 were spent in the intensive care unit.
4.4.6 Calculation of cost of each hospital stay
The cost of each stay was calculated as the sum of the cost of resources registered
for each patient, and the cost of resources apportioned to the patients on the basis
of (ength of stay in each ward.
4.4.6.1 Costs of resources registered for each individual patient
For each stay, all diagnostic and therapeutic interventions were registered from the
computerised anci manual databases of the different service departments as well as
from the medical records. The cost of each resource was calculated from the unit
costs. A few resources were not registered:
4.4.6.1.1 Electrocardiograms
Electrocardiograms are routinely taken of all admitted patients. The cost of one was NOK45 (USD 6).
We included the cost of one electrocardiogram for each stay.
4.4.6.1.2 Sternal punctures and bone marrow biopsies
Thesetests were performed bythe aboratory of haematology, see section 4.4.5.1.4.
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4.4.6.1.3 Radiation therapy
Nine patients received radiation therapy in the clepartment of oncology during their stays. The use of
this treatment was not registered for praetical reasons.
4.4.6.1.4 Pharmaceuticals
These were partly registered for each patient from the medical records, partly allocated according to
Iength of stay, as described in sections 4.4.5.2 and 4.4.5.3.1.
4.4.6.2 Costs apportioned according to length of stay
Length of stay in each ward was obtained from the hospital database. The costs of
nursing and physician labour, overhead, “hotel” and un-registered drugs were
calculated separately for each ward, including the coronary care unit and the
intensive care unit.
4.5 Statistical methods
The distributions of LEG, LQG and HYE were highly skewed to the left because of a
high proportion of observations with the value zero. For this reason, statistical
techniques making assumptions about normality of the distributions could not be
used. Neither would any transformation make the distributions more normal because
any transformed distribution would still have the same proportion of observation with
identical values.
The bootstrap algorithm makes no assumption about the distribution of the
observations and can be used for estimating confidence intervals in this situation
[1 56,157]. The algorithm was implemented in a Microsoft Excel spreadsheet, using a
random number generator for obtaining resamples and a simple macro for iteration.
Software made especially for this purpose would have been much faster, but the use
of a spreadsheet has the advantages of rapid implementation and easy debugging.
In multivariate linear regression analyses with one of the abovementioned variables
as the dependent, inspection of the residuals made it clear that their variances were
not constant, and that they were not normally distributed. For the same reason as
above, transformations could not solve this problem. This precluded the use of
ordinary methods for calculating confidence intervals for the regression coefficients
which were therefore also estimated with the bootstrap algorithm.







5.1 Agreement between the expert panels about assessments of healfh benefit
and appropriateness
On inclusion, each admission was given a probability of 0.10 of being randomly
assigned to group I for which discharge assessments were made by both expert
panels for the purpose of studying inter-panel agreement (n=57) (Figure 2). The
results for the assessments of LEG and LQG can be found in Paper 1. These
assessments were ciassified in categories of no/low, intermediate and high gain.
Agreement was measured with the weighted kappa statistics, which was 0.45 (95%
conficience interval 0.18 to 0.73) for LEG and 0.63 (95% confidence interval 0.45 to
0.80) for LQG. This level of agreement is commonly characterised as fair to good”
[158]. It was only slightly Iower than that found for other commonly used clinical
methods [159], and higher than found in a review of agreement of peer assessment
of implicit evaluation of patient-care episodes [160].
To investigate the ability of the panels to identify groups with either high or low gain,
the agreement was also studied with a method based on log-linear models. This
demonstrated better agreement about assessments in the highest and Iowest
categories for both measures.
Paper I also inciuded a detailed description of the methods used for assessing LEG
and LQG, as weII as a discussion of methodological problems.
Paper 3 reported the results of the agreement study for the measures of short-term
quality of life gain, le. the gains in quallty of life below the sensitivity threshold of the
time trade-off method. The weighted kappa statistic for HSQG was 0.70 (95%
confidence interval 0.62 to 0.79) and for NHSQG 0.08 (95% confidence interval -
0.20 to 0.35) (n=57). While there was no agreement about NHSQG, the kappa
statistic for HSQG corresponded to good agreement.
Paper 5 included the result of the agreement study for the assessment of
appropriateness. The overall agreement was 0.75, the kappa statistic 0.41 (95%
confidence interval 0.15 to 0.68), i.e. fair agreement.
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5.2 Health benefits from admissions to a clepartment of internal medicine
Paper 2 and 3 reported the panels’ assessments of the gains in life expectancy and
quality of life for the patients randomised to group 2 and 3 (n=422)(Figure 2).
5.2.1 Gain in life expectancy (Paper 2)
The distribution of LEG was skewed to the left with 61% achieving practically no gain
(<=0.10 years) while 5% had gains of 10 years of more (n=422). The mean LEG was
2.3 years (95% confidence interval 1.7 to 2.8). High age and the disease category
undiagnosed symptoms” predisposed for lower gain in a multivariate regression
analysis, and “endocrinological disease” for high gain. Only one patient was judged
to have experienced loss in life expectancy as a result of the stay.
A probabilistic sensitivity analysis was performed to study the possibility that negative
effects had been under-estimated and positive effects over-estimated. A mean life
expectancy gain of 1.4 years was found when assuming a rate of iatrogenic life
expectancy loss 30 times that observed, with each case experiencing a loss
corresponding to 50% of the average remaining lifetime of a person of the same age
and sex in the general population.
5.2.2 Gain in quality of life (Paper 3)
LQG measured with the time trade-off method also had a left-skewed distribution.
59% had LQG equal to or less than 0.00, while 2% achieved gains >=0.50 (n=422).
The 59% without LQG consisteci of 40% with only HSQG and 19% with no health
related quality of life gain.
In a multivariate regression analysis with LQG as the dependent variable, high àge,
emergency admissions and the diagnostic categories “endocrinological diseases”
and ‘pneumonia and influenza’ were associateci with higher gain (P<0.05). The
categories “undiagnosed symptoms” and cerebrovascular diseases” were
associated with lower gain (P<0.05).
Since there was no agreement about NHSQG, it cannot be excluded that some of
the admissions without health-related benefits may have had improvements in quality
of life as an unspecific effect of hospitalisation.
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5.2.3 Diagnostic gain for patients not experiencing health benefit
In addition to the health benefit assessments, the expert panels assessed whether
the admissions had resulted in diagnostic gain (Appendix i and 2). The result of
these assessments have not been reported elsewhere and are included here for the
sake of completeness. The relation of this type of gain to health benefit was
discussed in section 4.3.1.
The kappa statistic for the assessment of diagnostic gain in the agreement study was
0.57 (95% confidence interval 0.34 - 0.80), i.e. good agreement (n=57). Of the 72
patients without either LEG, LQG or HSQG in group 2 and 3, 38 had received a
diagnosis that provided an explanation of disease manifestations (n=422).
5.3 The relationship between appropriateness and cost
In Paper 4, the LEG and LQG of group 2 and 3 (n422) were expressed as gain in
HYE (zHYE) (the more weII-known term QALY” was used in both Papers 4 and 5).
The mean AHYE was 2.3 per admission, and its distribution is shown in Figure 3.
Seventy-two (17%) admissions resulted in neither zHYE nor HSQG, i.e. in no health
related benefit. Thirty (7%) of the admissions with either type of benefit could have
obtained the same benefit on a lower care level. Consequently, there were 102
(24%) inappropriate admissions.
The direct costs to the hospital from each stay were estimated. The inappropriate
admissions had a Iower mean cost (NOK 18,990 or USD 2,532) than the appropriate
(NOK 43,500 or USD 5,800) (difference USD 3,268; 95% confidence interval 1,025
to 5,511). When adjusting forthe effects ofgender, age, admission category and
diagnostic category in a multivariate regression analysis, appropriate admissions
were still associated with higher costs (P<0.001). The 24% inappropriate admissions
accounted for 12% ofthe total costs.
5.4 Prediction ofappropriateness andpotential for cost reductions
In Paper 5, the sensitivity and specificity for predicting that an admission would be
appropriate were estimated with the discharge assessments as the gold standard
(n=422). The potential costs saved and HYE lost from excluciing the predicted
inappropriate admissions were estimated. Elective and emergency admissions were
analysed separately.
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For elective admissions (n=152), the sensitivity was 89% and the specificity 31%.
Denying admission for the 18% of elective admissions predicted to be inappropriate
would have resulted in savings of 9% of the total costs (95% confidence interval 5%
to 15%). At the same time, 5% of the AHYE from elective admissions would have
been lost (95% confidence interval 1% to 12%). If the sensitivity and specificity had
both been 100%, the numberofelective admissions could have been reduced by
34%, and a cost reduction of 17% would have been achieved.
For emergency admissions (n270), the sensitivity was 88% and the specificity 24%.
Exclud ing the 14% inappropriate emergency admissions would have resulted in
savings of 14% ofthe total costs (95% confldence interval 5% to 26%), and 18% of
the total HYE from emergency admissions would have been lost (95% confidence
interval 6% to 34%). If the sensitivity and specificity had both been 100%, the
number of emergency admissions could have been reduced by 19%, anci a cost
reduction of 10% would have been achieved.
If the predicted inappropriate admissions had been excluded, the savings per HYE
lostwould have been USD 3,910 (95% confidence interval 1,887 to 21,548) for
elective admissions and USD 1,693 (95% confidence interval 474 to 6,525) for
emergency admissions.
A multivariate regression analysis demonstrated differences in the predictions
between men and women for elective admissions. If predicted inappropriate elective
admissions had been excluded, a higher percentage of costs would have been




6.1.1 Validity ofthe health benefit assessments
A measure is sald to be valid if it is unbiased relative to a gold standard. In the
present study, the gold standard for the health benefit assessments would have
been the results obtained by randomising patients to admission or denial of
admission. This would have provided a control group and made it possible to assess
the effects of the hospital stays as such. However, though at least two studies in the
1970s did use this design for selected patients [161,162], practical and ethical
problems made this approach unfeasible in the present study.
Another way of obtaining a control group would have been to bok for patients who
had for some reason been denied admission, but who were otherwise comparable to
the admitted patients. This method has been used in a study comparing the mortality
in an intensive care unit to the mortality of patients who had been refused admission
because it was full or lacked trained nurses [163]. In the present study, it would have
been impossible to obtain a control group of sufficient size, since virtually no-one is
refused admission because of back of capacity. Because of the heterogeneity of the
study population, the number of included admissions would have had to be very high
to ensure comparability between two groups for all relevant variables. Even in the
referred study, there was a difference in case-mix between the two groups.
Accepting that it was not possible to obtain a control group in this study, the second
best method would have been to assess health benefits on the basis of randomised
controlbed trials (RCTs) of the therapeutic interventions the patients had undergone.
For several reasons, this was not possible. First, it is well known that many common
interventions have not been evaluated with RCTs. Ellis et ab estimated that onby 53%
of the treatments used in a department of general medicine were supported by this
kind of evidence [164]; a finding that was later reproduced in a study by Michaud et
ab [165]. Second, though many RCTs use gain in life expectancy as an endpoint, few
have so far included gain in quality of life. Third, there is a difference between
demonstrating a treatment efficacious in the carefully controlled setting of a RCT and
its effectiveness when used in daily clinical work [166]. Last, the patients included in
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RCTs are often not representative of patients seen in clinical practice. In particular,
patients with complicating diseases are commonly excluded, which makes it difficult
to apply the results directly to all patients.
This leif us with methods relying on clinical judgement, which have also been used in
almost all other studies of inappropriate health care [43,59,71]. This does not mean
that clinical judgement was used as opposed to a method based on RCTs. The
experts were instructed to use the best available evidence in each case, preferably
the results of RCTs. However, for cases where there was not sufficient empirical
evidence for making an estimate, the experts had to use their clinical expertise.
The method involved separate assessments of the expected health of the patients
with and without hospital admission, e. assessments of health in the future and in a
hypothetical situation. For same conditions, these estimates can probably be made
with a high degree of accuracy: A patient with meningococcal septicaemia who would
otherwise have died, may be restored to full health after successful treatment. For
other conditions, there will be greater uncertainty: An elderly overweight patient with
diabetes mellitus and manifestations of generalised atherosclerosis discharged after
having been treated with a thrombolytic agent for acute myocardial infarction, would
probably have had a worse prognosis without this treatment, but how great would his
life expectancy gain be? Comorbidity prevents us from applying the results of RCTs
directly to such cases.
There is little reason to assume that this and similar assessments can be made with
a high degree of precision and accuracy compared to the hypothetical gold standard
discussed above [167]. However, we would expect the clinical experts to be able to
make valid judgements on an ord mai scale of broad categories of gain. A similar
assumption about physicians’ predictive abilities underlies all ordinary clinical
practice. Although health gain, taken as the difference between two assessments,
has not been investigated, same studies have examined clinicians’ ability to predict
survival (Table 3). As expected, predictions of length of survival were not very
accurate, but the most of the studies showed a positive correlation between
predictions and actual survival. Several studies demonstrated good discriminative
abilities for assessments of probability of short-term survival. In most of these
studies, the estimates were made by only ane physician. Estimates based on
consensus methods would probably perform better.
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Even if these studies lend some support to the assumption that panels of expert
dllnicians can make rough estimates of health benefit, we cannot deny the fact that
the method used in this study has not been formally validated. The reasons for using
it anyway was threefold:
• At present, there is no other method for estimating health benefit for unselected
patients to departments of internal medicine. An increase in medical knowledge
will hopefufly enable us to make more precise estimates in the future. However,
there wilI probably always remain a gap between the knowledge provided by
research and that needed for assessment of the individual patient. This gap wiIl
have to be fihled by chinical judgement, as also admitted by the proponents of so
cahled Evidence-Based Medicine [183]. Therefore, in studies like the present, we
will most likely never be able to do without dllnical judgement.
• Although assessment of heahth benefit was one of the aims of this study, its
primary aim was to explore whether clinical judgement could in principle be used
for identifying inappropriate admissions at the time of admission (section 3). At
the present, it is difficult to imagine a method for classifying admissions according
to appropriateness without relying on chinical judgement, either directly ar for
vahidating screening inStruments. Consequenthy, assessing appropriateness on
the basis of expert chinicians’ estimates of health benefit seems justified.
• Estimates of the health benefits from health care programs are needed now.
Important decisions about priority setting and resource allocation are made from
surrogate measures of the effect of health care as number of treated patients,
waiting hist lengths and others. It is tacitly assumed that these measures correlate
with the issue of real concern, i.e. health benefit. One good example is the use of
utihisation review in the USA to reduce the number of hospital admissions without
knowing how this affects the health of patients. It seems that an attempt to use
the best, although imperfect, methad we have to assess heahth benefit directly is
worth the effort, and that it is ane useful step forward relative to our present
knowledge. A wise man has said: Imperfect information at the point of decision is
more useful than perfect information after it has been taken”.
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6.1.2 The magnitude and distribution of health benefits
When health benefits were estimated as AHYE and HSQG, the distribution of gains
across the patients was left-skewed. Most patients were judged to have experienced
small benefits while a few obtained gains corresponding to life-saving treatment. The
gain of these few was sa great as to result in a mean 1HYE of 2.3. Because most of
the tXHYE was won as LEG, and little as LQG alone, this result was similar to the
mean LEG.
The mean HYE may seem high compared to other interventions. Wright and
Weinstein recently tabulated the gains in life expectancy from a variety of medical
interventions (Table 4) for use as a benchmark for new interventions. The table was
compiled from publications found by searching MEDLINE [184]. The mean LEG
found in the present study, 27.6 months, was higher than most treatments on the
list. However, information about the effects of many of the more effective
interventions used in internal medicine cannot be found in MEDLINE, simply
because they have never been subjected to controlled trials. Antibiotics for serious
infections, hormone substitution for failure of endocrinological organs and
hemodialysis for renal failure are examples of treatments that are considered to be
life-saving, and which for ethical reasons will never be subjected to RCTs. Table 2 in
Paper 2 shows that several of the patients with the highest gains in the present study
bad received such treatments. One third of the total LEG was achieved by these ten
patients. The patient with the highest gain was an 18 year old woman who was
treated for meningococcal septicaemia. The panel judged the treatment to have
been life-saving and to have gained 63 life years.
There is, however, littie reason to believe that the experts have been able to make
an accurate estimate ofthe mean health benefit measured in HYE. Even so, all kinds
of bias that do not affect the rank order of gain would have resulted in the same
shape of the distribution curve. More confidence should therefore be placed in this
than in the numerical estimates. It is probably characteristic of departments of
internal medicine that the benefits of most patients are small, but that the life of an
occasional patient is saved. I am not aware of other studies of health benefit from
consecutive hospital admissions. It would be interesting to know whether the results
in e.g. a surgical department would be different.
43
HYE and QALY have been developed for measuring and comparing health gains.
Most of the studies using these measures focus on chronic conditions with health
states of stable reduced quality of life. It is significant that 28% (Paper 4, Table 1) of
the admitted patients had gains that were below the sensitivity threshold of the
instrument we used for measuring zHYE. The reason was that the time scales of the
instrument could not register the very small trade-offs made by relatively healthy
persons with temporary reductions in quality of life. For instance, a 20 year old man
with painful tonsillitis from infectious mononucleosis would probably be willing to
trade off very littie of his expected lifetime of 53 years to obtain full health for the 7 to
10 days this condition lasts. If we assume a quality of life of 0.3 for 10 days, the
maximum gain from the palliative treatment avallable for this condition would be 0.02
HYE, which could not have been registered by our time trade-off instrument.
Though time trade-off instruments for measuring temporary reductions in quality of
life exist, I know of no study where it has been used for measuring health benefits as
small as this. Comparing the hypothetical mononucleosis patient to the patient with
the highest gain in our study (63 HYE), there is a difference in gain of 3 orders of
magnitude.
It is important that treatment of conditions of short duration will result in small gains
relative to the high-gainers no matter how severely their quality of life is reduced.
Admitting these patients for hospital treatment is now commonly accepted, but if
rationing on the basis of cost-effectiveness should be implemented, these treatments
would have to have very low costs to defend their place. This seems to be in conflict
with our instinct that acutely ill patients should be treated, and in practical life, other
factors than cost-effectiveness alone may play a role when deciding whether
resources should be allocated to such conditions.
6.1.3 Factors associated with health benefit
In the search for factors predisposing for health benefit, multivariate linear regression
analyses with LEG and LQG as dependent, and age, gender, admission category
and diagnostic category as independent variables, were performed (Paper 2, Table
3, and Paper 3, Table 3). As expected, the diagnostic categories were the most
important regressors. Since the diagnostic categories in the anafyses were
heterogeneous, and comorbidity was not taken into account, little weight should be
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attached to the actual parameter estimates except to demonstrate that diagnosis
matters.
Age was negatively associated with LEG, but the regression coefficient was low
compared to those of the diagnostic categories. An increase in age by 10 years only
decreased the expected LEG by 8 months. The presence of an endocrinological
disease increased the expected LEG by 9.9 years, and undiagnosed symptoms
decreased it by 2.1 years relative to the reference “other”. Accordingly, as judged by
the expert panels, age was not an important determinant of LEG. However, cases
can easily be imagined where age must play a more important role for LEG. The 18
year old patient who was cured for septicaemla no doubt would have had a lower
LEG if she had been 50. On the other hand, for some conditions, e.g. a non-curable
malignant disease, the disease itseif sets the limit for the LEG obtainable by
treatment that has no chance of restoring the patient to full health. This is more
typical of chronic diseases. Presumably, the experts considered most of the cases in
the study to fall in this category. It is, of course, also possible that they under
estimated the magnitude of the negative association between age and LEG.
Age was positively associated with LQG. Again, the regression coefficient was low
compared to those ofthe diagnostic categories. An increase in age of 10 years
increased LQG by only 0.01, while the presence of endocrinological disease
increased it by 0.15.
The regression analyses of LEG and LQG resulted in adjusted R2 of 0.17 and 0.13
respectively, meaning that littie ofthe variance ofthese two measures couid be
explained by the variables in the model. The low precision of our method for
measuring health benefits was also an important source of variation. A more detailed
ciassification of diagnosis and disease severity might have improved the fit of the
model.
6.1.4 Admissions resulting in no health benefit
This study was designed to detect all direct benefits to the admiffed patients. The
results of the agreement study demonstrated that the panels made reliable
assessments about health-related benefits, but that the agreement about non-health
related short-term quality of life gain (NHSQG) was poor. Thus, some of the patients
without health-related benefits may have had benefits from hospitalisation that were
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not caused by specific care or treatment. However, of the 72 patients without health
related gain, none were scored in the category “high” and only 2 in the category
“intermediate” NHSQG. Even allowing for disagreement between the panels, these
72 patients (17%) probably had either no or very little benefit.
In the instructions to the experts, care of the dying was especially mentioned as a
type of benefit that might qualify as NHSQG. However, half of the 20 patients who
died in the hospital were scored for health-related benefits. This probably means that
they received palliative treatment.
The possible reasons why a patient did not achieve health benefit from a hospital
stay are listed in Table 5. The admissions were not classified according to these
categories in the present study. In other studies, significant rates of inappropriate
interventions have been found (see section 2.4). Many patients would also be
expected to fall in the category of no available effective therapy.
6.1.5 latrogenic health losses
In studies from the USA, adverse drug events have been found in 2.4% [185] and
6.5% [186], and adverse events in general in 3.7% [187] of hospital admissions. One
study reported that iatrogenic disease was the cause of 5.4% of hospital admissions
[188], and another iatrogenic illness in as many as 36% of the patients admitted to a
general medical service [189]. The percentages for some patient groups, e.g. the
elderly, may be even higher [190]. There is littie doubt that many of the events have
serious consequences. In the Harvard Medical Practice Study, which reviewed
30,121 patient records, 13.6% ofthe adverse events led to death [187]. In a study
from a department of internal medicine in Norway, adverse drug events were the
probable cause of 11.8% ofthe in-hospital deaths [191]. Two other Norwegian
studies have found percentages of adverse events as causes of admission to
departments of internal medicine of 5 [192] and 7 [193], i.e. ofthe same magnitude
as in the USA.
Health benefits from hospital stays should be balanced against the health losses
resulting from adverse events. The health Iosses detected by the instrument used in
the present study were small. Only 1 admission (0.2%) resulted in a negative LEG of
0.07 years, and only 3 (0.7%) in negative LQG. Although not strictly comparable,
these percentages were Iower than in the studies referred to above. The reason may
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be that most adverse events are minor and have no consequences for patient health
in the long-term. Also, the experts may have been biased towards over-estimating
positive and under-estimating negative treatment effects.
Paper 2 reports a sensitivity analysis of assuming a much higher rate of negative
LEG than observed. Based on data from other studies of adverse events, it was
concluded that the total positive LEG by far outweighed the negative. As LEG
generated most of the AHYE, it follows that the total zHYE was also positive by a
wide margin.
The study did not include an instrument for measuring short-term quality of life losses
from adverse events analogous to HSQG for positive gains. Since many treatments
have high rates of adverse effects, it may be safely assumed that many patients
suffered short-term reductions in quality of life. The important question is whether
these losses outweighed the benefits for some of the 28% who were judged to have
had only HSQG (Paper 4, Table 1), and, consequently, whether this percentage was
over-estimated. If so, the percentage of admissions without health benefits may have
been under-estimated.
6.1.6 Carelevel
If a patient did achieve health benefit, the experts considered whether the same
benefit could have been obtained in primary care or in the outpatient clinic.
Accordingly, the assessments of necessary care level depended on the assessments
of health benefit, and the kappa statistic for the agreement between the panels about
this measure would incorporate the disagreement about both health benefit and care
level. This was solved by estimating kappa for the combined judgement that the
patient either had experienced no HYE or HSQG, or that the same gain could have
been achieved on a Iower care level. This corresponds directly to the definition of an
inappropriate admission used in this study (section 3). Fair agreement was found for
this assessment (kappa 0.41).
For one of the benefit measures (NHSQG), the kappa statistic indicated no
agreement between the panels. Though this measure was excluded from further
analysis, disagreement about this measure could possibly have influenced the care
level assessments and thereby lowered the kappa statistic for the combined
judgement considered above. This could have happened if a panel had made the
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judgement that, for some patients, hospitalisation was necessary for NHSQG, but not
for AHYE or HSQG. However, this combination of assessments seems very unlikely,
and it is a reasonable assurnption that the disagreement about NHSQG did not
influence the agreement about appropriateness to any noticeable extent.
The panels judged 24% of the admissions to have been inappropriate (17% had had
no health benefit and 7% could have been treated on a lower care. level). In
comparison, studies from the USA have found percentages of inappropriate hospital
admissions ranging from 10 to 40 with most observations in the interval 10 to 20 (see
section 2.6). Cur percentage was slightly higher. It was also higher than the results in
most European studies, where percentages from 1.3 to 25 were found. However, the
percentage was Iower than in the two investigations from Kirkenes Hospital (35 and
48%) [87,89].
6.2 Cost
6.2.1 Appropriateness and cost
An important finding ofthe present study was thatthe inappropriate admissions had
a fower mean cost than the appropriate. In a sensitivity analysis, this result was
robust to variations in the estimates of unit cost. A multivariate linear regression
analysis indicated that it was also independent of gender, age, admission category
and diagnostic category. The regression was repeated without three appropriate
admissions with lengths of stay of more than 6 months and very high costs. In this
analysis, the regression coefficient for the appropriateness-variable was virtually
unchanged and its P-value 0.0001. Repeating the analysis after changing the status
of these three admissions from appropriate to inappropriate also gave essentially the
same result.
Since the expert panels had information about the use of ancillary resources and
length of stay when assessing appropriateness, the possibility of information bias
from differential misclassification of appropriateness relative to cost must be
considered. The expert panels might have been biased towards classifying stays
using more resources as appropriate. This possibility was discussed in Paper 4,
where it was concluded that the observed difference in mean cost was too large to
be explained by this type of bias.
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6.2.2 Limitations of the cost analysis
In the cost analysis, the use of resources was registered for each individual patient.
Because it was impossible to perfarm on-site registration for this large number of
patients, we could only register use of resources fram the medical records and the
hospital databases. “Hotel”, and physician and nurse labour costs had ta be
allocated on the basis of ength of stay, except for the labaur costs included in the
unit costs of ancillary services as e.g. gastroscopy or hemodialysis.
Since nursing was the second most important cost, the error made by this method
could be substantial. Obviously, the use of this resource varies greatly acrass
patients and should preferably have been registered for each individual. It was
considered whether ta use the nursing costs of the patients’ DRG as basis for
allocating these costs, but in the Norwegian version ofthe DRG-system, nursing
costs have been based an clinical judgement and not on an investigatian of actual
use by patients [194]. In the present study, nursing casts were allocated according to
length af stay at ward level. Using ward instead of department level assures at least
same homogeneity in the patient group with regard ta the need far nursing. This is
especially important for the intensive and coronary care units, where nursing costs
are high. lt has alsa been estimated that a high percentage af nursing time is used
for administrative tasks, which also provides same justificatian for this approach
[155].
6.2.3 Marginal vs. average casts
For estimating savings fram denying admission, marginal costs, i.e. the cost of
treating ane additional patient, would have been preferable average casts.. However,
marginal casts depend an the time perspective of the cost analysis.
In the very shart run, the total casts af personnel and major equipment wauld have
been constant and the marginal cast wauld have been the cost af non-reusable
resaurces cansumed by the individual patient as laundry, faod, drugs, intravenous
fluids etc. For the hospital in general, personnel costs accounted far abaut twa thirds
ofthe tatal casts, and, cansequently, in this time perspective, marginal costs would
have been less than ane third of the average casts. This assumes that the
department operated below full capacity. If the capacity was exceeded, extra labour
would have had ta be bought at a high cost, and marginal casts might have been
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higher than the average. As referred in Paper 5, the median bed-occupancy rate in
the study period was 0.84, which does not indicate high costs for extra labour. In the
long run, costs can be saved by downscaling the entire hospital, which means that all
costswould decrease proportionally. In this situation, the savings obtained would
approach our estimates at average costs.
6.2.4 The time perspective of the cost analysis
The cost analysis included only direct costs to the hospital incurred during the
included stays. For patients with subacute ar chronic conditions, interventions
planned during these stays would sometimes be performed in the outpatient clinic ar
in another department after discharge. Thus, the decision to hospitalise the patient in
the first place could cause additional direct costs to the hospital after discharge. The
inclusion at costs only during the included stays could under-estimate the cost
reductions that woulci follow fram a decision to deny admission.
An alternative method would have been to include the costs of all interventions
planneci during the stay. However, it is often difficult to decide what has been
explicitly planned. Some patients are discharged after having been scheduled for
e.g. a coronary artery bypass graft ar a percutaneaus transluminal angioplasty, the
costs of which wauld have been included with this method. Others are discharged
with plans for performing further investigatians, e.g. myocardial scintigraphy, that
may ultimately lead to the decision to perform these pracedures. In these cases, the
cost of a revascularisation would not have been included. The same problem would
apply to many other patients who are discharged with appointments for follow-up.
Same of the difficulties could be solved if ane chose a method that included all direct
costs to the hospital for a set time period. However, the problem at the cost of
lifelong chronic conditions in need for continuos follow-up remains. It is hard to see
how this would be an improvement over the method chosen, i.e. to restrict the cost
analysis ta the included stay.
It could be argued that the limited time perspective at the cast analysis prevents us
fram drawing conclusions about the relationship between appropriateness and cost.
More specifically, it could be that an inappropriately admitted patient with law costs
during the included stay was scheduled for costly interventions later, which would
tend to invalidate the conclusion that inappropriate admissians are less costly. To
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investigate this problem without performing an actual analysis of costs after
discharge, we registered plans for follow-up and interventions for each stay. Fewer
appointments were made for inappropriately admitted patients (Table 6)(P<0.001). In
particular, fewer of them were scheduled for surgery (1 vs. 8%), which would be
expected to incur the highest costs. Although it does not constitute a proof, this
suggests that the these admissions would also have had lower costs in a longer
perspective.
While the cost of each stay can be estimated, there is no analogous method for
estimating the health benefit that results from a single hospital stay in a series of
stays and other interventions, as discussed in section 4.3.2. For this reason, we
defined the health benefit from an included stay as the benefit for which it was a
necessaiy condition. This method introduced an incongruence between the methods
for estimating costs and benefits. As explained in the previous paragraph, it was not
possible to define a series of future contacts with the hospital for which costs could
be estimated, as would have been preferable. Accordingly, the cost-effectiveness of
the admissions could not be estimated, although some considerations ofthe upper
bounds of the cost-effectiveness-ratios relative to that of other interventions are
presented in a later section.
6.3 Prediction of appropriateness
6.3.1 Sensitivity and specificity
At admission, the panels were generally too optimistic about the results of the
hospital stays. The number of inappropriate admissions was predicted to be 66
(16%), whereas 102 (24%) was observed (Paper 5, Table 1).
In clinical epidemiology, sensitivity and specificity are indices used for characterising
a diagnostic test. The results of the diagnostic test are compared with a gold
standard and the indices calculated according to standard formulae [195]. In the
present study, the panels’ predictions of appropriateness at admission can be
thought of as a diagnostic test, and the appropriateness as judged by the other panel
after discharge as the gold standard.
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For the prediction that an admission would be appropriate, a sensitivity of 88% and a
specificity of 27% were found. Thus, while the majority of appropriate admissions can
be identifieci at admission, the panels’ abillty to detect the inappropriate was poor.
One might assume that the reason for this could be that the threshold for judging that
anyone haci had health benefit had been set very Iow, and that it would have been
easier to predict very high gains. When the specificity for predicting gains >= i OHYE
was calculated, a higher value was found (96%), meaning that the experts were able
to identify almost a patients with Iower gains. However, this would have been
achieved at the cost of a Iower sensitivity (33%), meaning that two thirds of the
patients achieving these high gains would not have been identified.
For elective admissions, the panels had Iower sensitivity and higher specificity for
women than for men. This finding was discussed in Paper 5.
6.3.2 Possible causes of poor predictions
6.3.2.1 Lack of direct contact with the pafients
The validity of the medical record as basis for assessment of quality and outcome of
care has been questioned in some studies. Fessel et al found considerable disparity
in the frequency of documentation of common symptoms of appendicitis in three
different hospitals, but no association between documentation and diagnostic
accuracy or outcome [196]. Romm et al reported incomplete recording of information
when comparing the medical record to transcripts of outpatient visits [197]. Burns et
al found paucity of information about functional status in the medical record
compared with patient seif-report [198).
On the other hand, the medica( record has been found sufficient for several
purposes, including detecting aciverse events [199,200], finding the indication of
medical procedures [201] orjudging impairmentoforgan function [202]. One study
examined the influence of the completeness of the medical record on identification of
inappropriate days of care with the Appropriateness Evaluation Protocol. Significantly
higher rates of inappropriateness were found for Iower Tevels of completeness.
However, the differences were small and not significant when adjusted for other
factors associated with inappropriateness [203].
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If predictions of health benefit and care level should be used for reducing hospital
admissions, they would have to be made by the admitting physicians, who would
have the advantage of direct contact with the patient. If this should enable better
predictions than the expert panels, these would have to rely on information that was
not documented in the medical record or communicable in written form. In the
present study, the first possibility was counteracted by Letting the project co-ordinator
check the medical records for missing information the day after admission. Even if
the protocol did not allow him to obtain additional information directly from the
patients, this procedure would seem to exclude the possibility that information
systematically omitted from the medical records was responsible for poor preclrctions.
The second possibility would imply that some form of global assessment of the
patient was an important factor for predicting health benefit. At least one study has
found that clinicians agree poorly on such assessments [204]. Even If such factors
did play a role, the experts haci several advantages relative to the admitting
physicians. First, they had longer experience than the average intern or resident.
Second, they had the opportunity of discussing difficult cases with the equally
experienced members of the panel. Last, they probably had more time for
considering each problem. In all, there is little reason to believe that the admitting
physicians would have made better predictions than the panels.
6.3.2.2 The composition of the expert panels
Instead of using three internists, specialists from two related disciplines were chosen.
A similar design was used in a recent study of the health benefit from helicopter
evacuation [152]. Some studies have shown that the composition of expert panels
matters for their assessments, but it is not known which composition is optimal.
Leape et al found that, for carotid endarterectomy, a panel composed exclusively of
surgeons found fewer operations inappropriate than a multi-disciplinary panel [205].
Similar results were reported by Scott et al for cholecystectomy [206]. Coast et al
used two panels consisting of general practitioners and one consisting of consultants
for assessing necessary care level. The consultants judged hospital care necessary
for a higher percentage of the admissions than did the general practitioners [207].
Ayanian et al found that cardiologists rated coronary angiography as more
appropriate than primary care physicians for some indications [208].
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Whether these results reflect a tendency towards over-estimating the effects of one’s
own speciality, is not known. In the present study, one of the reasons for choosing
different specialists was to eliminate this source of bias, if present among internists.
However, we cannot exclude the possibility that panels consisting of three internists
would have made better predictions.
6.3.2.3 The instrument
The present study used an instrument that was designed to consider all the criteria
necessary for deciding whether an admission would result in health benefit on an
appropriate care level or not. The instrument was rather complicated, and training
and a detailed instruction manual were necessary. Even if a pilot study was
performed to identify problems, the complexity of the instrument may have
contributed to the poor predictions. Although this cannot be excluded, the agreement
found for the instrument was comparable to that of other studies of peer assessment
of patient-care episodes [160]. This makes it less likely that we could have obtained
better predictions with another instrument.
Some factors may have made the assessment of care level difficult. The alternatives
were specified as primary care, outpatient clinic or hospital admission. While the
facilities in the outpatient clinic are well defined and well known by the experts, this
may have been different for primary care. Some primary care centres include a
general practitioner hospital, and other facilities differ as well. Since the summaries
were blinded with respect to geographical data, the experts had to rely on their
concept of the facilities typically avai!able. Better predictions of care level might have
resulted from a better specification of the alternatives to hospital admission.
6.3.2.4 Disagreement about health benefit assessments
Two expert panels were used to avoid bias from letting one expert panel assess the
same admissions both at admission and after discharge. Otherwise, the preciictive
abilities might have been over-estimated because the panels could have
remembered their predictions at admission when making their discharge
assessments. Another consequence of this design was that the quality of the
predictions also reflected the inter-panel variation in estimation of health benefits.
Even if the panels had been able to predict their own discharge assessments
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perfectly, their predictions of the other panels assessments might have been poor if
the inter-panel variation was high.
To examine this possibility, the study included an investigation of the agreement
between the panels (section 5.1). The agreement was found satisfactory and
comparable to the agreement about other clinical methods [159]. Even so, we would
expect the disagreement between the panels to have made some contribution to the
poor quality of the predictions. To assess the magnitude of this effect, one panels
sensitivity and specificity for predicting” the other panel’s estimates of the same
cases in the agreement study were calculated (patient group i in Figure 2). A
sensitivity of 83% and specificity of 59% were found (n=57). Since the corresponding
values for the predictions made at admission were 88% and 27% (n=422), it was
easier for the panels to “predict” which admissions would be judged inappropriate by
the other panel when the information coUected during the stay was avallable.
However, the rather low specificity (59%) demonstrates that the disagreement
between the panels also made a contribution to reducing the quality of the
predictions at admission. Variation in the assessments of inappropriateness between
admitting physicians would also occur in clinical practice. This constitutes an
additional difficulty when trying to use clinical judgement for reducing inappropriate
admissions.
6.3.2.5 CIinicaI uncertainty
Clinical uncertainty at admission will always prevent us from attaining perfect
sensitivity and specificity when predicting appropriateness. Some patients are
admitted without a conclusive diagnosis while there is uncertainty about the effect of
planned treatment for others. In these cases, there is not sufficient information for
making an accurate prediction. This was probably the most important cause of the
poor predictions. In daily clinical work, most clinicians deal with this uncertainty by
keeping the threshold for admission 10w.
Because emergency admissions are not planned, very little can be done at the time
of admission to reduce the uncertainty by obtaining more information. The situation
is different for elective admissions, of which 34% (Paper 4, Table 4) were
inappropriate. By communicating with the referring physician, the doctor in charge of
planning the admission has the opportunity to let the patient undergo diagnostic
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interventions in primary care or an outpatient clinic before admission. The possibility
that this could improve the predictions should be investigated.
6.3.2.6 Spectrum bias
The mediocre ability of doctors to predict which patients would benefit from a hospital
stay is worrying since a reliable gate-keeper function is crucial for our health care
system. However, the sensitivity and specificity were estimated forthe population of
patients actually admitted to the department. This population was already highly
selected by the referring physicians, and, accordingly, different from the population of
all patients who might have been candidates for admission. The primary care
physicians had already sorted out most of the patients that could easily have been
identified as inappropriate, and the studied population may have consisted of
patients with an obvious need for hospitalisation n addition to a small number of
problem” cases. The result was a population that generated low specificity for
predicting appropriateness by so-called spectrum bias [209].
If we take primary care physicians’ referral of a patient for admission to represent
their prediction that the admission would be appropriate, there is good reason to
assume that their specificity for detecting appropriateness must have been higher
than that of the expert panels. Since only a minority of all consultations in primary
care results in hospital admission (for emergency consultations about 10% [210]),
only a few of the potentially inappropriately admitted patients are actually admitted
(unless the percentage of inappropriate patients in the population is very low, which
is unlikely). This means that the primary care physicians’ specificity for detecting and
admitting appropriate patients in this population was probably better than that of the
expert panels’ for the actually admitted patients. Of course, we know nothing about
the sensitivity, which might be poor, i.e. that patients who would have benefited from
a hospital stay may not have been admitted. However, the decision to admit a patient
or not is seldom final. By using time and the course of the disease as diagnostic
tools, general practitioners may also attain a reasonable sensitivity for detecting
those patients who will benefit from a hospital stay.
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6.3.2.7 Bias in (he final assessments of appropriateness after discharge
In section 6.1.1, the validity of the health benefit assessments made after discharge
was discussed at length. Since the quality of the predictions of appropriateness were
judged by comparison with these assessments, it should be considered how their
validity might have affected the conclusion that this quality was poor. Suppose that a
method which had formally been demonstrated as valid had been used for the
discharge assessments, and that the actual discharge assessments of the panels
were poor compared to this method. Could the sensitivity and specificity of the
predictions have been higher If they had been compared to this hypothetical gold
standard? Since this assumes that the predictions could have been better estimates
of the gold standard than the panels’ discharge assessments, the answer is no. At
discharge, the experts used the same instrument and had access to the same
information that was available at admission and, in addition, all information gathered
during the stay. If it is assumed that more information must lead to better estimates,
the discharge assessments must have been better estimates of the hypothetical gold
standard than the predictions. Accordingly, the predictions would also have been
poor compared to this gold standard.
This has the important consequence that the conclusion that the predictions were
poor did not depend on the validity of the panels’ discharge assessments.
6.4 The potential for cost reductions
6.4.1 Cost reductions and health losses
The purpose of trying to predict appropriateness was to explore the potential for cost
savings and health losses. Elective and emergency admissions were analysed
separately. For both types of admission, modest cost reductions could have been
obtained (9 and 14%), but atthe cost of a loss in HYE for patients falsely predicted
to have been inappropriately admitted (5 and 18%)(Paper 5, Table 5). The savings
per HYE lost would have been NOK 29,328 (USD 3,910) for elective admissions and
NOK 12,699 (USD 1,693) for emergency admissions. The main reason for the
difference was that more HYE would have been last per patient for emergency
admissions. Repeating the analysis after excluding the 3 outliers mentioned in
section 6.2.1 lowered the savings for emergency admissions to NOK 6,561 (USD
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875) per HYE lost, but gave the same result for elective admissions. If these 3
admissions had all been predicted to be inappropriate, the savings would have been
NOK 73,187 (USD 9,758) per HYE for elective and NOK 17,432 (USD 2,324) for
emergency admissions.
Costs saved per HYE lost from not performing an intervention, in this case admitting
a patient, is equivalent to the costs expended per HYE won from performing it. In a
recent study, Nord et al discussed the cost per QALY of differenttreatments [211].
Only hip replacement had a lowercost per QALY (NOK 12,750 or USD 1,700),
whereas the cost per QALY of 9 other referred treatments ranged from NOK 42750
(USD 5,700) to NOK 727,500 (USD 97,000). A commonly cited upper limit for cost
effective care has been NOK 375,000 (USD 50,000) per QALY [212,213].
Consequently, the relationship between costs and health losses of the proposed
strategy for reducing admissions would have been less favourable than for many
other interventions commonly accepted as cost-effective, even if there seems to be
little theoretical support for the USD 50,000-limit. Additional support for this
conclusion can be found in a study of life-saving interventions by Tengs et al. They
found that the median cost per Iife-year won of 310 medical interventions was USD
19,000 [214]. Considering thatthe cost per HYE would have been higher, the cost of
the HYE won by not trying to reduce the number of admissions in our study would
seem Iow.
In section 6.3.2.1, the probabilitythatthe admitting physicians would have made
better predictions than the panels was discussed. Paper 5 examined the effects of
improved predictions in a sensitivity analysis. Even with a sensitivity of 90% and
specificity of 50%, equal costs of the inappropriate and appropriate admissions, and
an over-estimation of HYE by 100%, the cost saved per HYE lost was still only NOK
195,984 (USD 26,131). This leaves considerable room for under-estimation of costs
before the limit of NOK 375,000 (USD 50,000) per QALY could have been reached.
If we had estimated marginal costs in the short run instead of average costs, this
ratio would have been even Iower and our conclusion strengthened. The same would
have been the case if it had been possible to estimate costs from a societal
perspective, because the costs of treating some patients on a lower care level would
have had to be subtracted from the estimate of savings in hospital. This assumes
that the health benefit they would have achieved outside hospital would have been
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negligible compared to what they would have obtained If admitted. Since the need for
hospitalisation was explicitly assessed by the expert panels, this seems reasonable.
Another possibility is that hospital treatment might have induced additional societal
costs after discharge, which would have increased the savings from not admitting
some patients. We considered this effect to have been small.
If a system for reducing the number of admissions on the basis ofjudgements of
appropriateness had been implemented, these judgements would have had to be
performed by the admitting physicians. Since the judgements would have been
based on the same information that is routinely collected in today’s system, the
additional costs incurred would have been negligible and were not included in the
cost analysis. If they had been, they would have had to be deducted from the
savings, which would have strengthened our conclusion.
6.4.2 Future costs
In section 6.2.4, the problem of costs to the hospital incurred after discharge from the
included stays, was discussed. The savings per HYE lost estimated in the previous
section could have been underestimated because of costs of planned interventions
and follow-up.
To explore this possibility, plans for follow-up of the 66 patients that would have been
denied admission were registered from the medical records (Table 7). Such plans
existed for 22 of them. The highest costs would probably have incurred for the 3 who
were scheduled for readmission and for the 2 who were scheduled for surgery.
The potential savings form denying care for these 66 patients would have been NOK
1,972,389 (USD 262,985) and the potential health losses about 135 HYE (calculated
form Table 4, Paper 4 and Table 5, Paper 5). If the NOK 375,000 (USD 50,000) per
HYE-Iimit is tentatively accepted, the savings would have had to be NOK 50,505,013
(USD 6,734,002), meaning that the future costs for the 22 patients with further plans
would have had to exceed NOK 48,000,000 (USD 6,400,000), which seems unlikely.




In section 6.3.2.3, it was discussed whether improvements could have been made to
the instrument for predicting necessary care level. However, patients who could have
been treated at a Iower care levet accounted for only 5% of the total costs, which
indicates that the potential for additional savings by predicting this group perfectly
was small.
Coast et al examined the alternatives to hospital care for acute admissions to a
department of general medicine and care of the elderly in the UK [207]. Using a
detailed list of alternatives and assessment by expert panels, she found that a Iower
care levet would have been a possibility for between 5.5 and 14% of the patients.
Her expert panels made their assessments on the basis of information available at
admission, but only assessed patients found to have been inappropriately admitted
by the screening tool ISD-A [71]. In another study, Coast et at made a cost analysis
of the alternatives to hospital care and found that few resources would have been
saved ifthese had been used [215]. Even ifthere are important differences between
Norwegian and British health care, these results suggest that the potential for
additional savings in our study from making a more detailed specification of the
alternatives to hospital care, might have been limited.
However, this refers to the way primary and hospital care are organised at present.
There are indicators that some of the treatments now reserved for inpatients could
be used on lower care levels without health loss. One example is the treatment of
myocardial infarction with streptokinase in primary care [216]. A restructuring ofthe
care levels could permit more treatment outsicle hospital. Whether this would be
more cost-effective than hospital care would have to be investigated.
6.4.4 Other studies of cost and predicted health benefit
I have not been able to find other studies of the relationship between predicted
health benefit and costs from departments of internal medicine. However, Pompei et
al studied charges and prognosis for 549 patients admitted to the medical service at
the New York Hospital during a 1-month period in 1984 [96]. The 5-year prognosis
was estimated as favourable or unfavourable by admitting residents. In contrast to
our study, these estimates were made within 24 hours of admission, and
consequently, some results of tests done after admission must have been available.
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When comparing the estimates with mortality at one year, this was 9% in the
“favourable” and 50% in the “unfavourable” category (P<0.01). Large expenditures
were associated with patients who died in the hospital, especially those whose death
was unexpected. Pompei concluded that the imprecision of clinical judgement at the
time of admission in predicting long-term outcome argues for aggressive
management of acutely hospitalised patients when there is any doubt about their
prognosis.
Detsky et al let house officers estimate the probability of survival until discharge for
1,831 patients admitted to an intensive care unit. Although this study population was
quite different from that in the present study, it will be reviewed briefly because of the
similarities in design. Detsky found that expenditures were positively correiated with
estimated probability of survival for non-survivors, but negatively for survivors. In
other words, the highest expenditures were found for the patients with unexpected
outcome. He concluded that prognostic uncertainty was important in determining
resource expenditures for the critically III [98]. Calculations from the data of Table 2
in Detsky’s paper show that 6% of the expenditures had been saved at the cost of
losing 1% of the survivors if he had chosen to admit only patients with a probability of
survival of greater than 20%. Cut-off levels at 40 and 80% would have yielded
savings of 14 and 46%, and oss of survivors of 3 and 25%, respectively. As it would
probably not have been acceptable to deny admission for a patient with a probability
of survival even as bw as 20%, it would not have been possible to obtain savings
based on prognostic assessments in this setting.
Although none of these two studies are directly comparable to the present study,
their conclusions resemble ours in their emphasis on prognostic uncertainty as an
important determinant of resource utilisation. This uncertainty causes clinicians to
keep a low thresho!d for admitting patients. The threshold may be Iowered further as
a result of the decreasing tolerance of mass-media and the public for physician
malpractice”.
6.5 Strategies for reducing Iength ofstay
Another possibility for obtaining savings would have been to reduce the use of
resources after admission. This could have been achieved by reducing length of
stay, which was the most important determinant of cost. Observation units, where
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patients undergo a rapid diagnostic work-up without actually being admitteci, have
been proposed as a way to quickly reach a decision about whether admission is
necessary and to reduce costs [217,218]. One study found thatthe cost of asthma
patients treated in an observation unit was lower than for admitted patients
(USD1202 versus USD 2,247) [219]. Another stuciy examined the predictive ablilties
of physicians in an observation unit for detecting the presence of pathology
necessitating hospitalisation for selected diagnoses. A sensitivity of 100% and
specificity of 86% weré found [220], raising the question of whether prediction of
inappropriateness in general would also have been better.
In the present study, inappropriately admitted patients already had a shorter mean
length of stay than others (4.3 vs. 10.0 days). The percentage of such patients was
24, and they used 12% ofthe resources. Let us assume thatthis group could have
been identified with a sensitivity and specificity of 100% after one day in the hospital.
If their use of resources was proportional to length of stay, we woulci have saved
12%*(4.3_1)14.3 ofthe resources, le. 9%. But since, in reality, the identification
would not have been perfect and more ancillary resources would probably have been
used the first day, the savings would have had to be lower, and there would still have
had to be some health oss. Consequently, the savings from reducing the Iength of
stays resulting from inappropriate admissions would have been modest in our
setting.
This leaves Us with the possibility that the Iength of stay for appropriately admitted
patients could have been reduced without reducing health benefits, which was not
investigated in the present study. However, there is little doubt that some of the
included patients stayed in the hospital longer than necessary. Three of the patients
with benefits had stays lasting more than 6 months because of insufficient nursing
home capacity. These 3 patients accounted for 12% ofthe total costs. Two ofthem
achieved gains of i and 4 HYE, and one only low degree HSQG. At adm ission, it
was erroneously predicted that the patient with the highest gain would not have
benefited. If these 3 patients could have been discharged when their medical
treatment was complete, the savings would probably have been of the same
magnitude as when identifying inappropriate admissions after one day’s stay. It must
be assumed that the length of stay could have been reduced for other patients as
weII. However, there is probably a limit to the reduction in average Iength of stay that
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can be achieved without increasing the per diem cost of nursing. In the USA, one
study found that the amount of nursing per patient per day increased when length of
staywas reduced [221].
Some studies have investigated interventions to reduce Iength of stay. In the USA,
Wachter et al studied length of stay, cost, 6 month mortality rate, readmissions and
patient functional status after reorganising half of the wards in an academic medical
service to involve faculty members more in inpatient care. The other half was left
unchanged. The hypothesis was that more expertise would reduce costs. When the
wards were compared, mean Iength of stay was shorter (4.3 vs. 4.9 days; P=0.01)
anci mean cost Iower (USD 7,007 vs. 7,777; P=O.05) for the reorganised wards.
However, the cost difference, which was of borderline statistical significance, is
difficult to interpret because the cost analysis did not include physician costs. It must
be assumed that use of higher expertise in direct patient care would incur extra
costs. There were no differences in patient outcomes [222].
Two recent British studies compared hospital at home care to ordinary inpatient care.
Hospital at home care refers to home based nursing and rehabilitation services
designed to prevent hospital admissions or facilitate early discharge. Shepperd et al
randomised patients recovering from selected surgical and medical conditions to
home care or ordinary inpatient care to investigate whether length of stay could be
red uced and costs saved. There were few differences in outcome measures and no
differences in total health care costs between the two groups [223,224]. Richards et
al used a similar design for early discharge of stable elderly medical patients. Again,
there was no difference in the outcome measures, but over 3 months the mean total
health care costs for home patients was £2,5 16 and for inpatients £3,292. Because
these estimates were made from incomplete datasets, statistical tests could not be
performed. However, a sensitivity analysis seems to indicate that home care was
less costly even if the cost of inpatient care had been over-estimated [225,226]. The
opposite conclusions of these two studies indicate that substitution of lower level
care for hospital care does not guarantee cost reductions. Although it may be
possible to obtain savings, this probably depends crucially on how the substitution is
organised and on which patient groups are targeted.
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6.6 Finalremarks
Our finding that 24% of the admissions were inappropriate is similar to the results of
other studies. At present, general practitioners have the main responsibility for
deciding who will be admitted. Factors other than considerations of the patient’s
health may influence these decisions. The practice of so-called “defensive medicine
means that clinicians seek to defend themselves against accusations of malpractice
by being overtly cautious. However, as discussed in section 6.3.2.6, the general
practitioners’ specificity for predicting appropriateness is probably good, at least for
emergency admissions. Since little is known about the sensitivity of these
predictions, the important issue may be how many patients suffer health loss
because of not being admitted when they should have been.
Contrary to common belief, the resu)ts of this study suggest that little is gained by
increasing the efforts to detect inappropriate admissions at the start of the hospital
stay. We suspected that inappropriate admissions could be identified by a better
consideration of information available at admission than is possible for relatively
inexperienced admitting physicians. To investigate whether this was possible in
princip!e, we recruited board-certified speciafists with long experience, provided them
with all available information about the patients, and, in addition, the opportunity to
discuss difficult cases. However, the clinical information available at the time of
admission was not sufficient for making good predictions of whether a patient would
benefit from his hospital stay. Presumably, admissions which could easily have been
identified as inappropriate had already been sorted out by the traditional
gatekeepers.
As far as we know, no study has previously tried to predict inappropriate admissions
or to estimate their costs. Assessments of rates of inappropriate admissions have
generally ignored the fact that they must be identified before resources are spent to
obtain cost reductions. The results of this study emphasise the important role of
clinical uncertainty as a determinant of cost. Clinicians keep the threshold for
admission low to ensure that most of those who will benefit, are admitted. The
potential savings obtained by raising this threshold were small compared to the
health losses. In addition to the poor predictions, this was caused by a lower mean
cost for the inappropriate admissions because of a shorter mean length of stay. This
suggests that, even in today’s system, these patients are identified and discharged
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after an initial diagnostic work-up. Perfect identification of inappropriate admissions
would not have saved more than 12% ofthe total costs.
Accordingly, in the investigated department, we were not able to demonstrate that
savings could have been obtained by trying to reduce inappropriate admissions, and
it can be discussed whether it is correct to label these admissions “inappropriate” at
all. An important question is to what extent this result can be generalised to other
departments of internal medicine. In a study of the rate of emergency admissions to
such departments in Norway, the investigated department was found to have a Iower
rate than others [210]. One could speculate thatthis implies that it was more difficult
to obtain savings in our hospital than in the other hospitals in this study, none of
which were teaching hospitals. Non-teaching hospitals usually have a higher
percentage of emergency admissions than university hospitals. In the present study,
the percentage of inappropriate emergency admissions was Iower than elective (19
vs. 34). In addition, it was more difficult for the panels to identify these than the
inappropriate elective admissions. This suggests that it would also have been difficult
to achieve cost reductions in non-teaching hospitals with higher percentages of
emergency admissions. Higher cost savings relative to health losses could also have
resulted from higher costs of inappropriate admissions relative to the appropriate.
This was considered in the sensitivity analysis of Paper 5, but the savings remained
modest even under this assumption. Consequently, it is questionable whether other
departments of internal medicine would have found it more worthwhile to reduce the




In the investigated depar(ment of internal meciicine, clinical judgement was
unsuccessful in identifying inappropriately admitted patients at the time of
admission. The most important reason for this was probably uncertainty about
diagnosis and the effect of planned treatment.
Costs could have been saved by excluding admissions predicted to be inappropriate.
However, this would have resulteci in loss of a high percentage of the total health
benefits. When compared to other interventions considered to be cost-effective,
these losses were high relative to the savings.
• Secondaty conclusions
As juclged by the expert panels, the health benefits were unevenly distributed across
the patients. A few patients had high gains corresponding to life-saving treatment,
whereas the majority had low or no benefit. Diagnosis was the most important
determinant of health benefit. Age had little effect. About one quarter of the
admissions were classified as inappropriate. The mean cost of the inappropriate
admissions was less than halfthat ofthe appropriate, and they represented only
12% or the total costs.
When assessing health-related benefits, the agreement between the two expert
panels was fair to good. The agreement about non-health-related benefits was poor.
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8. Policy impIicatons
8.1 For departments of internal medicine to which our results can be
generalised
• Based on our present knowledge, caution should be observed when attempting to
reduce admissions by using clinical judgement for predicting inappropriate
admissions. While it may be possible to obtain modest cost reductions, these wUI
probably be Iow compared to the health losses.
8.2 For other departments and othersectors ofhealth care
• Strategies for saving resources by limiting access to care according to expected
health benefit should not be implemented without assessing their actual effects
on both health benefits and costs.
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9. Suggestions for further research
9.1 Evaluation ofprimary care physicians’ decisions to admit patients to
hospital
The quality of the expert panels’ predictions of appropriateness in the present study
was poor. As discussed in section 6.3.2.6, littie is known about the ability of primary
care physicians to identify patients who will benefit from hospital admission. Although
there is reason to believe that their specificity for preciicting appropriateness may be
satisfactory, the sensitivity is unknown. In other words, some of the patients seen in
primary care who would have benefited from a hospital stay may not have been
admitted. This is an issue that deserves closer scrutiny.
9.2 The effect of reducing length ofstays in departments ofinternal medicine
An investigation of the effects on health benefits and costs of an intervention to
reduce length of stays should be undertaken. With a clearly defined intervention, it
shoulci be possible to randomise admitted patients to the intervention or a control
group. Different kinds of interventions are possible, e.g. an effort to co-ordinate the
service of other departments for patients staying in the department of internal
medicine. It is well known that much time is lost while waiting for the response to
referrals to other departments.
9.3 The effect of betterplanning of elective admissions
The effects on health benefit and costs of better planning of elective admissions to
the department of internal medicine should be investigated. An intervention should
be made to obtain more information about the patients before acimission to allow
better predictions of health benefit. If this coulci be achieved, our results indicate a
potential for cost reductions. The costs incurred by the intervention in other sectors
of health care would have to be estimated.
9.4 Investigation ofadmissions to a department ofsurgery
While our results may probably be generalised to other departments of internal
medicine, at least in Norway, it is an open question whether different results would
have been obtained in other types of departments. Because departments of surgery
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also account for a high percentage of all hospital admissions, it would be of great
value to carry out a similar study in this setting.
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Table I Appropriateness Evaluation Protocol criteria for appropriateness of admission
An admission is considered appropriate fane of the following criteria is met:
A. Severity of iliness criteria
1 Sudden anset of uncansciousness ar disorientation
2 Puls rate
A. <50 per minute
B. >140 per minute
3 Blood pressure
A. Systolic <90 ar >200
B. Diastolic <60 ar >120
4 Acute loss of sight ar hearing
5 Acute ass af ability ta mave a body part
6 Persistent fever> 37.8 orally far mare than 5 days
7 Active bleeding
8 Severe electralyte/blaad gas abnarmality (any af the fallawing):
A. Na<123or>156
B. K<2.5 ar >6.0
C. standard HCO3 (unless chranically abnarmal) <20 ar >361
D. Blood pH <7.30 or >7.45
9 Acute pragressive sensory, mator, circulatory ar respiratory embarassmerit
sufficient ta incapacitate the patient (inability ta mave, feed,
breathe etc.) Nate: Must alsa meet lntensity af Service criterian
simultaneausly ta certify. Da not use far back pain.
10 EKG evidence af acute ischemia; must be suspicion afa new Ml.
11 Waund dehiscence ar evisceratian
B. Intensity af service
1 Intravenaus medications and/ar fluid replacement (daes not include tube
feedings).
2 Surgery ar procedure scheduled within 24 hours requiring:
A. General ar regional anesthesia
B. Use af equipment, facilities available only in hospital
3 Vital sign manitaring every 2 haurs ar more aften (may include
telemetry ar bedside cardiac manitor)
4 Chematherapeutic agents that require cantinuaus abservatian far life
threatening taxic reactian
5 Treatment in an ICU
6 Intramuscular antibiatics at least every 8 haurs
7 lntermittent ar cantinuous respiratar use at least every 8 haurs
Override aptions
8 Other services justifying appropriateness?
9 Criteria met, but inappropriate nevertheless?






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Thrombolytic therapy with recombi
nant tissue plasminogen activator
during suspected acute myocardial
infarction
Thrombolytic therapy with recombi
nant tissue plasminogen activator




Ticiopidine as compared with aspirin
Cancer
Radical prostatectomy or radiation
therapy, as compared with watch






Autologous bone marrow transplanta
tion as compared with standard
chemotherapy
Other
Prophylaxis against Pneumocystis carinii
pneumonia and toxoplasmosis
Prophylaxis against Mycobacterium
avium complex, fungal infections,
or cytomegalovirus








55-year-old men who survive acute
myocardial infarction
Low risk of recurrence
Medium risk of occurrence
High nsk of recurrence
Patients with suspected acute myo
cardial infarction




Survivors of cardiac arrest with recur
rent ventricular arrhythmias that
do not respond to conventional
therapy
Survivors of cardiac arrest with recur
rent ventncular arrhythmias that
do not respond to conventional,
therapy
Candidates with end-stage cardiac
failure
Patients at high risk for stroke
65-year-old men with Iocalized
prostate cancer
Women with breast cancer
Node-positive
Node-negative
Patients with extensive small-cell
ung cancer
Patients with advanced non-small
cell lung cancer
Men with advanced testicular cancer
Patients with relapsed non-Hodgkin’s
Iymphoma
Patients with advanced HIV disease
Patients with advanced HIV disease
50-year-olds with symptomatic gaV
stones
35-year-olds with chronic hepatitis B
who are positive for hepatitis Be
antigen and do not have cirrhosis














Table 4 Treatment o persons with established disease (from reference 184)




























Disease resolves spontanecusly without treatment
Disease does not resolve spontaneously
No palliative or curative treatment







No effect ar adverse effect at treatment
Due to chance
Due to 10w quality of care
Due to poor patient compliance
Table 6 Appointments for follow-up according to appropriateness (n=422)
Inappropriately Appropriately Total (%)
admitted patients(%) admitted patients(%)
Patients without appointment for follow-up 78 (76) 173 (54) 251 (59)
Readmission scheduled
Readmissiori for surgery i (i) 27 (8) 28 (7)
Readmission without surgery 4 (4) 31 (10) 35 (8)
Appointment in outpatient clinic
Furtherdiagnostic interventions planned 5 (5) 11 (3) 16 (4)
Ordinary follow-up 14 (14) 78 (24) 92 (22)
Total 102 (100) 320 (100) 422 (100)












































































































































































































































Figure 1. Admissions included in the Tromsø Medical
Department Health Benefit Study
All admissions to the
department during
















Figure 2. Design of the Tromsø






- - ----- =assessment after discharge
















Figure 3. Distribution of gain in healthy










EVALUERING VED INNLEGGEISE FOR PASIENT ML — I”
_____
i
Tenk deg at pasienten ikke var blitt innlagt og ikke behandlet annet sted fso- det atI4Ie p,.blrwt
1. Marker med et kryss på en av skalaene nedenfor hvor lang genståendc le idpasicnlen daiiflc ket i det
sannsynlige fodopct av tilstanden. (NB! Angi gjenståcade levetid, - Ikke den faktisk ononådde alder ved dod!)
2. Tenk deg selv i pasientens tilstand. Bestem deg for hvor mye av den gjenstående levetiden (som rhi nå har kci( et
kryss) du ville være villig til å ofte firr å lå være helt frisk fram til dedstidspirnklct Marker den gjr1fnL. kvdirkn do du
ville hattmeden loddrett stickpåenavskalaasc.
0 . 10 20
Dager . . . . fl fl
I 3 ‘2.
Månedcr, . g , g - • i g I
10 20 3) Ç k) 10 0
I • . fl . . fl fl I I I I I
Ft.t g5d. 1.tid f — kk
Tenk deg pasientens situasjon etter dette sykehusoppboldd
3. Marker med et kryss på en av skalaene nedenfor hvoc lang gjenstående levetid pasienten vil ha oppnådd mer mest
sannsynlige resultatet av oppholdet (NB! Angi gjenstående levetid, - Ikke den faktisk oppnådde alder ved dod!)
4. Tenk deg selv i pasientens tilstand. Bestem deg for Irrur mye av den gjenståcade lcvetidcn (sinn du nå har markert med et
kryss) du ville være villig til å ofre for å lå være helt frisk fram til dodstidspunklet. Marker ike gjenstående k’.tti&n dli da
ville hatt med en loddrett strek på en av skalaene.
0 10
20
l)ager i I I • I.Iflflflfl I • fl ifl fl fl fl fl
I 3 q ‘2.
flåneder, . i fl • fl I
I 10 20 30 o 5c, fQ 10 °
År i • . • fl fl fl • 1 fl i fl
qj5d 1.1.id £ j.gl fik p. .d — p.5k.
5.1 hvilken grad vil dette sykehusopphotdct kunne fare (il kortvarig bedring av passe.tens helserelaterte livskvalitct ..derog like
etter sykehusoppholdet i forhold til om hanlhun ikke var blitt innlagt? (lindring av soinatiskc og psykiske plager osv):
Sett kryss i gg av rutene nedenfor.
ingen liten moderat stor -
I I I I I I I I
6.1 hvilken grad vil dette sykebusoppboldct kunne fare til kortvarig bedring av pasicatens livskvalitet på annen måle .nder og like
etter sykebusoppholdet i forhold til om hanlbun ikke var blitt innlagt? (avhjdping av sosial nsd, d.dspleie osv.):
Sett kryss i g av rutene nedenfor.
ingen liten moderat stor
I I I I I I I I
7. Vil pasienten ha diagnostisk utbytte av sykehusoppholdet?:
Sett kryss I gg av rutene nedenfor.
ja nei
I I I
8. Forutsatt at pasienten oppnår utbytte av sykebusoppholdet, hva ville vært det laveste nodvendige omsoi-gsnivået for å oppnå
denne gevinsten?:
Sett kryss i en av rutene nedenfor.
Primærhelsetjenesten Medisinsk poliklinikk lnnleggelse
I I I I I




£VALUERING VED 1JTSKRIVELSE FOR PASIENT NR. —
G,,.
Tdtg _L — ikkear bStt .iagt og ikke behet an.ct ftrd f.r det pr.bIrt
L1det krvm på ra av .1&wln lang rtå lesjetid jdn da ville hatt i det mest
dopdavh33. (NB! A.gi levetid. - Ikke dra bkti* avildeaied ded!)
2.Ttkg lv i tilI Bdeg kwbmye av dra gjrnct1. levctidra (ann chi III har nuikeet med et
htysa) chi vl&vze ,ilhg til å cd’ae åte helt ftiha III dadstiikplmkiet Maeker de. gjensilende lcvdiden chi chi
ville hattden k,dckett tiz på en av____
s 15 3°
i i • I -
I 3 q
- I i I i I 1 I I
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W_I..L Id p t. ikk
Tenk deg p..rd-O hiasj.. etter dette sykokew1ipbddet
3. Maaka- med et krvns påen fr.Ow lns lang ..dtnI1e levetid psmeziiaa bar oppnådd ann det m
asy.lige itsultatet av qdeL (NB! Ångi gjruårmk levetid, - Ikke den kii oppnådde alder ved dod!)
& Tc.k&g mlvi p2I..i tiIdnd Bideg hvor mye av den fr01o.1r lcvdiden (ann chi nå har markat med et
kzyas) dovillevæse villig til å iiefiwåvæse helt fri fram til dedstidspunkt& Maiker den gjrndtenle lcvetidai chi da
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5.1 hve. grad har dette sykohasqiph.ldet fort til kortvarig bedring av paiir.to.s hdserolsterte livskvalitd ..der og like etter
—- i forhold t11 ha.Jho. ikke var blitt i.al.gt? (lladri.g zv Ii’. og psykiske plager nov.):
Sett kryss i enav na ieokr
higen Sten moderat stor
I I I I I I I I
Iho grad har dette sylcehowpphddet fort til kortvarig bedring av p2rf. liv*valitd på anno. åte ..der og like etter
i fid til — hanlhoi Ikke var blitt lanlagt? (avhjclpg av sndal ..d, d.dspleie osv.):
Sett kryss i avnizfiw
.Igen Sten moderat stOr
I I I I I I I I
7. Har paole.(o. hatt agnos1ide otbytto av sykehos.ppholdet?:
Sett kryss i en av rutene nede.for.
ja nei
I I I I
5. For.tsstt st paolonte. har hatt utbytte av sv-krhosoppholdct, hva ville vært det laveste n.dwe.digc oaisorgonlv-åct for å oppnå
denne geshisto.?:
Sett kryss ir. av ndaæ nedenfor
Primærhelsetjenesten Medisinsk pohkhnikk Innleggelse
I I I I I I





VEILEDNING FOR UTFYLLING AV EVALUERINGSSKJEMAENE.
I denne studien vil vi sammenligne utbyttet av et sykehusopphold med det utbyttet som forventes
ved innleggelse. Hver pasient vil bli evaluert av forskjellig ekspertgruppe ved innleggelse og
utskrivelse. Evalueringene i de to situasjonene foretas på samme måte: først angis forventet
gjenstående levealder og livskvalitet for det tenkte tiifellet at pasienten ikke var blitt innlagt,
deretter anslås på samme måte den nytten man antar pasienten vil få eller har hatt av
sykehusoppholdet. I tillegg skal det både ved innleggelse og utskrivelse vurderes helsegevinst og
livskvalitetsforbedring på kort sikt diagnostisk utbytte og det laveste nødvendige omsorgsnivå
forpasienten.
EVALUERING VED INNLEGGELSE FOR PASIENT NR
Tenk deg at pasienten ikke var blitt innlagt og ikke behandlet annet sted for det aktuelle problemet:
Man tenker seg her at pasienten ikke var blitt innlagt og at han heller ikke haddefått noe tilbud
på lavere omsorgsnivå (vurderingen av om omsorg på lavere nivå ville vært tilstrekkelig til å gi
utbytte kommer i spørsmål 8). I de fleste tifelle vil det kunne tenkes flere muligheter for hvordan
det vil gå med pasienten uten innleggelse. På bakgrunn av tilgjengelige medisinske data og sunt
klinisk skjønn må du angi evalueringen i forhold til det forløpet du antar er mest sannsynlig. Det
er altså ikke det verst tenkelige forlopet uten behandling det spørres etter, men det mest
sannsynlige. Denneforskjellen er viktig, siden vi er vant til å begrunne innleggelser medfaren
for alvorlige komplikasjoner, selv om de kan være forholdsvis sjeldne.Det er heller ikke det
forventede eller “gjennomsnittlige “forlopetfor en gruppe av pasienter i statistiskforstand du skal
fram til, men hvordan du tror det vil gå med akkurat denne pasienten! Dersom du feks antar at
pasienten lider av tilstand x som i 50% av tflfellenefører til snarlig død, men i de resterende 50 %
helbredes uten behandling, må du bestemme deg for et av disse forløpene. I en del tilfelle vil du
her måtte g/ette. Bli ikke frustrert av dette, fordi usikkerheten i denne situasjonen er noe av det vi
vil måle med denne undersøkelsen.
I. Marker med et kryss på en av skalaene nedenfor hvor lang gjenstående levetid pasienten da ville hatt i det mest sannsynlige
forlopet av tilstanden. (NB! Angi gjenstående levetid, - ikke den faktisk oppnådde alder ved død!)
Sett først et kryss på tidsskalaen for den gjenstående levetid du tror pasienten ville hatt. Dersom
du tror det dreier seg om mindre enn i måned, setter du et kryss på den øverste skalaen. Dersom
du tror det dreier seg omfra I måned til I år setter du et kryss på den midterste skalaen. Dersom
det dreier seg om mer enn et år bruker du den nederste skalaen. Det kan settes kryss hvor som
helst på skalaene; ikke bare for hele dager, måneder eller år der det er angitt markeringer.
Gjennomsnittligforventet levealder for en frisk person med samme alder og kjønn er angitt med
en red prikk som et referansepunkt. Det er selvfølgelig anledning til å anta at pasienten vil leve
lenger enn gjennomsnittet, d.v.s. sette krysset til høyre for det røde punktet. Legg merke til at det
er gfenstående levetid i forhold til innleggelsestidspunktet det spørres etter; ikke den alder
pasienten faktisk vil oppnå.
2. Tenk deg selv i pasientens tilstand. Bestem deg for hvor mye av den gjenstående levetiden (som du nå har markert med et
kryss) du ville være villig til å ofre for å få være helt frisk fram til dodstidspunktet. Marker den gjenstående levetiden du da
ville hatt med en loddrett strek på en av skalaene.
Når krysset som angirforventet gjenstående levetid er satt, går du videre med å angi pasienten.
forventede livskvalitet uten innleggelse påfølgende måte: Tenk deg at pasienten fikk valget mello,i
to alternativer:
* å leve sin gjenværende levetid med den livskvalitet du antar han da vil ha, eller
* å gi avkall på noe av sin gjenværende levetid i bytte mot å få være helt frisk hele tide;
fram til dadstidspunktet
Jo dårligere livskvalitet pasienten antas å ha i detførste tifellet, jo kortere tid ville han/hun kunn
akseptere å leve dersom han/hun kunne ha full helse. Marker med en loddrett strek de;
gienstående levetid medfull helse som for pasienten ville være likeverdig med å leve den faktisk.
gjenstående levetiden med redusert livskvalitet. Denne streken må nødvendigvis lokaliseres ti
venstre for eller oppå krysset som markerer gjenstående levetid. Det må taes med i beregninge1
at pasientens livskvalitet kan variere i løpet av den gjenstående levetiden, feks. at en me
uhelbredelig cancer vil hafallende livskvalitet.
Et eksempel: La oss tenke oss at en pasient med hjertesvikt har en gjenstående levealder påf ek
2 år. Dette markeres med et kryss på den nederste skalaen. Ubehandlet vil pasienten ha my
plager med dyspnoe, ødemer o.s. v. Avhengig av hvor mye dette reduserer livskvaliteten, v
pasienten antagelig være villig til å gi avkall på noe av denne levetiden dersom han i stedet kunn
være frisk fram til dødstidspunktet. Tenk deg i pasientens sted, og bestem deg for hvor mye a
levetiden du selv i denne situasjonen ville være villig til å gi avkall på utfra dine preferanser. L
oss si det dreier seg om 0,5 år (tallet er tiifeldig valgt). Du ville da oppfatte det å leve i 1,5 år sol
frisk, som likeverdig med å leve i 2 år med de hjertesvikt-plagene du antas å ville få. Marker 1,5
på nederste skala med en loddrett strek. Legg merke til at dette er et tanke-eksperiment som ti
uførerfor åfå et mål for pasientens livskvalitet. Tanke-eksperimentet er ikke avhengig av om dt
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Tenk deg pasientens situasjon etter dette sykehusoppholdet
Man tenker seg det mest sannsynlige sykdomsforlopet etter utredning og behandling og gjør
samme to markeringene på tidsskalaen i denne rammen som ovenfor. Igjen må det understrekes
det er det mest sannsynlige for!opet man skal fram til, i motsetning til det optimale, d.v.s. forløp
med den største helsegevinsten pasienten kunne tenkes å oppnå under oppholdet. I en del tilfel
vil behandling som muliggjores av diagnostikk under oppholdet først bli gjennonfort under
senere opphold ([eks. kirurgisk behandling av nydiagnostisert neoplasme), eller strekke seg over
?ere senere opphold ([eks. cytostatika-kurerfor leukemi). Også i disse ti(fellene vil behandlingen
og behandlingsresultatet stå i et årsaksforhold til det aktuelle oppholdet, og taes med i
betraktningen når man tenker seg pasientens sykdomsforlop. Er eksempel: Pasienter som legges
inn for utredning av coronar hjertesykdom med angiografi m.t.p. operativ behandling må vurderes
i forhold til den situasjon en de vil være i etter en senere operasjon, dersom man antar at
utredningen vilføre til at slik behandling er aktuell.
3. Marker med et kryss på en av skalaene nedenfor hvor lang gjenstående levetid pasienten vil ha oppnådd som det mest
sannsynlige resultatet av oppholdet (NB? Angi gienstående levetid, - ikke den faktisk oppnådde alder ved død!)
4. Tenk deg selv i pasientens tilstand. Bestem deg for hvor mye av den gjenstående levetiden (som du nå har markert med et
kryss) du ville være villig til å ofre for å få være helt frisk fram til dodstidspunktet Marker den gjenstående levetiden du da
ville hatt med en loddrett strek på en av skalaene.
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5. I hvilken grad vil dette sykehusoppholdet kunne fore til kortvarig bedring av pasientens helse under og like etter
sykehusoppboldet i forhold til om han/hun ikke var blitt innlagt? (lindring av somatiske og psykiske plager osv.):
Sett kryss i gg av rutene nedenfor.
ingen liten moderat stor
I I I I I I I I
Her er det spørsmål om kort3’arig bedring av helse som følge av sykehusoppholdet, sett iforhold til
om pasienten ikke var blitt innlagt. En spontan bedring av helsen uavhengig av tiltak satt i verk
under oppholdet regnes derfor ikke som gevinst her. Medforbedring av helse mener vi herfeks:
Lindring av somatiske plager(smerte, ubehag, kvalme etc., etc.)
Lindring av psykiske plager (depresjon, angst etc.)
Bedring avfunksjonsevne
etc.
For å gi en pekepinn om hvilken bedring som vil svare til de fire kategoriene ovenfor, vil vi be deg
kikke på EuroQol-skalaen i protokollen (vedlegg 3). En bedring av helsen er moderat dersom den
omtrent tilsvarer en forbedring på et trinn på en av de 5 dimensjonene i skalaen. Bedringen
betegnes som stor dersom den omtrent tilsvarer et sprang på to trinn av en av dimensjonene eller
en forbedring på mer enn en av dimensjonene. Dette er bare ment som en illustrasjon på hva som
legges i kategoriene ovenfor; det er ikke meningen at du skal bruke EuroQol-skalaen når dette og
det neste spørsmålet besvares.
6. I hvilken grad vil dette sykehusoppholdet kunne føre til kortvarig bedring av pasientens livskvalitet på annen måte under og like
etter sykehusoppholdet i forhold til om han/hun ikke var blitt innlagt? (avhjelping av sosial ned, dndspleie osv.):
Sen kryss i en av rutene nedenfor.
ingen liten moderat stor
I I I I I
Dette spørsmålet skal omfatte alle typer kortvarig bedring av livskvaliteten som ikke omfattes av
spørsmål 5. Eksempler.
Avhjelping av akutt vanskelig sosial situasjon (feks. akutt pleie)
Bedreforståelse av egen helsetilstand ved at manfinnerforklaring
på symptomer, får informasjon om egen sykdom 0.1.
Dcdspleie
etc., etc
Spørsmålet besvares på samme måte som spørsmål 5, og også her vil vi vise til EuroQol-skalaen
for å illustrere hvordan kategoriene brukes.
7. Vil pasienten ha diagnostisk utbytte av sykehusoppholdet?:
Sen kryss i en av rutene nedenfor.
ja
Pasienten regnes å ha hatt gevinst av diagnostikk uçført under oppholdet dersom resultatene av
diagnostikken ville kunne gi gevinst i h.h.t spørsmål i - 6, eller dersom den girforklaringpå
sykdomsmanfestasjoner (symptomer, tegn, patologiske prøvesvar o.l.). Avkrefting avforeslåtte
diagnoser eller diagnostikk uten at det blir stilt noen diagnose, gir ikke gevinst her.
8. Forutsatt at pasienten oppnår utbytte av sykehusoppholdet, hva ville vært det laveste nødvendige omsorgsnivået for å oppnå
denne gevinsten? (Spørsmålet skal besvares for alle pasienter):
Sett kryss i av rutene nedenfor.
Primærttelsetjenesten Medisinsk poliklinikk Innleggelse
I I I
Dette spørsmålet besvares for alle pasienter, uansett om man tror de vil ha utbytte eller ikke.
Dersonz man ikke tror pasienten vilfå noe utbytte, skal men evt. krysse avfor laveste kategori.
Medprimærhelseijeneste menes alle typer tilbud som omfattes av helse- og sosialijenesten i de
fleste kommuner. Med medisinsk poliklinikk menes vanlig eller a. hj. -konsultasjon på medisinsk
poliklinikk. Overnattingpå sykehotell regnes ikke som en del av tilbudet på medisinsk poliklinikk.
Vi har alle en oppfatning av hvilke pasientkategorier som bør behandles på deforskjellige
nivåene. Det er imidlertid ikke det vi her vilfram til, men hvilket nivå som ville være nødvendig i
forhold til den gevinsten pasienten faktisk ventes å oppnå.
EVALUERING VED UTSKRIVELSE FOR PASIENT NR.
Denne evalueringen er nesten identisk med den som foretas ved innleggelse. Forskjellen er at man
nå har data samlet inn under sykehusoppholdet som grunnlagfor å anslå sykdomsforlopet både
med og uten innleggelse. I den grad det fortsatt er flere mulige forløp, velges det mest
sannsynlige. For noen pasienter vil diagnostikk under oppholdet ha muliggjort behandling som er
planlagt og avtalt, men ennå ikke gjennomført under oppholdet. Effekten av slik behandling på
forløpet må taes med i betraktning (feks operasjoner, strålebehandling, cytostatika-kurer o. a.)
PÅFOR GJERNE TEKST MED PRESISERINGER OG MARKERING AV USIKKERHET DERSOM DU ØNSKER, nen
husk på at alle spørsmålene på skjemaene skal besvares.
DIVERSE
Ei’alueringene må returneres til prosjektkoordinator fortlapende ettersom de j5’lles ut. Både
evalueringsskjemaet og pasientopplysningene skal returneres. Dersom det oppstår praktiske
problemer m. h. t. evalueringen, kan prosjektkooidinator kontaktes (kl. 0800 - 1600 tf 083 26000,
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Agreement between two expert panels in assessing gain in lite expectancy ând quality ot lite trom
unselected stays in a department of internal medicine was investigated. Weighted kappa statistics of
0.45 for gain in lite expectancy and 0.63 for gain in quality at lite were found.
The rising cost of health care makes the optimal allocation of resources a vital issue.
To find the best allocations, it is necessary to estimate the health benefit of competing




health care programs. Methods for the quantification of health have been developed
(15), but have rarely been used for this purpose. The reason may be that the measure
ment of health is connected with both practical and conceptual difficulties, some of
which have been discussed elsewhere (11).
Health can be defined as a function of life expectancy and some measure of the
quality of Life (15). Although survival and gains in life expectancy are frequently
end points in clinical trials, these results are of limited value in estimating life expec
tancy gain from hospital care, because restrictive inclusion criteria often make it
difficult to apply them to ordinary patients. Many technologies and treatment modal
ities have never been evaluated properly in clinical trials. Information about improve
ments in quality of life is even more scarce. Consequently, evaluation of health
benefits from empirical data alone is not possible, and we are left with clinical judg
ment as the second best alternative.
Methods based on expert clinical judgment have been used in many different
ttings for the evaluation of health care programs. Usually, a selected group of
ptients is evaluated according to program-specific criteria, which makes compari
sons hetween different programs difficult. To our knowledge, no study has so far
assessed improvement in such general health measures as life expectancy and quality
of life for a group of unselected patients admitted to a hospital department.
The Tromsø Medical Department Health Benefit Study relies on consensus in
panels of expert clinicians to estimate gains in life expectancy and quality of life
arising from hospital stays. It was designed to study health effects and resource
utilization in a department of internal medicine. A major objective of the study was
to identify patient groups with very low health gain. To investigate the reliability of
the method, the interpanel agreement for the health measures was studied in a random
sample of the patients included in the study.
MATERIAL AND METHODS
Subjects
In 1992, 4,567 patients wereadmitted to the Department of Internal Medicine of
the University Hospital of Tromsø. During a six-week period from February 1, 1993,
all admissions to this department were considered for inclusion in the Tromsø Medical
Department Health Benefit Study. The groups excluded were: (a) patients transferred
from other university hospitals (n = 3); (b) patients admitted for evaluation or
continuation of treatment started during a previous stay (n 27); and (c) patients
admitted for inclusion in drug trials (n = 2). One patient was xcluded because his
medical record could not be found. Of the 488 remaining, nine planned readmissions
were merged with the primary admission, resulting in the inclusion of a total of 479
hospital stays. Each stay was given a probability of 0.10 of being randomized to the
present study for the purpose of investigating interpanel agreement. Randomization
was performed with a pseudorandom number generator.
Expert Panels
Two expert panels were established. Each expert panel consisted of one internist,
one surgeon, and one general practitioner. All the experts were board-certified special
ists in their respective fields. None of them had any connection with the department
being studied. All the hospital stays in this study were evaluated by both expert panels.
Before the study began, the experts examined and discussed the evaluation pro
tocol thoroughly. The study was approved by the Regional Ethics Committee and
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Expected remaining lifetime and quality of life without hospital stay:
Expected remaining lifetime and quality of lite atter hospital stay:
Figure 1. Time scales for assessing gain in lite expectancy and quality of lite. It wasassumed that the patient would not have received any treatment for the current healthproblem had he or she not been admitted to hospital. a = Life expectancy of person ofsame age and sex in the general population (information given by the project coordinator);b1 = lite expectancy of the patient had he or she not been hospitalized; b2 lite expectancyof the patient atter hospital stay (lite expectancy gain from hospital stay = b2 — bi); ci =lifetime in perfect health atter having traded off time equal to b1 — c1 in the hypotheticalsituation without hospitalization; c2 analogous to c1 in the situation atter this hospital stay.Mean quality of lite without hospitalization = c1/b. Mean quality of lite atter hospital stay
= c21b. Gain in quality of lite from hospital stay = c2/b —c1b.
the Norwegian Data Inspectorate. It was subsequently tested in a pilot study with
10 cases.
Data
Detailed descriptions of each hospital stay were compiled from the patients’ discharge
reports and medical records by the project coordinator (BOE), who is a board
certified specialist in internal medicine. The descriptions included social history,
previous ilinesses, current problem, medication, physical findings, results of tests,
treatment during the stay, and plans for further treatment. For patients transferred
to other departments in the hospital, the discharge reports from these departments
were included, as was information from planned readmissions or further diagnostic
procedures within 2 months of the primary admission. The summaries were blinded,
both with respect to the identity of the patients and of their physicians.
Evaluation of lmprovement in Lite Expectancy and Quality of Lite
As part of a questionnaire on the health benefit of the hospital stays, the experts
assessed gain in life expectancy and quality of life. Life expectancy was recorded on
two separate time scales (Figure 1): one for the patient’s situation after the stay (b2),
and one for the hypothetical situation had he or she not been hospitalized or treated
elsewhere (b1). Life expectancy gain was calculated as the difference between these
two assessments. The experts were given information about the life expectancy of
a person of the same sex and age in the general population by a mark on the timescales (a).
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Quality of life was measured with the time trade-off techniques (16). Using the
same two time scales as above, the experts were asked to decide how much of their
remaining lifetime they would have been willing to exchange for perfect health up
to the time of death, had they been in the patient’s situation. The lifetime left after
this trade-off was recorded on the time scale, with the average quality of life calculated
as the ratio between this quantity and the total remaining lifetime (Figure 1). A ratio
of 0 corresponded to the lowest possible quality of life, i.e., coma or death; 1.0 to
perfect health. This procedure was carried out for the patient’s situation If he had
not been hospitalized or otherwise treated (c1), and then again for his actual situation
after this hospital stay (c2). The gain in quality of life was defined as the difference
between the average quality of life in the two situations.
Consensus Criteria
The hospital stays were first evaluated by each expert individually. For each of the
two expert panels, consensus between the three experts was defined to exist if: (a)
the difference between the maximum and minimum life expectancy gain estimates
did not exceed 25% of the average estimated life expectancy of the patient after the
hospital stay; and (b) th difference between the maximum and minimum quality-of
life gain estimates did not exceed 0.20. When both criteria were met, the panel’s
assessment was defined as the median of the three individualassessments. Otherwise,
the case was discussed in a meeting of the three members of the panel, led by the
project coordinator who did not take part in the discussion. After the discussion,
the experts revised their individual estimates, and the median was again taken to
represent the panel’s assessment, even if the consensus criteria were not met.
There was no contact between the two expert panels during the study.
Statistical Methods
To investigate the structure of agreement between the two panels, the assessments
were divided into categories of low, intermediate, and high gain and tabulated against
each other in a 3 x 3 contingency table. The log-linear model of nonhomogeneous
agreement described by Tanner and Young (14) was used for finding separate pararne
ters characterizing each category, the antilog of which we will define here as agreement
parameters. The agreement parameters can be interpreted as the ratio between the
modeled probability of agreement for a category and the probability expected from
chance alone. A value greater than 1 indicates higher agreement than expected by
chance, and a value less than 1, lower agreement. Before fitting log-linear models,
sampling zeroes in the contingency tables were elirninated by calculating pseudo-Bayes
estimates of the cell counts (1).
The weighted kappa statistic was calculated with the squares of the number of
categories of disagreement used as weights (3). Statistical significance was set at p < .05.
RESULTS
Of the hospital stays included in the main part of the Tromsø Medical Department
Health Benefit Study, 57 were randomized to the present investigation of interpanel
agreement.
Life Expectancy
The final estimates of life expectancy gain by both expert panels are shown in Figure
2. The median difference between the assessments of panel A and B was 0.0 years
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Figure 2. Life expectancy gain from hospital stays in years estimated by both expert
panels (n = 57).
(range: — 12.0 to 7.0 years; 5010, — 5.2 years; 95%, 2.5 years). There was agreement
that there would be no life expectancy gain in 26 cases (46%).
Agreement between the expert panels was analyzed with assessments categorized
into low (0—0.5 years), intermediate (0.5—5 years), and high (>5 years) life expectancy
gain (Table 1). The model of nonhomogeneous agreement provided an excellent fit
with a log-likelihood ratio of 0.01, df = i (p = .91). The agreement parameter for
iow gain was 7.01, for intermediate gain, 3.60, and for high gain, 10.22.
The overall agreement in Table 1 was 0.67, and the weighted kappa statistic was
0.45 (95% confidence interval, 0.18—0.73).
Quality of Lite
Estimates of gain in quality of life are shown in Figure 3. The median difference
between the assessments of panel A and B was 0.00 (range: —0.25 to 0.35, 5%,
— 0.05; 95%, 0.18). There was agreement that there would be no quality of life gain
in 29 cases (51%).
In the analysis of agreement, the assessments were grouped into three categories:
110 gain(0), intermediate gain (0—0.10), and high gain (>0.10)(Table 2). The dividing
line between the middie and upper categories was set as Iow as 0.10, because there
were very few patients with a high gain. The model of nonhomogeneous agreement
fitted the data weIl with a Iog-likelihood ratio of 0.26, df = I (p = .61). The





Expert panel B 20
10
0
cases at the orij Expert panel A
130 INTL. J. OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 12:1, 1996
Assessing health benefit
Table 1. Hospital Stays Categorized According to Life Expectancy Gain by Both Expert
Panels (Pseudo-Bayes Estimates of Cell Counts) (n = 57)
Expert panel B
0—0.5 years 0.5—5 years >5 years Total
0—0.5 years 29 (27.5) 15 (14.4) 3 (3.2) 47 (45.2)
Expert panel A
0.5—5 years 0 (0.4) 6 (6.0) 0 (0.4) 6 (6.9)
>5 years 0 (0.4) i (1.4) 3 (3.2) 4 (5.0)
Total 29 (28.3) 22 (21.8) 6 (6.9) 57 (57.0)
0.8
0.6
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Figure 3. Quality of life gain estimated with the time trade-off method by both expert
panels (n = 57).
Overall agreement in Table 2 was 0.68, and weighted kappa was 0.63 (95%
confidence interval, 0.45—0.80).
DISCUSSION
The health benefit from a hospital stay is not simply the difference between health
status on admission and discharge. An explicit evaluation of the patient’s prognosis
without hospitalization and without any other form of treatment must also be made.
In this study, we assessed the quantity and quality of life in both situations to find
the effect of the hospital stay, which is the difference between these two assessments.
Agreement
For both measures, the median difference between the assessrnents of the two expert
panels was zero, and the 90% interpercentile interval quite narrow. However, inspec
tion of the data (Figures 2 and 3)revealed poor agreement when one of the assessments
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Table 2. Hospital Stays Categorized According to Quality of Life Gain as Assessed With
the Time Trade-off Method by Both Expert Pan&s (Pseudo-Bayes Estimates of CelI Counts)
(n = 57)
Expert panel B
0 0—0.1 >0.1 Total
0 29 (27.5) 9 (8.8) 0 (0.4) 38 (36.7)
0—0.1 3 (3.2) 6 (6.0) 1 (1.4) 10 (10.6)Expert panel A
>0.1 1 (1.4) 4 (4.2) 4 (4.2) 9 (9.7)
Total 33 (32.1) 19 (19.0) 5 (5.9) 57 (57.0)
differed from zero. The favorable median and interpercentile intervals were a result
of agreement that there would be no improvement in life expectancy for 46% and
in quality of life for 51% of the patients. In addition, there was reasonable agreement
on a few patients with high gain for both measures. To analyze this pattern, the
assessments were divided into categories oflow, intermediate, and high gain. Because
the weighted kappa statistic gives no information about agreement for the separate
categories of a contingency table, modeling with log-linear models was used. Models
of nonhomogeneous agreement fitted the data very well, with the probability of
agreement for categories of low or high gain from 7.01 to 12.81 times that expected
from chance alone. From the perspective of priority setting, the ability of a method
to identify patient groups with a very low or high health benefit is essential.
In a recent study, Goldman examined the interreviewer agreement of peer assess
ment of implicit evaluation of patient care episodes based on a review of medical
records or record abstracts (7). He found only two of 12 studies with kappa values
were consistently above 0.40, the conventional dividing line between agreement char
acterized as “poor” and “fair to good” (5). For our two measures, weighted kappa
values were 0.45 and 0.63, which compare favorably.
It is also relevant to compare this type of clinical judgment with the reliability
of other clinical methods. Koran (9) reviewed the interobserver agreement on clinical
signs and found kappa values ranging from 0.51 for palpation of the dorsalis pedis
pulse to 0.70 for interpretation of ECGs, which is only slightly better than the expert
panels’ judgments about health benefit. Such judgments obviously can be made with
a reliability comparable with that of methods generally accepted as valuable clinical
tools.
Vahdity
The validity of the method was not examined in this study. The gold standard would
have been randomization of patients to hospital admission or no treatment followed
by patient self-assessment of quality of life at regular intervals for the rest of their
lives.
For ethical and practical reasons, this was not possible. Instead, clinical judg
ment, refined by a consensus process, was used to assess the expected prognosis in
the two situations. In clinical practice, it is assumed that doctors can make this type
of judgment about the patient in a consistently valid and rational manner. These
judgments are important determinants of resource allocation in the health care
system. In an investigation of the relation of health benefit to resource utilization,
a method based on clinical judgment will therefore give meaningful results even in
the absence of validation by external criteria.
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Because the method involves assessments of hypothetical situations with varying
health states, patient self-assessment of quality of life was not possible. Medical
knowledge and experience are necessary to make these kinds of judgments. It can
be argued that the patients could have been provided the necessary information by
their doctors, but for practical reasons this would only have been possible for a small
number of patients, and only for those well enough to participate. For some patients,
it would have been unethical to provide detailed prognostic scenarios for the purpose
of this study alone.
Time Trade-off Method
In the study reported here, time trade-off assessments were made using marks on a
time scale instead of interviews. A similar technique was used by Pliskin et al. (12)
in a questionnaire in which they let judges directly assess the number of years to
trade-off for improvement in quality of life. This procedure gives the number of
years in full health equivalent to the patient’s life expectancy and quality of life, and
can be regarded as a direct assessment of heaLthy years equivalents (HYE), a measure
of health status proposed by Mehrez and Gafni (10). They argue against the use of
time trade-off for measuring MYE as we have done, because the standard gambie
technique must be used to place the HYE within the framework of utility theory (6).
However, several authors argue convincingly that the methods are equivalent (2;4;
8;13).
In many applications of the time trade-off technique, a constant leve! of quality
of life is assumed. In this study, most of the patients would be expected to have
varying quality of life, and this assumption could not be made. When making time
trade-off in this situation, the HYE of the patient’s !ifetime hea!th profile was assessed
direct!y. Mehrez and Gafni (10) also eva!uated an entire lifetime health profile with
varying hea!th state directly, but used the standard gamb!e instead of the time
trade-off technique.
To find the mean quality of life, we calculated the ratio between the HYE and
the patient’s total remaining lifetime. Since the HYE imp!icit!y incorporates time
preference, i.e., the tendency to value future health states lower than present ones,
this is the mean qua!ity of life after discounting future health states.
Composition of Expert Panels
Three specia!ists of internal medicine in each pane! might have performed better
than three different specialists, but we believe that this would have overemphasized
the importance of the specialized professiona! viewpoint. This study was concerned
with the final effect of the hospital stay on the patient’s health and, therefore, a
broader perspective than that provided by three internists was needed. The general
practitioner has experience with long-term follow-up outside the hospital of many
of the patients treated in departments of internal medicine and with patients with
similar conditions who for various reasons are never admitted to hospital. The sur
geon and the internist often cooperate ciosely and treat many of the same diseases.
The leve! of agreement obtained indicates that the interaction between these three
perspectives was usefu!.
Even though considerations about life expectancy and quality of life underlie
decisions about patients in c!inical practice, clinicians rarely evaluate these quantities
numerically. The consensus process was essential for limiting the variation that cou!d
be expected when doctors were asked to do so. Nevertheless, there was only agreement
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about broad categories of health gain. Given the paucity of empirical data and the
degree to which the experts were left to rely on judgment alone, this was not surprising.
CONCLUSION
The method described here cannot be used by individual doctors for accurately as
sessing improvements in life expectancy and quality of life for individual patients,
but was shown to produce reliable results when used by expert panels for identifying
groups of patients with low, intermediate, and high health gain. The level of
agreement was well above that expected from chance and better than that between
most peer assessments in a recent review of other studies. Moreover, it was only
slightly lower than the leve! of agreement for other generally accepted clinical
methods.
APPENDIX
To illustrate the assessment technique, some cases with common conditions seen in
a department of general medicine are presented below.
Agreement in both categories ot lite expectancy gain and quality ot lite
gain:
Man, 77 years old, widower, retired farmer. Diabetes mellitus from 1976, treated
with an oral agent. Terminated this medication himself after having experienced side
effects. Admitted for initiation of insulin treatment. Symptoms and physical findings
consistent with peripheral neuropathy. Serum glucose 30 mmol/L on admittance.
Given two injections a day of intermediate acting insulin with resulting improvement
in serum-glucose. Appointment made for further adjustment of insulin dose in the
outpatient clinic.
Lifeexpectancygain: panel A, 3.0 years panel B, 0.6 years
Quality of life gain: panel A, 0.03 panel B, 0.03
Agreement in category of lite expectancy gain, disagreement in category
of quality of lite gain:
Man, 63 years old, retired fisherman. Except for musculoskeleta! pain, not previously
ill. Admitted with acute chest pain caused by an acute postero!ateral myocardial
infarction. Treated with streptokinase. Course complicated by transient clinical signs
ofpulmonary congestion, pneumonia, and a possible postmyocardial infarction syn
drome. Echocardiography demonstrated pronounced hypokinesia of the posterolat
eral walI of the left ventricie and some pericardial effusion. Discharged with aspirin
and enalapril.
Lifeexpectancygain: panel A, 10.0 years panel B, 7.0 years
Quality of life gain: panel A, 0.45 panel B, 0.10
Disagreement in category of lite expectancy gain, agreement in category
ot quality ot lite gain:
Woman, 67 years old, married, on sick leave from job as shop assistant. Hyperten
sion. Angina pectoris for 1 year, NYHA class III despite treatment with propranolol,
isosorbide dinitrate, and diltiazem. Admitted for percutaneous transluminal coronary
angioplasty. Tandem stenosis in the second segment of the left anterior descending
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artery dilated successfully. Treated with heparin for I day because of uncertainty
about a possible intimal lesion, no signs of myocardial infarction. Performed 100W
on exercise ECG before discharge. Discharged with reduced doses of propranolol
and diltiazem plus aspirin.
Life expectancy gain: panel. A, 0 years panel B, 2.0 years
Quality of life gain: panel A, 0.13 panel B, 0.13
Agreement on no gain for both measures:
Man 68 years, retired fisherman. Several stays for chronic obstructive pulmonary
disease, acute myocardial infarction 5 years ago. Admitted for worsening of his
dyspnea and acute chest pain. No evidence of new myocardial infarction. Treated
with prednisolone for his chronic obstructive pulmonary disease. Doxycycline was
added because he also had fever. Discharged after gradual improvement of his
dyspnea.
Lifeexpectancygain: panel A, 0 years panel B, 0 years
Quality of life gain: panel A, 0 panel B, 0
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ABSTRACT. Doubts about the effectiveness of medical care in improving patient health h
ave been raised by
epidemiological studies and by studies of geographical variation and inappropriate use of health c
are To investi
gate this problem, the life expectancy gain (LEG) from consecutive admissionS to a dep
artment of intemal
medicine during a six.week period was assessed by two espert panels, each consisting of an inremist
, a surgeon,
and a general pracritionel. The mean LEG for all admissions was 2.25 years (n = 422). Six
ty-one percent had
a LEG of 0.10 years or less, whlle 5% had a LEG of more than 9.98 years. In a probabilisti
c sensitivity analysis,
the mean LEG remained greater than zero under assumptions of overestimated positive LEG
and underestimated
negative LEG. \Ve conclude that the Ife expectancy of ihe majoriry of the parienta was not influe
nced by the
admission, but that a minority had substantial gainS, resulting in a high overall mean LEG
. I CLIN EPIOEMIOL
50;9:987—995, 1997. © 1997 Elsevier Science Ene.
KEY WORDS. Life expecrancy, outcome assessment health care, quality of care, Monte
Carlo method, sensitiv
ity analysiS, iatrogenic disease.
‘1TRODUCTION
)espite impressive medical triumphs over the last decades,
ealth care has come under attack, and the scientific foun
ation ofmedicalpractice is being questioned [1,2]. Claims
an be heard that medical care has litrle [3,41 or even a
egative effect on population health [5,6], and that scarce
;sources are heing used inefficiently L7,8]. Studies ofappro.
riateness of care and of practice s’ariation indicate that all
ealth care cannot be equally effecrive [9,101. New techno!
gies are often introduced without proper scientific evalua
on [11,12], svhtle randomi:ed clinical trials sometimes
sow that sve11estabIished technologies yield no health
enefit when they are evaluated in the end [13,14]. Also,
-se decline in rnortality from infectious diseases, prior to
se introduction of imlnuni:atlon and antimicrohial agents,
sdicates that medical innovations may have heen less im
srtant contributors to health itnprovements in this century
san is sometimes believed 115—17].
ddrcss for correspondence: Ejorn Odvar Eriksen, Deparrmenr cl Med,
nr, University Hospital 0f Tromsø, 9038 Tromsø, Nonvai.
Acceptcd for pablication nr, 9 Jsmc 1997.
Though none of the studies referred to above directly in
vestigateS the beneht obtained by individual patientS from
encounters with the hea1thcare system, they all suggest that
on average it may be Iow or even non-existent. The aim of
the present investigation, ss’hich was undertaken as a part
of the Tromsø Medical Department Health Benefit Study
[181, was to explore this possibility by assessing the gain in
life expectancy frorn consecutis’e admissions to the deparr
ment of intemal medicine of a university hospital. To inves
tigate claims of ineffciency, we were particularly interested
in the proportion of admissions w’ith no or very low life
expectancy gain. Ideally, estimation of Iife expectancy gain
should be hased on ti-se results of randomized clinical trials
(RCTs). However, a recent study found that only 53% of
the primary interventions applied to patients in a depart
ment of general medicine were supported by RCTs [19]. in
addition, the extemal validity of RCTs can solnetimes be
questioned hecause they are performed on selected patient
groups and often cannot be applied directly ro orher pa
tienrs. Thus, estimation of the Ilfe expectancy gain from
hospital stays from this kind of “hard” evidence alone is not
possihle at present. As the second best solution, we chose
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a method wherc litt cstpectancy gain was assessed by panels
of experi cliniui,ins. Tbis metbod bas been shown ro pro
duce reliable resulis for i randoio sample of rhe admissions
included in tbe Tromsø Medicil l)epirtincnr Health Bene
fit Study [18], and has also heen used in orher similar studies
[20]. However, a rnethod based on clinical judgment has its
nbvious limitations. For tbis reason, the robustness of our
conclosions was tested in a sensirisity analysis assuming dif
ferent degrees of hias in the assessments. In particular, data
from the litetature about tbe occurrence of adverse evenis
during bospiralization were used to ins’estigate tFie effect of
a possible underestimation of iarrogenic life expectancy loss.
MATERIAL AND METHODS
Subjects
In 1993, 5151 patients were admitted to the departinent of
internal medicine at rbe Untversiry Hospital of Tromsø in
tbe norrbern part of Norway. During a six-week period from
I February 1993, all admissions were eligible for inclusion
in the Tromsø Medical Deparrmenr Health Benefir Stody.
Patients rransferred from otber university hospitals (n = 3),
patients admirted for evaluarion or enntinuation of treat
ment started during a previnus stay (n = 27), and patients
admitted for inclusion in drug trials (n = 2) were excloded,
as weIl as one parient wbose medical record could not be
found. Nine planned readmissions were inerged witb tbe
primary admission, resulting in a total of 479 incloded ad
missions. For a study of interpanel agreement, a randoin
sample was nbtained by giving each admission a prohahiliry
of 0.1 of being drawn. Tbe results of this stody have been
publisbed previously [18]. Tbe remaining admissions were
used for the present investigation.
Tbe study was approved by the Regional Ethics Commir
tee and the Norwegian Data Inspectorare.
Expert Panels
Two experr panels were recruired, each consisting of an in
teniist, a surgeon, and a general practitioner. All the experts
were board-eertified specialists in their respective flelds.
None of them bad any connecrion with the department be-
ing investigated.
Assessmast of Life Expeetancy Gain (LEG)
When a patient was discharged or died in the hospital, a
summary containing his coinplere medical history and all
data from the current stay was eompiled by the projecr coor
dinator, a board-certitied specialist of internal medicine.
The summaries were intended to be comprehensive, and
included a social hisrory, previous illnesses, cutrent health
problem, medication, physical findings, results of tests, diag
nosis, treatment doring rhe stay, and plans for furrher treat
ment. ‘Tbey were used by the experrs for assessing various
aspects of health henefir frorn t1se hospital stays. Ihe result
of the evaluarion of life expecrancy gain (LEG) will be re
ported here.
To estimate the gain in life expectancy attrihutahle ti
tbe hospital stay, the experts estiinated life expecraney fo
two siruarions: (i) for the patient’s prognosis after this bospi
tal stay, taking into actount the expected outcome c
planned rreatmenr after discharge, and (ii) for the patient’
expected prognosis in the hypothetical situation bad be no
heen admitted to hospital nr tteated elsewhere for his cur
rent health problem. LED was rhen ealculated as the differ
ence between these rwo assessments. The experts were in
structed to base tbeir assessments on rhe best availab[
evidence in each case: RCTs, otber empirical data, nr elini
cal judginent alone. They were also told to consider th
intluente of otber diseases and risk factors on life expec
rancy. As an aid, the experts were gis’en information ahnu
rhe average life expectancy of a person of the same sex an’
age in the general population.
The experrs also assessed whether patients with a positiv!
LED could have achieved the same gain in an outpatien
clinic nr in primary care.
Assesssnent Protocol
Each admission was randomly assigned to be assessed by on
oftbe two experr panels. In the panels, rhe admissions wer
first assessed by each expert indn’idually. The esnmares c
the three memhers of each panel ss’ere tben compared. Con
sensus ss’as defined to exist when the difference berween th
inaximum and minimum LEG esrimares did not exceed 259
of the average estimated life expectancy of the patient afre
rhe hospital stay. When this erirerion was met, the panel’
assessment was defined as the median of the three individua
assessments. Otherwise, the case was discussed in a rneetin
of the rhree members of rhe panel. After the diseussion, th
experts revised their individual estiinates, and the mediai
was again taken as the LEG, even if rhe consensus enten
were not mer.
There svas no contact hetween the rsvn experr panels dui
ing rbe study.
ICD9 Codea
All ICD9 codes were rroncated ro three digits and cheeke
by rhe projeet coordinarnr for consisrency with the diagnos
tic conclusinns in tbe disebarge repnrrs. When there ss’s
more than nne ende, be alsn cheeked thar tbe prineipt
diagnnsis enrrespnnded ro tbe patient’s corrent bealr
problem.
S:atisticol Metkoda
Approximare 95% eonfidence intervals nfstatisrieal parair
eters were estimared by raking rhe 2.Srh and 97.Srh pereer
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tiles of the bootstrap distribution of the paramerer in ques
rion. The bootstrap distributions were obtained with Monte
Earlo simulations by drawing 1000 random resamples ofstze
22 with replacement from the original observations. The
ootsrrap distributions ofregression coefficients in multivar
ate linear regression analyses were found by calculating the
east-squares estimates of the coefficients for each of 10,000
esamp1es.
erasitieity Anexlysi.s
rhe rnean LEG for all admissiona is a function of the pro
aortion of admissions achieving LEG and the magnitude of
:he LEG obtained through each admission. From this
imount must be subtracted iatrogenic life expectancy losses
le., negative LEG), which are a function of the proportion
f admissions suffering loss and the magnitude of loss suf
red by each admission. To investigate the dependence of
:he mean LEG on these four variables, a probabiliatic sensi
iviry analysis waa performed [21]. Following a rnethod de
cribed by Doubilet et at. [22], the variables were varied si
nultaneously by drawing them fram logistic-normal
robability density diatributions in a Monte Carlo sirnula
ion. In a logistic-normal distribution, the logit transform
og(X/1-X), of each variable is normally distributed. For
nch variable, the parameters of this distribution were calcu
ated from the baseline value and the bounds ofa 95% con
dence interval.
The baseline proportion of admissions obtaining a posi
ive LEG was taken from the present study, and the lower
md upper bounds of this variable were set equal to the esti
flateS of expert panels A and B, respectively. The baseline
nagnitude of LEG and ita 95% corsfidence interval were
miso estimated on the basis of our own data by calculating
he mean LEG for adrnissions with LEG greater than 0.10
‘ear.
Estimates of the proportion of admissions resulting in life
xpectancy loss were found in the literature. The percent
ge ofpatients suffering an iatrogenic death in departments
f intemal medicine was estimated by Kneet at 2% [23] and
y Brennan at 0.5% [24]. The percentage suffering major
dverse events, defined as events that produce considerable
lisability or threaten life, was 9% in Kneet’s study, while
he percentage with permanent disability was 0.1% in Bren
san’s study. The sums of the two estimates for each of the
tudies were taken ss the lower (0.6%) and upper (11%)
ounds for the percenrage of admissions with negative LEG,
nd their average as the baseline percentage.
The baseline amount of negative LEG suffered by these
dmissions ass arhirrarily ser at 50% of the average life ex
ectancy of a person in the general population svho is of
be same age and sex ss the patient. The lower and upper
ommnds ss’ere set at 25% and 75%.
The analysis ass repeated with the additional assumption
hat all LEGs svere overestimated by 50%.
RESULTS
Ofthe 422 patients included in time study, 160 (37.9%) were
women, and 262 (62.1%) men. The mean age was 61.6
years; for women 61.0 years (range 16—94), for men 61.9
years (range 15—90). 152 (36.0%) were elective and 270
(64.0%) emergency admissions. Twenty (4.7%) patients
died in the hospital.
Diagnosis
In total, 110 different ICD9 principal diagnosis were used.
Similar diagnoses were merged sa that each diagnostic group
included 10 hospital stays or more (Table 1). Angina pecto
ris and acute myocardial infarction togerher accounted fot
27.2% of the admissions.
Differences Between rhe Two Expert Panels
Two hundred fifteen admissions were assessed by expert
panel A (50.9%), and 207 by expert panel B (49.1%). The
difference between the mean LEG of these two groups was
0.32 years (95% confldence interval —0.88—1.42). The per
centage of admissions assessed to have bad a gain less than
0.10 year was 70.2% by panel A and 52.2% by panel B. The
difference between the two was 18.0% (95% confldence in
terval 8.7—26.9%). In the following analyses, the estimates
of the two panels were pooled.
Life Expectancy Qain (LEQ)
The total LEG for all admissions was 949.17 years, and the
rneanLEG 2.25 years (95% conlidence interval 1.74—2.84).
Only one stay (0.2%) was estimated to have resulted in a
negative LEG, i.e., that the hospital stay shortened the pa
tient’s life. This patient was an 80-year-old man who had
initially been admitted for hematochezia, and who died
after surgery for a suspeoted sigmoid cancer. His LEG was
—0.07 years, which is a life expectarscy loss of about 1
month. The final dmagrsosis was diverticulitis with obstruc
tion, svhich probably also would have been fatal if it had
not been treated surgically.
Ofthe admissions, 259 (61.4%> bad a LEG of 0.10 years
or less, svhile 5% bad a LEG of more than 9.98 years. The
distribution of LEG is shown in Fig. 1, and the LEG ac
cording to sex, age group, admission category, and diagnos
tic group in Table 1. The assessments for the 10 patients
svith the highest LEG are presersted in Table 2. These pa
tients together accounted for 33.1% ofthe total LEG in the
material.
Regression Analysis
The effects of sex, age, diagnosis, and admission type (elec
tive ar emergency) on LEG svere examined in a multivariate
linear regression analysis. Dummy variables seere used for
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TABLE I. Mean LEG according to sex age group, admission category and diagnostic group
for patienis admitted to a departnsent of internal medicme (n = 422)
Mean LEG Percent
in years of’ total
ICD9.code n (%) (95% CI) LEG
Total
— 422 (100.0) 2.25 (1.74—2.84) 100.0
Sex
Men
— 262 (62.1) 2.03 (l.56—2 59) 56. I
Womcn
— 160 ( 37,9) 2 60 (1.51—3.96) 43.9
Ac trosiJ
<50 eirs
— 93 (22.0) 4.12 (2.19—6 49) 40.4
50—69 year
— 180 (42.7) 2.18 (1.61—2.80) 41.4
70 ycars
— 149 (35.3) 1.16 (0.88—1.45) 18.2
Admission CitCOI’V
Eleciivc
— 152 (360) I 81 (1.31—2.37) 29.0
Emcrcncy
— 270 (64.0) 2.50 (1.73—3.38) 71.0
fliagnostic grotip
lrifectious diseases 001—139 I? (4.0) 8.88 (1.25—18.86) I 5.9
Malignant diseases 140—208 42 (10.0) 0.95 (0.58—1.38) 4.2
Endocrinological diseases 240—259 11 (2.6) 12.28 (4.36—21.17) 14.2
Acure myocardial infarction 410 30 (7.1) 1.03 (0..35—1.83) 3.3
Angina pecroris 411—414 85 (20.1) 1.79 (1.15—2.53) 16.0
Other hearr diseases 420—429 45 (10.7) 2.63 (1.78—3.50) 12.4
Cerebriivascular diseases 430-438 21 (5.0) 0.22 (0.00—0.49) 0.5
Pneuinonja and influenza 480—487 16 (3.8) 2.97 (1.38—5.02) 5.0
Chronic olstr. pulrn. disease 496 20 (4.7) 1.24 (0.10—2.99) 2.6
Heparohiliary/pancreatic diseases 570—579 13 (3.1) 2.23 (0.22—4.98) 3.0
Undiagnosed symptoms 780—769 30 (7.1) 0.07 (0.00—0.23) 0.2
Other 92 (21.8) 2.33 (1.40—3.55) 22.6
AI+rcs’iatri,ns: Cl = confidence interv.iI. LEG lite cxpcctancy gain.
300 —_________________
— I —-
-0.1-0.1 0.1-1 1-5 5-10 10-15
FIGURE 1. Distribution of
LEG from hospital stays at as.
sessed by the two expert pen.
els (n = 422).
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TABLE 3. Multivariate linear regression analysis of LEG (n = 422)
Independent variables’ Estimate 95% C1
liiICft(’I’I 5.79 (3.05—9.21)
Sex 0 M, I — I-) 0.09 (—0.95—1.25)
Age —0.07 (—0.13 —0.02)
Admission category (0 = elective, I = crnergency) 0.88 (—0.15—2.01)
Intectioui diseases 5.21 ( — I 63 15.01)
Milignant diseases —0.60 (— 1.74 0.53)
Endocrinological diseases 9.85 (2.38—18.09)
Acute rnviscardial inlarction —0.74 ( —2.04—0.57)
Angina pectorls 0.13 (—1.15—1.40)
Other beart diseases 1.21 (—0.15—2.69)
Cerehrovascular diseases —1.09 (—2.18—0.05)
Pneutnonis and ifltliien:a 1.42 I —0.46 3.50)
Chronic ibsrructive psilinoniry disease —0.76 ( — 2.46— I .33)
Hepatohiliary/pancreatic diseases 0.21 I —2.26 3.20)
Undiagnosed syinptorn —2.06 (‘—3.35 — 1.06)
Abbrcviitions CI — conhdence intervil, LEO = lile cxpccsancy gain.
The disease carcgory “orher” serves as rclerence for tEr durnm variablesol tEr disease caregories.
Esirmired svith tEr hoorsrrrp algorrthrri form I 0,000 resarnrles.
the diagnosric groups witb ‘other diagnoses’ as reference.
Because of non-normal residuals, che hootstrap algoritbm
was used for finding 95% confidence intervals for the regres
sion coefficients. The confidence intervals of the coefli
cienrs for age, endocrinological diseases, and undiagnosed
symproms did not include zero. Higher age and undiagnosed
symproms were associared witb lower and endocrinological
diseases svith bigher LEG (Tahie 3).
Levet of Care
Five of the patients could have ohtained a sirnilar LEG in
primary care nr in an outparient clinic. The toral LEG of
these patienrs was 9.04 years, which was I .0% of tbe total
LEG in the material.
Probabilistic Sensitivity Analysis
The haseline and lower and upper hounds for the s’ariables
in ihe probabilistic sensitivity analysis model are sbown in
Table 4. In a Monte Carlo simulation of 10,000 runs ofthe





Positive life expect.rncy gain 0.388 0.298 0.478
Negative Ide expecrancy gain 0.058 0.006 0,110
Life expectancy gain
Positive life expectancy gain
(years) 5.82 5.03 6.62
Negative life expcctancy gein,
(fraction ot Irfe expectancy
in general popirlation) 0.50 0.25 0.75
model, the distribution of the mean LEG bad a median
1.40 years (mean 1.34, standard deviation 0.42, ran
—1.48—2.57 years, 2.5th percentile 0.36 years, 97.5th ps
centile 2.04 years). A total of 99.2% of the runs resulted
a mean LEG grearer than zero.
Rursning the model under the additional assumption tb
all positive LEGs bad been over-estimated by 50% result
in 3 median mean LEG of 0.76 years (mean 0.71, standa
deviation 0.36, range —2.13—1.60 years, 2.5th percent
—0.14 years, 97.5th percenrile 1.27 years). A total of 95.9
of the runs yielded a mean LEG greater than zero.
DISCUSSION
Prolongation of Ide is one of the primary aims of heal
care. The degree ro which this aim is attained in routi
clinical practice is ohviously of grear inrerest to cliniciat
healrh administrarors, and politicians. The present inves
garion has addressed this issue by focusing on inremal mc.
cine, which accounts for a large part of patient care
hospitals.
When studying the LEG from unselected admissions
a department of inten’sal medicine, assessment by exp
panel is probably the best merhod available ar present.
a previous srudy of the reliahiliry of such assessments svh
caregorized as Iow, inrermediate, and high LEG, we repori
an overall agreement of 0.67 and a weighred kappa of 0
[18]. Tbis levd of agreement is usually regarded as “Gir
good” 1251. However, rhough reliahle, tbe assessments n
all have been subject to tbe same hias [26]. To avoid so
of tbe mosr ohvious sources of bias, we chose experts v.
bad no connection with tbe department heing studi
Also, surgeons and general practitloners seere included
the panels ar least in part because it was assumed that ti
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vould be less susceptible to upward bias than would inter
LiStS.
In other studies using expert panels, speciflc guidelines
Jr evaluating various outcomes have often been made [rom
terature studies and expert opinion. In our study, it was
Lot feasible ro use this method fot all the different cases
dmitted to a department of intemal medicine. Instead, the
xperts were instructed to use the best evidence available
s each case. They were also instructed to take into consid
ration all relevant aspects of the patient’s situation that
Jight influence his life expectancy, including other III
esses and risk factors.
4ean LEG
)ur main finding was that mean LEG from admissions to
departrnent of intemal medicine was 2.25 years, which
learly does not support ihe claim that medical care has
ttle or no positive effect on patients’ health.
A probabilistic sensitivity analysis was used to investigate
e effect of possible bias on the conclusion that mean LEG
as grearer than zero. We assumed that upward bias could
sult from (i) awarding LEG to patients who actually did
ot benefit, and (ii) underestimating a possible negative ef
ct of the hospital care on patient life expectancy, i.e., that
)me patients had actually suffered iatrogenic life expec
LflCY Ioss. In the model, both the percentages of admissions
sulting in positive and negative LEG, as well as the magni
ides of positive and negative gain, were varied simulta
ously in a Monte Carlo simulation.
We were especially interested in studying the effect of a
igher percentage of iatrogenic life expectancy loss than
sat estimated by the expert panels (0.2%). Therefore, base
ne data for this effect were taken from the Iiterature. As
r as we know, studies of the occurrence of life expectancy
ss as such do not exist, but at least two studies provide
timates of the probabiliry of major adverse events, these
ing defined as events that produce considerable disability
threaten life [23,24]. The estimates differ widely (0.6%
rsus 11%), and the baseline probability of life expectaricy
ss was taken as their as’erage (5.8%). This percenrage was
arly 30 times the estimate of the expert panels (0.2%).
‘e could not 6nd information on the magnirude of life
pectancy loss suffered by each patient in the literature,
id the baseline of this variable ss’as arhitrarily set as high
50% of the remaining life expectancy of a person of rhe
me age and sex in the general population. Since patients
ve a shorter life expectancy than the general population,
ere is good reason to helieve that the true value is losser,
Jich means that this assumption would hias che model
ward a lower mean LEG.
When running the model with these inputs (Table 4),
e inedian men LEG ssas Iower ihan estimated by the
pert panels, hut stil as high as 1.40 years. Ninety-nine
percent of the 10,000 Monte Carlo simulations gave a posi
tive mean LEG. Repeating the run under the added assump
tion ihat all positive LEGs had been overestimated by 50%
still resulred in a positive median mean LEG of 0.76 years,
and a positive mean LEG in 96% of the simulations.
It is not ciear svhether these results from the medical de
partment of a teaching hospital are representative of otber
parts of health care. One would expect better results from
a teaching hospital than [rom a local hospital, but we are
not aware of data that would support this assumption. In
surgical deparrrnents, the opportuniries both for life expec
tancy gains and losses may be grearer than in departmenrs
of intemal medicine, but studies wouid be needed to find
out whether the balance is positive or negative.
The finding of a zero or negative mean LEG would have
supported the claim that medical care has linJe effect on
population longevity, but a positive mean LEG does not
necessarily imply a positive effect on the population level.
An estimate of the effect on the population level wouId also
have to take into account the proportion of the population
treated in hospitals and the frequency of readmissions. For
example, if a patient is saved from diabetic coma several
times, this adds to population life expectancy only once, but
each admission would increase the mean LEG of a hospital
department.
However, even if our results do not directly contradict
the views of the most extreme critics of health care [5,6],
orher studies, svhich have examined the effect of medical
care on the population level, do. Mackenbach et al. [27]
found the gain in life expectancy in the Netberlands [rom
the 1950s to 1980s due to the reduction in morrality for
conditions amenable to medical treattnent to be 2.96 years
for males and 3.95 years for females. Studies of causes of
death amenable to medical treatment in orher countries
show similar results [28—30]. Bunker er af. [31] estimated
the effect of curative medicine for selected diagnoses on ife
expectancy ar birrh in the United States [rom data about
the effect of treatments and population at risk. He found
that curative medicine prolonged life expectancy about 3.5
years. Hadley’s [321 study of mortality rates in the United
States also concluded with a significant effect of rnedical
care. These studies all indicate a non-trivial effect of medi
cal care on life expectancy.
Distribution of LEÇ
Alrhough the mean LEG was positive, the hospital stays
bad linJe or no influence on the Iife expecrancy of the ma
Joritv of the patients. On the other hand, a minority bad
considerable benefits (Fg. I). The positive mean LEG was
a result of the high gain for these few parients, who, in the
opinion of the experr panels, would have suffered premarure
deaths if they bad not heen admitted.
Ofrhe ren parients with the highest gains, none was alder
994 B. 0, Eriksen er al.
than 50 years (Table 2), md highcr age was associared wmth
a Iower LEG in the regression mnalysis. Gender was not a
significant regressor. Endocrmnologmcal diseases predisposed
for hmgh LEG, whereas patlenrs s’ho were not given a spe
cific diagnosis were least likely to henetit (Tible 3). The
list of che ren patienis with rhe highesr gains (Table 2)
shows that a large proportion of the total LEG came from
treating lifethrearening bacterial infections, complications
ofdiabetes inellitus, and one patient with cardiac complica
tions of thyrotoxicosis. Sorne parienrs vith coronary heart
disease also achieved higb gains, hut acute myocardial in
farction and angina pecroris were not significantly associ
ated with a higb LEG (Table 3).
lt is noteworthy ihit a considerable percentage of the
total LEG was attributable to interventions that have heen
available for decades (honnone substitution, antirnicrobial
agents). lnfectious and endocrinological diseases together
accounted for 7% of the admissions and 30% of the total
LEG. In most industrialized countries, these diseases are not
very frequenr causes of death. In contrast, malignant, and
cardiovascular diseases eiere che cause of 53% of the admis
sions, hut only 37% of the total LEG (Table 1).
A high proportion of admissions with low gain is consis
tent with the high rate of inappropriately performed proce
dures found in some studies [331. An mnappropriately per
formed procedure would have a low probability of a LEG
but exposes the patlent to an unnecessary risk of iatrogenic
health loss. The sensitivity analysis indicated that there was
a wide margin hefore this could outweigh a positive LEG,
but the analysis did not consider loss in quality of life, which
is probably more common than loss in life expectancy.
Geographical variation in the rate of hospital admissions
without any noticeable difference in mortality [341 could be
explainecl by variation in time numher of adrnissions svith a
low LEG. As long as the minority of patients with high gain
is identied and admnitted, the total number of admissions
wmll not necessarily be correlared with morrality.
Life Expectancy versus Quality of Life
Ir would be premarure to conclude that rhe large percentage
of admissions wmth negligible LEG were unnecessary or mdi
cared inefficient use of health-care resources. Some claim
that the effect of modern health care should be jtidged more
frorn irs effect on qualiry of life than on longeviry 135—371.
It is possible that rhe majoriry of parienrs with a low LEG
in this study bad bad an improvernenr in their quality of
life, and that rhe percenrage of patients with no benefir at
all was lower. Tbis issije will be addressed in another paper.
CONCLUSIONS
Admission to a deparrment of internal medicine had rio
influence on the life expecrancy of the majority of rhe pa
rienrs. A minoriry bad substantial LEGs, resulting in an
overall mean LEG of 2.25 years. When assuming that LEG
bad heen overestimared and iatrogenic life expecrancy loss
underestmmated in a sensitivity analysis, the mean LEG was
still positive in almost all 10,000 runs of a Monte Carlo
simulation.
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Does admission to a department of internal medicine improve
patients’ quality of life?
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Abstract. Eriksen BO. Kristiansen IS. Nord E. Pape JF,
Almdahl SM, Hensrud A, Jæger S, MOrer FA,
Robertsen R, Thorsen G (University Hospital of
Tromsø; University of Tromsø; National Institute of
Public Health. Oslo: Kommunelegekontoret i Bardu,
Bardu; Nordland Central Hospital, Bodo: Rana
Hospital, Mo; Åsgård Psychiatric Hospital, Tromsø;
and Harstad sykehus, Harstad, Norway). Does admis
sion to a department of internal medicine improve
patients’ quality of life? J Inter,l Med 1998; 244:
397—404.
Objectives. The Tromsø Medical Department Health
Benefit Study was designed to estimate health gains
from admissions to a department of internal medi
cine. We have previously reported that the hospital
stays had no effect on the life expectancy of 61% of
the patients. However. it has been claimed that mod
ern medicine has a greater effect on quality of life
(QoL) than on life expectancy. The aim of the present
study was to investigate this issue by estimating gains
in QoL for patients admitted to a department of inter
nal medicine.
Design. The time trade-off method (TTO) was used
for assessing QoL gain from consecutive admissions
during a 6-week period. The assessments were made
by one of two expert panels, each consisting of an
internist, a surgeon and a general practitioner, on
the basis of summaries of all relevant clinical infor
mation about the patients. Short-term improvements
in QoL during the stay or shortly after discharge were
scored on an ordinal scale.
Results. Of the admitted patients, 41% bad gains in
QoL measured with the 1]’O (mean gain = 0.06:
95% confidence interval = 0.05—0.07; n = 422),
and eight of these had gains equal to or greater than
0.50. Another 40% had gains in health-related
short-term QoL measured with the ordinal scale. In a
multivariate linear regression analysis. emergency
admissions, high age and the disease categories
‘endocrinological diseases’ and ‘pneumonia and
influenza’, were associated with higher gain, and
‘undiagnosed symptoms’ and ‘cerebrovascular dis
eases’ with lower gain.
Conclusions. As judged by the expert panels, the
in’estigated department of internal medicine was
effective in improving the QoL of 81% of the admit
ted patients. Whilst most of the patients achieved
small gains, a minority had gains in QoL correspond
ing to the treatment of life-threatening diseases.
Keywords: health priorities, health services research,
health status indicators, hospital, patient admission,
quality of life.
Introduction
During the last 20 vears. it has been discussed to
what extent modern health care has a positive influ
ence on the health of patients. Geographical varia
tions in the use of health care 11-41 and a high
proportion of inappropriately applied procedures in
hospitals [5) suggest that all medical care cannot be
equally effective. Furthermore, a high percentage of
unnecessary adrnissions to hospitals [6—8] implies
that many patients run the risk of complications
from unnecessary interventions. In addition, epi
demiological studies have cast doubt on the effect of
health care from a population perspective [9—111.
© 1998 Blackwell Science Ltd
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The ‘l’ronsso Medical lJepir1 men I lealth llenelit
Study was designed to assess gains in quuntilv and
quality ol health in deparLnient ol inleroIl mcdi—
cine 121. We hive previously reported [hat
i tli ou gli soiiw pu I icn [5 1111(1 50 hsl i hat li fe
expec1Incy gains. llie lite expeetancy of as many as
(i I [i, 55’iiS uiiat leeted 1 3[. ‘hus could indicate a
Wastc ol resoorees, bot some uuthors clainu [hat
nioderii health care should be judged more Irom its
etTeet on quality of Lite than on life expectancy
114—1 6]. Accordingly. one should expeet that more
paticnts WoUld have bad iinprovements in quahly of
life Ihun in life expectancy.
‘l’lie aim ot thie present study was to iddress this
issuc by estinlatmg gains in qualitv of lif for thc
same patients as in our previous invesligatioli ol lite
eXpcctancy guins Il 31. To assess quality of lite gain
attribu i able to a hospital st uy, il is necessary to make
an expiicit evaluation of thc expeeted quality of lite
wit[out hospital admission. l(eeause this presunws
medicul knowledge. the asscssments werc made by
pancls of expert phvsieians. Por nleasuring quulitv nI’
life, we used the time trude—off teelunique (‘110).
which hus been validuted by others 1171 and hus
been lound by us to produce reliable results nr a ran—
dom sainplc ol [be patients included in ilie ‘l’romso
Medical I)cpar[mcnl I lea Itlu Benelit St ody II 21.
Metbodological issoes raised by (be mehod have
been disco,sed elsewliere [121.
Material and metliods
‘fbe 11 niversily Il ospital of ‘l’ronuso is located in [be
northern Part of Norway Iluring a 6—week period
starting on 11w 1 Pebruary I 99 3. all 52 I admilted
piil ients werc considered tor inclusion in tlie si ud
I ‘at ien ts tra nsferred rom ol lier o i iversity hospitu Is
In = 3), udmilted lr evuloiilion nr eontinuation of
trealnwnl sturted doring a previoos stuy Iii 27) or
admitied 6w inelusion in drug (rials Iii 2) were
exeluded, as well as one patienl whose medieal
record eoo ld 001 be fl lu nd. Ni ne plan ned readnus—
sions were merged wi thu 11w liri mii ry adm ission,
resolling in u total of 479 ineloded admissions.
‘l’wo expert punels I A and 11) were recruited, euclu
con sist in g ni u iu in teri i isi. a sorgeon and a general
praclihioner. All Ihe experts werc board-eertilied spe
cialists.
On admission. the 479 ineluded admissions were
ru ndomized to grou p 1 . 2 or 3 wil h probabil ities of
(1.1(1. 11.45 and (1.45. respectiveiy. ‘l’he Pul ienls iii
group 1 were all ussessed by botlu expert punels flir
(lie pu rpose 1)1 invesl igat ing in terpu nei agreemen I.
(roup 2 was ussessed by espen pwl i\ only. ,md
grou p 3 by pa neI Il oo1’. ‘Ihie espen s werc bli ndcd lo
wbieb admissions were ineloded in gmup I . ‘l’he ran—
domizal ion resu I led in 57 adm issiol s iii grou li I
21 5 in group 2 and 267 in groop 1.
,1sses,ill?i(s oJ pililis iii qiuili(ij 91 lifr
Vhen a put eiut wus dise li rged or d ied in I be hi ispi —
tal, a su nunuary con tun in g Ihe coni pleIe niedica I li is—
tony and ull data fron i (be cu rrenl stuy was compi led
by [be pro)ect coordi n ator (13011). whio is a til >anil—i-en—
tihicd specia(isi of internal iuiedicine. ‘11w sommiirv
svas osed by I be experts lor asscssi ng hcu Il li benet I
rom tbe hospital stay. ‘l’he resu Its ol I be cvii in al i i
of gain in quahity of lite (Oold witl be reporled here.
Loiiq—irr,n qitality o,/ lik qalu. ‘l’be patien(s’ cxpec[cd
QoL was asscssed separatehy by the expert paucls tor
two situations: (1) tor [1w expected prognosis aller
[he li ospital stiiy. taking in to iiccou 01 plan ti ed I real —
ment atter discharge: and (2) tor (be expc’ted prog—
nosis in the hypotbelicul situatioii bad [1w Piiti1.’Ol
i ot bei’n admil ted to I iospi I ul or trca led cl scwherc 6
[be curren I bea li h problem. I ong—tcrm Qol ga in
(LQGI was tbcn calculated as Ihe differcnce between
thcse [syn assessments to md the improvL’nienl in
OoI, al tri bo tabte to I be hospital s[av. ‘I’lic I wo assess—
metuts were inude syd li the tinie trtide—olf ioslrunicnl
(‘hl’O) whieh gives a meusure of ol, in [be interval
rom (1) eorrcspondi ng to conla on dcii [li) 1(1 1 (cc irre—
sponding to full beallb 17). Wben usilig (be ‘110.
I be cx perLs hirst estiinated th e pa I ien I’s rema (oil ig
hifelimc. ‘l’huev [hen decided bow mucb ol I Iuis t bey
wou Id li uve bccn wih in g to exchi unge fl ir lJerk’’I
bea ltb u t to thc time of dcii th. bad I liev bcen iii t lic
palient’s situution. ‘l’hc Iifetiine hell aller tbis lrude—otf
divided by [be lifetiine belone trade—olT is [be ‘I’l’O
assessmcnl of [be pa I ien t’s meun 1)01,. I )el i i Is of i be
proccclu re have been gis’en pnt’s’iously I I 2 I and i i
example of its use can be fou od in ,\ppend ix ,\.
,S’litn’t—U’nn qLulliti) c.;/ hit’ picici. Ilccause (lie ptiticnt’s
nemaining Iifetiine was used as [be starting point lon
I rade—i iff, the ‘ll’O’s sensitivity hr impnn’emeil I il i
OoL ol short dunution rclative to [be nemaining lite—
time was himiled. ‘lo Compensute for this, [be cxpcnts
I ‘)55 III,ickwetl Sca’,,,c Ild 6,,II ,iat l,,s’, cu( Ahsti,,,h’ 244. [57—4111
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also classified Ihe improvement in Q0L during the
hospital stay or shortly after discharge in the cate
gories no, low, intermediate or high gain relative to
the expected QoL without admission. As some
patients may have experienced short-term QoL gains
which were unspeciflc effects of hospitalization, a for
ther djstjnction was made between health-relatéd
short-term Q0L gain (HSQG) and non-health-related
short-term QoL gain (NHSQG). The former was
defined as QoL gain resulting from any speciflc med
ical intervention or care, e.g. the relief of mental or
somatic symploms such as pain, nausea or depres
sion. NHSQG was defined as all other types of QoL
gain, e.g. when the hospital stay provided shelter for a
homeless person or relief from a difficult social
situation.
Ei’aluation protocol
The aclmjssions were first assessed by each expert
individoalW Agreement between the three members
of each panel was defined to exist when (1) the differ
ence between the maximum and minimum LQG esti
mates was 0.20 or less, aud (2) the HSQG and
NHSQG assessments did not differ by more than one
category. Otherwise. the estimates were discussed in
a meeting and revised. Their median was taken to
represent the panel’s assessment.
Statistical »wthods
Ninety-five per cent confldence intervals (CI) of sta
tistical parameters were estimated with the bootstrap
algorithm [18]. The bootstrap distribution was
obtained with a Monte Carlo simulation by drawing
10 000 random resamples of size 422 with replace
ment from the original observations.
A high proportion of observations had the ‘alue
zero for the dependent variable LQG. In Ihe multh’ari
ate linear regression analysis. the variance of the
residuals was therefore not constant. Since this prob
lem cannot be solved by transforming the dependeni
variable. the bootstrap algorithm was chosen for esti
mating confldence intervals for the regression coeffi
cients as well. Their bootstrap distributions were
found by calculating the least-squares estimates of
the coefflcients for each of the 10000 resamples
[18]. All confldence intervals were estimated with
the bias-corrected and accelerated method described
by Efron andTibshirani [18].
The weighted kappa statistic was used for assess
ing agreement betwcen the expert panels [19]. The
squares of the number of categories of disagreement
were used as weights when calculating the statistic.
This study was approved by the Regional Ethics
Committee and the Norwegian Data Inspectorate.
Results
Agreement bet ween lite e.vpert panels
For health-related short-term QoL gain (HSQG). the
wcighted kappa statistic for agreement between the
two expert panels of admissions in group i was 0.70
(95% CI = 0.62—0.79: ti = 57). For non-health
related short-term Qol, gain (NHSQG), it was 0.08
(95% CI from —0.20 to +0.35: n = 57). Thus, the
agreement for the first measure was good, whereas
the second was no better than expected from chance
[20].
The results of the investigation of agreement for
long-term QoL gain (LQG) have been published previ
ously. The mean difference between the panels’
assessments was 0.02 (95% CI = 0.00—0.04:
ti = 57). When classilied in categories of no. Jow and
high gain, the weighted kappa statistic was 0.63
(95% CI = 0.45—0.80: n = 57). i.e. good agreement
[12].
Assessments of groups 2 aud 3 (n = 422)
These groups were assessed by only one of the two
expert panels. For the rest of the analyses, they were
pooled. giving ti = 422. Of these. 160 (38%) were
women, and 262 (62°,) men. The mean age was
61.6 years. for women ( 1.0 years (range 16—94) and
for men 61.9 years (range 15—90). A total of 152
(3 6%) were elective admissions, and 270 (64%) were
emergency admissions: 20 (4.7%) paticnts died in
the hospital. The mean length of stay was 8.6 days
(SD = 20.5).
ICD9-codes were truncated to three digits. Related
diagnoses were merged so that each diagnostic group
included 10 admissions ur more (Table 1).
Long-terin quality of l(fc gain. The mean LQG for all
admissions was 0.06 (95% CI = 0.05—0.07)
(Table 1). The distribution of LQG is shown in Fig. 1:
247 (59%) patients hud LQG 0.00 (ti = 422).
Three of these had negative LQG. A 66-year-old man,
who was admitted in a coma with cerebral haemor
rhage, and who was discharged to a nursing home
1998 aIcktvell Scienre Ltd jottrirnl cf Ititernal ,\lcdicinc 244: 397—404
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Table I Mean ong-lerm qualily oF life gain ([OG) estimaled wlLlt lhc time (radc-oft mohod. and median health-rekited ohort-lerni qualily
of life gain (HSQG) from admissions to a departmenl of internal mcdiciiic ti
Nuniher Mean LQG Mcdian
ICD9-code of pallenLs (‘II (955 contideoce interval( HSQG
Total 422 (11(00 11.116 I),)) 5—43.117 [vw
Scx
Men 262 (625) 1)1)6101)5—11,1)81 [vw
Women 161) 38%) 0,1)6(0.04—1)1)8) l.vw
Age group
<5)) ycars 93(22%) (1.1)410.02—11.061 Iw
50—69 years (8(1(43%) (11)5 (0.04—0.07) [vw
70 ycars 149(35%) (1,1)90.06—0.11) Lvw
Admission category
Elecilve (52 ) 36’))) ([040.03—41.041 [vw
Emergcncy 27(1(64%) (1,080.06—11.10) Mnderae
Diagnost)c group
lnfcctious diseases 001—139 17)4%) 0.11 (0.02—0.201 Moderate
Maflgnan) diseases 140—208 42)10% ((.06101)3—{l.08( [vw
Endocrlnologlca( diseases 240—259 (1 (1%) (1.20(0.06—0.37) Moderate
Acule myocardial infarction 410 307%) ([06(0.01—0.11) [vw
Angina pecioris 411—414 SS 12(1%) 0.03(0.02—0.041 1w
Olher heart diseases 420—429 45 I I IX.) 1). I I (0.07—0. 161 [vw
Cerebrovasculard(seases 430—438 21 (5%) (1.01 (—0.02—0.03) [vw
Pneumon(a and )nlluenza 48(1—487 (6(4%) 0.18(01)8—0.26) Moderate/high
Chronic obstrucflve pulmonary disease 496 20) 55.) 0.04(0.01-0.10) Moderale
[Iepatoblliary/pancrea(ic dlseases 570—579 13 (3% (1.07(0.01-0. 14) Lvw
Undlagnosedsymptoms 780—789 30)7%) 0.01(0,00—0,01) [vw
016cr 92)22%) 0.06 (0.04—0.091 Lvw
Esttmated wtth Ihe bootstrap a(gori(hm from 10 000 resamples.
Fig. I Jistribution of (cing-lerm
qualtty of lite gain (LQ(2) from
admissions to a depar(meiu of
internal medicine at estimaled with
(be time (rade-olt technlque
(ti = 422).
422)
whilst still in coma, had a LQG of —0.17. An 18-
year-old man adniitted for syncope and treated with
a beta-blocker for a possible long QT-syndrome.
although there was serious doubt about the diagno
sis, scored —0.01. A 60-year-old man with angina
pectoris in New York Heart Association ciass II. treat
ed with percutaneous transluminal coronary angio
plasty. scored —0.03. The procedure was successful,







«.000 000 001—009 0.10—0.19 0.20—0,29 0.30—039 040—049 0050
L0ng4rm qaailty 0) (ila gal, (LQG(
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Table 2 The eight admosions with long-term guality of life gain (LQG) greater than or equal to 0.50 fri = 422)
Age ICD9 Admission
Sex in ycars code category LQG Detalis
Female 77 250 Emergency 0.90 Patient with diabetes mellitus tr
eated for hypoglycaemic coma
Male 74 420 Ernergency 0.80 Pulmonary oedema caused by
coronary heart disease treated
with drugs aud mechanical ventilation
Male 61 425 Emergency 0.65 Pulmonary oedmea with
atrial fibrillation caused by
cardzomyopathia treated with digitalis and other drugs
Female 67 428 Emergency 0.61 lncipient putmonary oedem
a caused by coronary heart disease
treated with drugs
Male 61 296 Emergency 0.53 Psychotic patient treated for dehy
dration and hypothermia,
antidepressive medication irsitiated
Female 18 036 Emergency 0.50 Successfufly treated meningoc
occal septicaemia
Male 63 038 Emergency 0.50 Patient with urosepsis treated w
ith antibiotics
Female 86 711 Emergeocy 0.50 lnfectious arthritis of the shoulder
treated with antibiotics
The eight patients with LQG 0.50 accounted for
19% of the total LQG in the material (Table 2).
Short-(erm quality of life gain. The HSQG is shown in
Table 1. The median for all admissions was low
HSQG. Of the 247 admissions with LQG 0.00, two
thirds had some degree of HSQG (four high, 59 inter
mediateand 10510w).
A total of 79 (19%) bad no health-related QoL
gain at all, either LQG or HSQG (n = 422). Of these
admissions, expert panel A judged 3% to have bad
intermediate, 28% low and 69% no NHSQG. The cor
responding percentages for expert panel B were 3, 5
and 93%, respectively. Neither of the panels consid
ered any of these 79 admissions to have bad high
NHSQG.
To summarize. 41% bad LQG with or without
HSQG, 40% had HSQG with or without NHSQG. and
19% had no gain or only NHSQG (n = 422) (Fig. 2).
L.Dng.term 001. gain













Fig. 2 Gain in quality of life from admissions to a departmerit of
iniernal medicine (n 422).
Regression analysis
The effects on LQG of sex, age, admission category
and diagnosis were investigated with a multivariate
li.near regression analysis (Table 3). Dummy van
ables were used for the diagnostic groups with otber’
as reference. ‘Endocrinological diseases’ and pneu
monia and influenza’ predisposed for higher gain,
and undiagnosed symptoms’ and cerebrovascular
diseases’ for lower gain than the reference.
Emergency admissions and higher age were also sig
nificantly associated with higher gain.
Discussion
The most important result of this investigation was
the uneven distribution of QoL gain, and in particu
lar the very low gain for a high percentage of tbe
admissions. Whilst a minority (2%) bad gains of
0.50 or higher as measured with the time trade-off
technique (Table 2), 19% of the admissions resulted
in no health-related QoL gain (Fig. 2).
An attempt was made to find out whether these
19% had bad QoL gain that was not bealth-related,
but it failed because of lack of agreement between
the experts for the NHSQG measure. It cannot be
ruled out that these patients did achieve some
improvement in quality of life, but neitber expert
panel estimated more than low NHSQG for more
than 95% of them. Because this type of gain was
defined as not resulting from specific medical inter
ventions, it can be assumed that they could have
achieved the same benefit without hospitalization.
Another 40% bad health-related QoL gain of too
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l’ahlc 3 MuI1ivirioIe Iiiic,ir regression analysis of long—Lerm (lLiaIitY øl’ life gain ll as eslimaled wilh (be time trade-olT lcchnique
lit = 422)
Independenl s’iriahles l’arameler eslimee 9S: conlidence inlerval
)ntercepl — 0.02 — 0(17—0(12
Ses 0. male: 1. 6malc) — 0(11 — (I.) 3—1)1(2
Age . I.))))) I 0.0004-0.0 (20
Admission category (0. elective. 1. emergenev) 0.1)3 0.01—0.05
Disease categorv
Other [.1)0
Infeelinus diseases ((3)6 — 1)3)3—41,1 5
Malignanl diseases —0(11 —1)1)5—41,03
Endocrinological diseases (1.1 5 (Ml 3—)). 37
Acule myocardial nfarction —(1.02 —((3)6—41.07
Angina pecloris —((.02 —11.05—0.0))
016cr heart diseases 1)1)4 —(1.111—4)09
Cerehroi’asctilardiseases —((1)8 —([.1310 —((1)5
l’neunionia and inl)uenza ((.1)) 11,1)3-11.2 I
Chronic obstruclire pulnsonary disease —41.1)3 —
Hcpatobiliarv/pancreaUc diseases 0.02 —((.05—0,08
t’ndiagnosed syinptoms —006 —1)09(0 —0.03
Adlusled R-squarc = 0.1 3.
The d[scase category othcr’ serves as a referencc for (be dummy variables of [be disease calegories.
1(stimated wlIh (be bootstrap algorithni (rom 1(1000 resamples.
short a duration to be detected by thc TTO technique.
This group consisted of patients who had experi
enced relief from, for example, pain faster than they
would have. had they not been treated. For most of
Ihem, the estimated gain was Iow. Even so. this kind
of benefit is an important part of what has been
called the Sarnaritan function of health care [141.
and must continue to be an essential task of
hospitals.
Forty-one per cent of the admissions resulted in
gains detectablc by the TTO method. The number of
patients expcriencing a certain QoL gain was inverse
ly related to the amount of gain (Fig. 1). A few
patients with gains of 0.50 or more had been suc
cessfully treated for Iife-threatcning conditions witb
severe reductions in quality of life (Table 2).
LI1SS in qualiiy of lifc
Only three patienis (0.7%) bad negative LQG even if
our implementation of the TI’O instrument allowed
for both positive and negative gains. The frequency of
adverse events in departments of general medicine in
other studies has varied from 3.6 to 36%, which
probably reflects differeoces in definitions and meth
ods [21, 22]. Because the TTO instrument bad limit
ed sensitivity for positive gain, the same may have
applied to negative gain. but it seems uniikely that
the panels would have missed adverse events with
major lasting negative effects on QoL
We bad no instrument for measuring short-term
QoL losses, which thercforc could have been experi
enced by some of the patients. Several kinds of treat
ments are known to reduce QoL lemporarily to gain
life expectancy or QoL in the long run. e. g. the treat
ment of malignant neoplasms with cytostatics.
Pactors prcdisposing for gain in quality of life
From the perspective of priority setting, it is impor
tant to identify factors associated with high Qo[. gain.
In the multivariate linear regression analysis, some
of the diagnostic categories were significant regres
sors (Table 3). Because the groups were heteroge
neous and did not take comorbidity into account.
these results should be interpreted with caution.
Even so. II is notewortby that patients with symp
toms without any specific diagnosis had significantly
lower gain than the reference. The same applied to
cerebrovascular diseases, for which cffective forms of
treatment in the acute phase are only now starting to
emerge.
High age also predisposed for higher QoL gain.
There has been a debate about how to contain the
costs of the rising use of acute-care hospitals by old
patients [23]. With regard to QoL, our results mdi
cate that it is not correct to limit access to health care
on the basis of higb age alone. When considering
© 1998 Blackwell Science Ltd JouraI si lnlerrwl Medicine 244: 397—41)4
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whether to admit a patient wjth the intention of
improving QoL, high age should weigh in favour of
admission rather than the opposite.
Since university hospitals often have a lower per
centage of emergency admissions than other hospi
tals, the finding that these admissions were
associated with higher gains might imply that the
mean LQG could be higher in these hospitals. A high
er mean age would also contribute to this tendency.
However, because Ihe diagnostic categories are
important regressors for LQG, Ihese effects could be
counteracted by differences in case mix.
Li,nitations
The most important limitation of the present study
was that its design did not allow patient self-assess
ment of QoL. This issue has been discussed in detail
earlier [12]. It can hardly be denied that the patients’
assessments must be the gold standard when it
comes to measuring their own QoL. However, it is
also clear that it is the doctors’ assessments of how
the patients experience different health states that
ultimately deterrnine which diagnostic and therapeu
tic interventions will be chosen. The good results of
the agreement study indicate that there is consensus
between doctors about QoL gain from hospital stays.
except for NHSQG.
Another important limitation concerns the gener
alizability of our results. Although there is little rea
son to believe that the results would have been much
different in other departments of internal medicine
in the developed world. generalization to other parts
of medical care is less straightforward. However. the
diseases treated by internists include many of those
with most severe prognoses. The potential for QoL
gain for patients admitted to departments of internal
medicine is therefore probably at least as great as for
patients in other departments or in primary care.
Conclusions
Based on expert judgement, 81% of the admissions
to a department of internal medicine resulted in
some improvement in health-related quality of life.
The gains were unevenly distributed. Half of these
patients bad only shorl-term improvement in their
QoL, whilst a minority bad high gains corresponding
to the successful treatment of life-threatening condi
tions. The remaining 19% bad either no improve
ment in QoL or improvement which had no direct
relationship to specific medical interventions and
which probably could have been achieved without
hospital admission. Diagnosis was the most impor
tant determinant of gain, but high age and emer
gency admissions were also independently associated
with higher gain.
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Appendix: An example of assessment of
long-term quality of life gain with the TTO
method
A 63-year-old man was admitted for urosepsis. The
cxperl panel estimated that he would have lived only
20 days in the hypothetical situation without hospital
admission or treatment elsewhere. Considering his
expected quality of life, they agreed that they would
have been willing to give up half of these in exchange
for living for only 10 days but in perfect health. Le. to
trade off lifetime in exchange for quality of ilfe. In this
situation, his mean QoL would have been the ratio
between the lifetime after the trade-off and the life
time before the trade-off, i.e. fl.50.
The expert panel then made the same assessment
for the situation after he had been successfully treat
ed in hospital. They expected a remaining lifetime of
12 years and a quality of life so good that they would
not have been willing to trade off any lifetime to
improve it. Thus, in this situation his QoL was 1.00.
The gain in QoL attributable to the hospital stay is
found by subtracting from this the value found with
out hospital admission, resulting in a long-term qual
ity of life gain of 0.50.
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Abstract
Objectives: High rates of inappropriate hospital admissions have
been found in numerous studies, suggesting that a high percentage
of hospital resources are, in effect, wasted. The degree to which this
is true depends on how costly inappropriate admissions are
compareci to other admissions. This study aimed to estimate both
the percentage and cost of inappropriate admissions.
Setting: Department of internal medicine at a teaching hospital.
Subjects: Consecutively admitted patients during a six-week study
period.
Main outcome measures: Assessments of inappropriateness were
based on estimates of health benefit and necessary care level.
These estimates were made by expert panels using a structured
consensus method. Health benefit was estimated as gain in quality
adjusted life years, or degree of short-term improvement in quality of
life during or shortly after the hospital stay. The direct costs to the
hospital of each stay were estimated by allocating the costs of labor,
“hotel” and overhead according to length of stay and adding to this
the cost of ancillary resources used by each individual patient.
Results: 422 admissions were included. The 102 (24%) judged to be
inappropriate had a lower mean cost (US$ 2,532) than the other 320
(US$ 5,800) (difference 3,268; 95% confidence interval 1025 to
5,511). The inappropriate admissions accounted for 12% ofthe total
costs.
2
Conclusions: Denying care for inappropriate admissions does not
generate cost reductions of the same magnitude. Policy makers
should be cautious in projecting the cost savings potential of
excluding inappropriate admissions.
Keywords
hospital, health benefit, cost analysis, quality-adjusted life years,
internal medicine, quality of tife
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I ntroduction
An “inappropriate hospital admission” can be defined as an
admission that does not result in any significant benefit for the
patient, or which results in benefit which could have been obtained
on a Iower care level. Studies from different countries have almost
invariably found high rates of such admissions, with most reported
percentages in the range of lOto 25 [1-8]. One reason forthe
interest in inappropriate admissions has been the bellef that they
represent a potential for proportional cost reductions. However, this
hypothesis depends on the assumption that inappropriate
admissions are as costly as beneficial ones, which has so far not
been investigated.
In the Tromsø Medical Department Health Benefit Study, health
benefits as judged by expert panels have been studied in a
department of internal medicine. We have previously reported that
61% ofthe patients admitted had no gain in life expectancyfg] and
19% no gain in quality of life [10]. In the present study, the benefits
of these patients were recalculated in terms of quality-adjusted life
years (QALY), and necessary care level assessed to estimate the
percentage of inappropriate admissions. In addition, the costs of all
stays were estimated. The primary aim of the study was to
investigate the assumption that significant savings could have been
obtained by denying care for inappropriate admissions. Second, we
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wanted to examine the potential for savings by reducing the number
of admissions with the lowest health benefits as well. This was done
by estimating cost according to degree of health benefit.
Ideally, costs should have been estimated from the societal
perspective, since many patients would have been treated elsewhere
if they had not been admitted. However, for the heterogeneous group
of patients admitted to departments of internal medicine, the
alternatives to care in hospital are numerous. It was therefore not
feasible to estimate costs for alternative care. Instead, an analysis





During a six-week period from ist February 1993, all admissions to
the department of internal medicine at the University Hospital of
Tromsø were eligible for inclusion in the study. Patients transferred
fram other university hospitals (n=3), patients admitted for evaluation
or continuation of treatment started during a previous stay (n=27)
and patients included in drug trials (n=2) were excluded, as well as
ane patient whose medical record could not be found. Nine planned
readmissions were merged with the primary admission. A 10%
random sample of the patients was used to study the extent of
agreement between the two expert panels recruited for the study
[11]. The remaining 422 admissions were used for the present
investigation.
The two expert panels each consisted of an internist, a surgeon and
a general practitioner. Each admission was randomly assigned to
assessment of health benefit by ane of them.
The study was appraved by the Regional Ethics Committee and the
Norwegian Data lnspectorate.
Health benefif and necessary care leve!
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Health benetit assessments were made from summaries containing
the patient’s complete medical history and all data from the current
stay. The time trade-off method [12] was used for estimating the gain
in healthy-years equivalents (HYE) from the hospital stay relative to a
hypothetical situation where the patient had not been admitted or
treated elsewhere. HYE is a measure of life years adjusted for
quality of life where i HYE represents one year in full health. The
time trade-off method finds the number of HYE which the patient
considers equivalent to living the rest of his life with reduced quality
of life because of disease. The measure ‘healthy-years equivalents’
is almost equivalent to uqualityadjusted lite years” (QALY), and the
term QALY will be used in this paper [13].
The time trade-off instrument has limited sensitivity for improvements
in quality of life of short duration relative to the remaining lifetime,
e.g. for the relief of symptoms associated with acute illness. To
compensate, the experts also graded the improvement in health
related quality of life during the hospital stay or shortly after
discharge in the categories no, low, intermediate or high gain. Details
about the assessments of quality of lite in this study have been
published previously [10]. The expected outcome of planned
treatment after discharge was taken into account when assessing
health benefits.
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The experts also assessed whether a patient with health benefit
could have obtained the same benefit in primary care or in an
outpatient clinic. If this was the case, or if an admission resulted in
no health benefit, it was defined as inappropriate, otherwise as
appropriate.
A structured consensus method was used for making the estimates
[14]. The admissions were first assessed by each expert individually.
When there was disagreement according to predefined criteria, the
case was discussed in a meeting of the three members of the panel.
After revision of the individual estimates, the median was taken to
represent the panel’s assessment. Further details of the method, a
discussion of methociological problems and results about its reliability
have been published previously [11].
Cost of hospital stays
Direct costs incurred during the stays in the department of internal
medicine were estimated from the perspective of the hospital. For
each patient, costs were estimated on the basis of unit costs and
utilization of services.
Overhead costs were allocated to the service and clinical
departments according to the step down allocation method [15]. The
allocation basis used was the number of employees, square footage,
number of admitted patients or number of patient-days as
8
appropriate. In the department of internal medicine, physician
salaries were apportioned to wards and services according to the
actual assignments of doctors in 1993.
The fee schedule for outpatients was used for calculating the unit
costs for the service departments. For each department, the charges
for the total production in 1993 was calculated as if all services had
been paid according to this schedule. The total actual costs of the
departments were then divided by these amounts to obtain cost-to
charge ratios which were multiplied by the outpatient fees to find the
unit cost of specific services. For some services, outpatient clinic
fees did not exist, and estimates of unit costs from an investigation in
a similar hospital were used [16]. Utilization of diagnostic and
therapeutic services for individual patients were recorded from
computerized and manual databases (radiology, clinical chemistry,
endoscopies, cardiologic interventions, hemodialysis, occupational
therapy, blood components, etc.). In the following, the cost of these
services and of pharmaceuticals will be termed ‘ancillary costs”.
The costs of pharmaceuticals were set at the prices charged by the
hospital pharmacy. Only drugs having a total cost of more than 1% of
the department’s total drug costs in 1993 were registered for the
individual patient. The costs of other drugs were apportioned
according to the length of stay for each ward separately, as were
also nursing and “hotel” costs.
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Capital costs of buildings and land are not included in the accounts
of the hospital, and were excluded from the cost analysis. The cost
of major equipment was accounted for directly without annual
depreciation, which is not routinely calculated in the hospital
accounts. Because these costs wiIl vary from yer to year, they were
averaged over the years 1992, 1993 and 1994 for each depariment.
All costs were measured in 1993 NOK and converted according to
the exchange rate US$1=NOK 7.50.
Statistical mothods
Ninety-five per cent confidence intervals of statistical parameters
were estimad with the bootstrap algorithm [17]. Multivariate linear
regression analysis was performed with the SAS statistical package
(SAS Institute, Cary, NC).
Sensitivity analysis
The difference between the mean costs of appropriate and
inappropriate admissions was explored in a probabilistic sensitivity
analysis where all unit costs were varied simultaneously by drawing
them from logistic-normal probability density distributions in 10,000
runs of a Monte Carlo simulation according to the method described
by Doubilet et al [18]. For each unit cost, the parameters of this
distribution were calculated from the estimated unit cost, and from
10




Inappropriafe admissions and health benefits
One hundred-two (24%) of the 422 admissions were inappropriate,
and 115 (27%) resulted in only short-term improvement of quality of
life during or shortly after the stay. Two hundred-five (49%) had
benefits measured as QALY (Table 1). The mean gain in QALY was
2.3 per admission.
Of the 115 admissions with gain in health-related short-term quality
of life, 74 had low, 38 moderate and 3 high gain (Table 1). Clinical
detaiis of the six patients in the low gain category with the highest
costs are listed in Table 2.
Two admissions resulted in a QALY loss, i.e. that the patient’s health
was made worse by the hospital stay (-0.1 and -0.6 respectively).
These admissions were defined as inappropriate. Details of the
admissions with health loss have been given previously [9,10].
Cost analysis
The total cost of the 422 admissions was US$ 2.1 million (Table 3).
Overhead (32%) and nursing costs (27%) made up the largest
proportions of this total. For both the appropriate and the
inappropriate admissions, the ancillary costs were 29% of the total.
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Table 4 shows the mean cost according to gender, age, admission
type and diagnostic category. The mean cost of the inappropriate
admissions (US$ 2,532) was lower than for the appropriate (US$
5,800)(difference 3,268; 95% confidence interval 1,025 to 5,511). In
a multivariate llnear regression analysis of IogarithmicaUy
transformed cost with appropriateness, gender, age, admission
category and dummy variables for the diagnostic categories as
independent variables, appropriate admissions were associated with
higher cost (P<0.001) (Table 5). The diagnostic categories “angina
pectoris” (P0.013) and “undianosed symptoms” (P=0.028) were
associated with lower costs. No interactions between
appropriateness and the other variables were detected (P>0.05).
The relationship between appropriateness, health benefit and cost is
further explored in Table 1. The 24% of inappropriate stays
accounted for 12% ofthe total costs. The 42% ofstays which were
either inappropriate or had only low, health-related short-term quality
of life gain, together accounted for 25% of the costs. The mean
length of stay for inappropriate admissions was 4.3 days (95%
confidence interval 3.1 to 5.8), for appropriate admissions 10.0 days
(95% confidence interval 7.9 to 13.1).
Sensifivity analysis
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When the unit costs were varied simultaneously in a Monte Carlo
simuiation of 10,000 runs, none resulted in a higher mean cost for




Few investigators of “inappropriate hospital admissions” provide a
definition of this term. Those who do, base their definition on the
concept “health benefit”, or just “benefft” [19]. We are not aware of
any study of inappropriate admissions which has included a
definition of “health benefit”, or a description of methods for
measuring it. Instead, assessments of health benefit have relied on
implicit clinical judgment, either directly or through validation of
instruments by expert physicians [2,19,20]. In the Tromsø Medical
Department Health Benefit Study, a set of explicit criteria designed to
be sensitive to all gains in Iife expectancy and health-related quality
of life was used in a two-round consensus process. Definitions,
descriptions of methods and results form the application of the
instrument to consecutive admissions have been reported in
previous publications from the study [9,10]. The instrument has been
found reliable for a random sample of the included admissions [11].
According to the final assessment of the two panels, 24% of the
admissions were inappropriate. Previously, we have discussed the
possibility that the experts had overlooked benefits for some of these
admissions [101. In particular, we were concerned that some of the
patients might have experienced improvements in quality of life from
having a tentative diagnosis confirmed or excluded, even if this did
not lead to improvement in health. The expert panels both estimated
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that less than 5% of the inappropriate admissions had achieved
more than the lowest degree of this type of benefit. Therefore, it is
unlikely that more than a few of the inappropriately admitted patients
had had improvements in quality of life that made hospitalization
necessary.
However, this result was based on assessments of the patients
quallty of life by physicians, and it coulci be argued that the rate of
inappropriate admissions would have been different if it had been
based on the patients’ own assessments. The justification for our
approach was that both inappropriate admissions and the costs of
hospital stays are the results of decisions made by clinicians. These
decisions will be determined by the clinicians assessments of the
health benefits for patients resulting from various alternatives.
Accordingly, these assessments are relevant measures in
investigations aiming to study the relationship between health
benefits and costs.
The percentage of inappropriate admissionsfound in this study was
comparable to those found in other studies, and confirms that there
is a potential for reducing the number of admissions without loss in
health benefits. However, the finding that the cost of these
admissions was less than 50% of that of the others challenges the
hypothesis that this would lead to savings of the same magnitude.
Even if the experts had been biased towards considering patients
16
who had undergone costly interventions as appropriate, this cannot
explain the entire difference in mean cost between the appropriate
and other admissions. Also, the costs of interventions were included
in the ancillary costs, which only accounted for 29% ofthe total
costs. This would limit the effect of this type of bias on the difference
in mean cost. The most important determinant of cost was length of
stay, which was considerably shorter for the inappropriate
admissions. One reason for this might have been that these patients
were discharged earlier because their low potential for benefit was
recognized soon after admission.
An attempt was made to identify subgroups of inappropriate
admissions with especially high costs by testing for interactions
between appropriateness and other variables in a multivariate
regression analysis. However, although some groups had lower
costs independently of appropriateness, we were not able to identify
any group for which a reduction of inappropriate admissions would
lead to a greater cost reduction than for others. The variables
investigated were gender, age, admission category and diagnostic
category, which specify a rather crude model relative to the detailed
clinical information available about each patient. The result of the
analysis does not exclude the possibility that a higher percentage of
savings could be obtained by targeting more carefully defined
subgroups of inappropriate admissions.
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The 24% inappropriate admissions accounted for 12% ofthe costs. It
should be noted, however, that we have estimated average costs of
care. When estimating cost savings from admitting fewer patients,
marginal costs, Le. the additional cost of treating one more patient,
are more relevant. Most of the labor costs, which represented about
two thirds ofthe hospital’s total costs in 1993, are fixed in the short
run. Accordingly, the savings from excluding inappropriate
admissions would have been much less than 12% in this time
perspective. In the long run, all costs are variable, and the cost
savings woulci have been in the orcier of 12%.
An important limitation of this study was that the cost analysis was
made from the hospital’s perspective and included only costs
incurred during the hospital stays. Some ofthe patients denied
hospital care would have been treated on a lower care level and
incurred costs here. Consequently, the savings from excluding
inappropriate admissions could have been lower from a societal than
from the hospital’s perspective. A cost analysis from the societal
perspective would have been preferable, but estimating costs
outside the hospital was not feasible in this study because it was
difficult to make assumptions about alternative care for this
heterogeneous group of patients. Coast et al estimated the potential
for societal cost savings from alternative care for inappropriately
admitted patients by assuming average speciality costs and the
same duration of care as in the hospital [21]. It was concluded that
18
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Table 3 Total costs (US$) and patient-days for 422 admisslons to a department of Internal
medicine according to appropriateness of admission
Inappropriate Appropriate All admissions
admissions (%) admissions (%) (%)
(n=102) (n320) (n422)
Ancillary costs 74,202 (12) 534,514 (88) 608,716 (100)
Nursing laborcost 66,083 (12) 505,084 (88) 571,167 (100)
Physician labor cost 17,493 (13) 118,258 (87) 135,750 (100)
Overhead 87404 (13) 593,472 (87) 680,876 (100)
‘Hotel” costs 13123 (11) 104,793 (89) 117,916 (100)
Total costs 258,305 (12) 1,856,120 (88) 2,114,425 (100)




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3bIe 5 Multivariate Iinear regression analysis 01 cost (logarithmically transformed)
‘admissions to a department of internal medicine (n=422)
dependent Parameter 95% confidence P-value
riable estimate interval
tercept 3.12 2.89 to 3.35 <0001
Dpropriateness (0=inappropriate, 1=appropriate) 0.35 0.23 to 0.47 <0.001
x (0=M, 1=F) -0.05 -0.16 to 0.05 0.307
0.00 0.00 to 0.01 0.104
mission category (0=elective, 1=emergency) -0.10 -0.22 to 0.01 0.067
iagnostc category
Infectious diseases 0.19 -0.07 to 0.45 0.159
Malignant diseases 0.01 -0.17 to 0.20 0.901
Endocrinological diseases 0.04 -0.27 to 0.35 0.806
Acute myocardial infarction 0.04 -0.17 to 0.25 0.696
Angina pectoris -0.20 -0.35 to -0.04 0.013
Other heart diseases -0.08 -0.27 to 0.10 0.378
Cerebrovascular diseases 0.20 -0.04 to 0.44 0.100
Pneumonia and inf]uenza 0.13 -0.15 to 0.40 0.361
Chronic obstr. pulm. disease -0.12 -0.36 to 0.13 0.348
Heapatobiliary/pancreatic diseases -0.09 -0.38 to 0.20 0.554
Undiagriosed symptoms -0.23 -0.44 to -0.03 0.028
Other 0.00 Reference
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Summary
Background
The high rates of inappropriate hospital admissions found in many studies are
commonly believed to represent a potential for significant cost reductions. However,
this presumes that these patients can be identified before the hospital stay. The aims
of this study were to investigate to what extent this is possible in a department of
internal medicine, and to estimate the costs saved if patients judged at the time of
admission to be inappropriately admitted, are denied care.
Methods
Consecutive admissions during a six week period were randomised for assessment
by one of two expert panels. On the basis of the information avallable at the time of
admission, the panels predictecf the health benefit from the stays and the lowest
necessary care level using a structured consensus method. Admissions with no
benefit or with a lower necessary care level were defined as inappropriate. For each
admission, a final judgement of appropriateness was made after discharge by the
other panel which had access to all information collected during the stay. The
predictions were then compared with these assessments as the gold standard. The
direct costs to the hospital incurred during each stay were estimated.
Findings
The panels correctly classified 88% of the appropriate (n=320) and 27% of the
inappropriate admissions (n=102). lftheelective admissions predicted to be
inappropriate had been excuded, 9% ofthe costs would have been saved and 5% of
the gain in quality-adjusteci life years (QALY) lost. The corresponding results for
emergency admissions were 14% and 18%.
2
Interpretation
The savings obtained by excluding admissions predicted to be inappropriate were
smali relative to the heaith losses. High rates of such admissions do not necessarily
imply that costs can be saved. Programs for reducing inappropriate heaith care
shouid not be impiemented without investigating their effects on both health
outcomes and costs.
Keywords




Increasing health care costs have given rise to a variety of strategies for cost
containment. One of them is to deny care when health benefits are negligible. It is
commonly believed that the reduction of unnecessary or inappropriate health care
would result in substantial savings 1-3 In particular, this applies to inappropriate
hospital admissions, for which high rates have been found in many countries
However, the finciing of a high rate of inappropriate admissions retrospectively does
not necessarily indicate a potential for cost reductions. To reduce the number of
such admissions and to obtain savings, clinicians must be able to identify them as
inappropriate before or at the time of admission, that is, before diagnostic and
therapeutic interventions are undertaken. The assumption that this is possible has, to
our knowledge, not been investigated 1012
In the Tromsø Medical Department Health Benefit Study, 24% ofthe admissions to
the department of internal medicine at a teaching hospital were found inappropriate
13 This estimate was made by expert panels using a structured consensus method
which has been found reliable for a random sample of the included patients 14 In the
present study, we investigated whether cost reductions could have been obtained by
letting the expert panels predict appropriateness solely on the basis of information
available at the time of admission. The aim of the study was twofold. First, to
estimate the sensitivity and specificity of the these predictions. Second, to estimate
the costs saved if they had been used for reducing the number of admissions and




In 1993, 5151 patients were admitted to the department of internal medicine atthe
University Hospital of Tromsø. During a six week period from i st February 1993, all
admissions were eligible for inclusion in the study. Patients transferred from other
university hospitals (n=3), admitted for evaluation or continuation of treatment
initiated during a previous stay (n=27) or admitted for inclusion in drug trials (n=2)
were excluded, as welI as one patient whose medical record could not be found.
Nine planned readmissions were merged with the primary admission, resulting in 479
included admissions.
These admissions were randomfy assigned to three groups with probabilities of 0.10
(group 1), 0.45 (group 2) and 0.45 (group 3). Two expert panels (A and B) were
recruited, each consisting of an internist, a surgeon and a general practitioner who
were all board-certified. For each admission in group 2 and 3, appropriateness was
predicted at admission by one of the panels, and a final judgement of
appropriateness made by the other panel after discharge (Figure 1). The admissions
in group I were assessed by both panels after discharge to study inter-panel
agreement 14




An admission was defined as appropriate if it resulted in health benefit which could
not have been obtained on a Iower care level. For prediction of health benefit, the
experts were provided with the patient’s complete medical history and the results of
the physical examination as obtained at admission. No information about the course
of the hospital stay after the time of admission was given. Using a method which has
been described in more detail previously, the experts then made predictions of the
health gain from the hospital stays in terms of healthy-years equivalents (HYE) 14
HYE is a measure of life years adjusted for quality of life where i HYE represents
one year in full health 1516 Although there are some theoretical differences between
HYE and the more well-known “quality-adjusted life years” (QALY), the latter term will
be used in this paper 17,18
The measurement of gain in QALY has limited sensitivity for improvement in quality
of life of short duration relative to the remaining lifetime. To compensate, the experts
also predicted the improvement in health-related short-term quality of life during the
hospital stay or shortly after discharge relative to the expected quality of life without
admission Finally, they predicted whether patients with health benefits could have
obtained the same benefit in primary care or in an outpatient clinic.
The predictions were first made by each expert individually, and then discussed in a
meeting of the three members of each panel when there was disagreement
according to predefined criteria. Further details of the method, a discussion of
methodological problems and results regarding its reliability have been published
previously 14
6
For each admission, final assessments of health benefit and care level were made
by the other panel after discharge. The results of these assessments, which in the
following wiII be termed the observations, have been reported in detail previously
131920 The predicted and observed appropriateness of the admissions were
determined from the assessments of health benefit and necessary care level. To
estimate the sensitivity and specificity of the prediction that an admission would be
appropriate, the predicflons were compared with the observations as the gold
standard. The formulae used were
no. of admissions both predicted and observed to be appropriate x 100
sensitivity=---- ——-- —
no. of admissions observed to be appropriate
and
no. of admissions both predicted and observed to be inappropriate x 100
specificity = —-------------------------—-------------------—----— —---— —----
no. of admissions observed to be inappropriate
Group 2 and 3 were poo!ed for this analysis.
7
Cost analysis
Direct costs in 1993 NOK (US$ 1= NOK 7.50) incurred by the patients during their
stays in the department were estimated from the perspective of the hospital.
Overhead costs were allocated to the service and clinical departments according to
the step down allocation method 21 For each patient, costs were estimated on the
basis of unit costs and utilisation of services. Unit costs were estimated for the output
of all service departments (radiology, microbiology, etc.). Utilisation of services was
registered from hospital databases and the medical record for each individual
patient.
The costs of nurse and physician labour and “hotel costs” were apportioned
according to length of stay for each ward separately.
Further details of the cost analysis have been given previously 13
Statistical methods
Multivariate logistic regression analyses were performed with the SAS statistical
package (SAS Institute, Cary, NC).
95% confidence intervals of statistical parameters were estimated with the bootstrap
algorithm, except for the logistic regression 22 The kappa statistic was used for
assessing agreement between the expert panels for assessments about the
admissions in group 1 23
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RsuIts
Ægreement between the expert panels
Group 1 (n=57), in which all patients were assessed by both expert panels after
discharge, was used for estimating the agreement for judging that an admission was
appropriate. The overall agreement was 0.75, the kappa statistic 0.41 (95% C 0.15 -
0.68), i.e. fair agreement24
Prediction of appropriateness
Of the admissions in group 2 and 3 (n422), the expert panels predicted that 66
(16%) would be inappropriate and 356 (84%) appropriate. The relationship between
these predictions and the observations made by the panets after discharge s shown
in Table 1. The panels were able to identify 88% of the appropriate but ony 27% of
the inappropriate admissions. In other words, the sensitivity and specificty off the
prediction that an admission would be appropriate were 88% and 27% respectively.
The sensitivities and specificities for subgroups are shown in Tabe 2.
To explore whether there was an association beteen the predictions and the
observations, a Iogistic regression anaiyis was performed with the predictions as the
dependent variable. The observations of appropriateness, gender, aje arid dummy
variables for diagnostic categories were ncudeci as independent variables. Eective
and emergency admissions were analysed separateiy. For ernergency admissions,
the fit of the model was poor (chi-square for covariates 17 56, d.f. 13, P0.18). For
elective admissions, the fit was better (chi-square for covariates 25,15, d.f. 10,
P=0.005) (Table 3). Only the observaton of appropriateness made after discharge
and gender were significant regressors. No interaction between these two variables
9
was observed (P=0.22). Because the odds ratio for the observations is indicative of
the panels’ predictive abilities in this model, the absence ofthis interaction means
that these abilities were the same for men and women. However, because of the
gender variable, the sensitivity and specificity for the two sexes were different. Based
on the crude data, the sensitivity for elective admission of men was 96% and of
women 75%. The specificities were 21% and 50% respectively. Sensitivities and
specificities estimated fram the model were similar.
Clinical detalis of the 5 patients with the greatest predicted health benefits who were
judged to be inappropriate after discharge, and of the 5 patients predicted to be
inappropriate with the greatest health benefits, can be found in Table 4.
Reducing the number of admissions
The mean cost of stay for the inappropriate admissions was US$ 2,532, and for the
appropriate US$ 5,800. The observed mean gain in QALY was 2.3. The median bed
occupancy rate in the study period was 0.84 (interquartile range 0.79 to 0.89).
Table 5 shows the effects in terms of costs saved and QALY last fram excluding
admissions predicted to be inappropriate. For elective admissions, 9% of the total
costs would have been saved and 5% of the total QALY lost. Far electively admitted
men, 10% (95% Cl 5 to 17) af the admissians wauld have been excluded, 5% (95%
Cl 2 to 9) ofthe costs saved and 2% (95% Cl 0 to 9) ofthe QALY last (n=102). For
electively admitted wamen, the carresponding percentages were 34 (95% Cl 22 to
48), 17 (95% Cl 6 to 39) and 12 (95% Cl 2 to 33)(n=50).
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The cost savings from denying care to inappropriate emergency admissions would
have been 14% and QALY losses 18% (Table 5).
Sensifivity analysis
The effect of better prediciions of appropriateness was expored. To obtain a best
case scenario, the most beneficial admisions arnong those which had been faIsey
ciassified as inappropriate were redassified as ppropriat, and the most caty
among ihose which had heen fase1y ctassfied as appropriate were reJasslfied as
nappropnate Assuming that the sensitivity could ony be irnproved sighUy frorn the
observed 68 to 90%, hut that the specificity çcud ir’crease from 28 to 50%, 6 and 23
patients, respectv&y, wouid need to be reciasified. Under these tssumptK?ns, US
11,983 was saved per QALY iost (Tab 6).
Savings and heafth losses were aso estirnated i.mder the assurnptions that the
inappropriaie admssions had the sirne cost s the ippropriate. and ihat a gas in
QALY had been overestmaed by 100%. Finav, when combning therse two
assurnptions with imprced sensitivity and specific;ty, US$ 26,131 ws avd per
QALY ost (Tabe 6).
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Discussion
At present, any strategy for reducing the number of inappropriate admissions to
hospitals would have to involve dllnical judgement in one way or another. To explore
whether this approach can be used for reducing costs without resulting in
unacceptable health losses, we used panels of experienced board-certified
specialists to provide a higher level of expertise than the average admiffing
physician. To ensure that the panels had all relevant data available, a board-certified
specialist of internal medicine (B.O.E.) prepared the summaries which were the basis
of their assessments. Even so, the panels’ predictions of appropriateness were poor.
While they were able to correctly identify 88% of the appropriate admissions, only
27% of the inappropriate were detected. If the admissions predicted to be
inappropriate had been excluded, significant savings would have been obtained
(12%), but at the cost of an almost equal percentage of the total benefit in QALY
(14%)(Table 5).
Some difficulty for one panel in predicting the other panel’s assessment after
discharge would be expected due to inter-observer variation. However, fair
agreement between the panels was found in the agreement study of group 1.
Uncertainty about diagnosis and effect of treatment at admission was probably the
most important explanation for the poor predictions. Presumably, there was
insufficient information for making any accurate estimate of the effect of the hospital
stays for many of the patients (Table 4). It is difficult to see how this situation could
have been improved for emergency admissions, but more information could perhaps
have been obtained for elective patients before admission to allow better predictions.
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Since ane third of these admissions were inappropriate as judged after discharge,
the potential for better selection of patients was considerable (Table 5).
Rationing based on the panels’ predictions of appropriateness would have saved
US$ 3910 per QALY lost for elective and 1,693 for emergency admissions (Table 5).
Since the cost analysis only included costs incurred during the included stays, the
savings may have been uncier-estimated. The reason is that many patients with
chronic diseases would subsequently have been treated in other parts of the
hospital, e.g. in outpatient clinics and other clinical departments, where more costs
would have incurred, partly as a consequence of decisions about follow-up made
during the included stays. If the patient had not been admitted in the first place,
these costs would have been saved in addition to the costs incurred during the
included stay. In some studies, US$ 50,000 per QALY has been used as an upper
limit for interventions considered to be cost-effective
25,26 which in the present
investigation would correspond to the minimum amount that would have had to be
saved per QALY last. However, even allowing for a substantial under-estimation of
costs and over-estimation of gains in QALY, the savings per QALY in the present
study would have been lower. In the sensitivity analysis, US$ 26,131 per QALY was
the maximum saving attained when assuming both higher sensitivity and specificity,
more costly inappropriate admissions and lower gains in QALY than observed(Table
6).
One possibility for improving the panels’ predictions could have been to give a more
detailed specification of the alternatives to hospital care. This approach was chosen
by Coast et al who considered 12 alternatives to admission to a department of
13
general medicine and geriatrics. However, although an alternative was found for
20%, few resources were saved by exploiting this potential .
An interesting finding of this study was that rationing of elective admissions would
have had different effects for the two sexes. Few resources would have been saved
and few QALYs lost for men, whereas a 17% cost reduction would have been
obtained at the cost of a 12% loss in QALY for women. The logistic regression
analysis indicated that this effect was independent of diagnosis. The difference was
not caused by different precfictive abilities for the two sexes, as this would have been
shown by a significant interaction term between gender and observed
appropriateness. This result suggests that reducing admissions in this manner might
have discriminateci women.
Most previous studies of inappropriate admissions have relied on the
Appropriateness Evaluation Protocol (AEP) anci similar instruments 27-29 The AEP
has also been used in a major effort to assess the extent of inappropriate health care
in the European Union 30• The main differences between the AEP and our method
were that i) the AEP partly relles on information that is only available after adm ission,
thus precluciing its use for predicting inappropriate admissions, and ii) that it is a
screening tool which has been validated against expert clinical judgement, whereas
we used clinical jucigement directly for evaluating the admissions 27,3132 Our results
question the assumption that this instrument could reduce hospital costs to any
significant degree without leading to health losses. The same applies to other forms
of utilisation review, which in the USA have been shown to reduce both the number
14
ofadmissions and costs 1o,11,3335 None of these studies includes an assessment of
how this affects the quality and outcome of care.
Two limitations of the cost analysis should be noted. First, we were not able to
calculate marginal costs, i.e. the cost of treating one more patient, which are most
relevant for estimating potentia savings. Since the department operated below full
capacity, the savings obtained would have been lower than our estimates. Second,
the cost analysis was made from the hospital’s perspective. A societal perspective
would have been preferable, but the task of estimating societal costs for the
heterogeneous group of patients in a department of internal medicine would have
been insurmountable. It can be assumed that many patients would have been
treated elsewhere if not admitted, and that the societal savings would have been
Iower than our estimates. Accordingly, a cost analysis without these limitations would
probably have supported our findings.
We conclude that, in the investigated department, reciucing the number of
admissions based on predictions of appropriateness at admission would have
resulted in unacceptable health losses relative to the savings. The extent to which
this conclusion can be generalised is uncertain, but it indicates that a high rate of
inappropriate admissions does not necessarily imply that cost savings of the same
magnitude can be obtained. In the absence of evidence to the contrary, decision
makers should not implement programs to reduce inappropriate admissions without
considering their effects on both costs and health benefits.
15
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Legends
Figure i Inclusion of patients and assessment of appropriateness in the Tromsø
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